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SUMMARY 
 
The maintenance of the naïve CD4 T-cell pool is critical for immune competence and is 
ensured by continuous thymic output. Moreover, the naïve population of FoxP3-
expressing regulatory T-cells (naïve-Tregs) is essential to control immune responses, 
given their enrichment in thymus-committed autoreactive suppressor cells.  
 
We investigated the ability of peripheral homeostatic mechanisms to counteract 
thymus impairment. For this purpose, adults thymectomized early in infancy, during 
corrective cardiac surgery, were grouped based on presence/absence of thymopoiesis 
and compared with age-matched controls. We focused on the role of IL-7, which is 
known to induce naïve cell survival, and to distinctively target the peripheral naïve 
subset expressing CD31 to induce low-level proliferation. 
 
We found that the homeostasis of the CD31 naïve compartment was independent of 
the thymus and that its size is tightly preserved by peripheral mechanisms, including 
extended cell survival. Conversely, a significant contraction of the CD31+ subset was 
observed in the absence of thymic activity, in association with impairment of in vitro 
PI3K-dependent responses of purified naïve CD4 T-cells to IL-7, namely proliferation 
and up-regulation of CD31 expression.  
 
Notably, naïve-Tregs were remarkably well preserved irrespective of thymectomy. 
Additionally, we provided ex vivo evidence of ongoing IL-7 responses and, our in vitro 
data supported that naïve-Tregs are able to up-regulate Bcl-2 and to proliferate in a 
PI3K-dependent manner in response to IL-7, whilst preserving their naïve phenotype 
and suppressive capacity. Complete thymectomized adults featured no clinical 
autoimmunity or increased prevalence of allergy/IgE-sensitizations, although higher 
levels of IgG against a cluster of antigens linked to autoimmune diseases were found 
using a large array.  
 
Our data show for the first time that IL-7 contributes to naïve-Treg homeostasis and to 
thymus-independent survival of functional naïve-Tregs. Moreover, our results 
 xii 
revealed the requirement of effective thymopoiesis for IL-7-mediated immune 
reconstitution of conventional naïve CD4 T-cells. 
 
Key words  
Naïve CD4 T-cells; Regulatory T-cells; IL-7; Thymus; Thymectomy.  
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SUMÁRIO 
 
Homeostasia das células T CD4 naïve em adultos timectomizados na infância. 
 
A manutenção do compartimento de células T CD4 naïve é importante para garantir a 
imunocompetência. Uma subpopulação destas células expressa FoxP3 (naïve-Tregs) e 
tem um papel fundamental na regulação de respostas imunes e supressão de 
autoreactividade.  
 
Neste trabalho questionámos a capacidade de mecanismos homeostáticos periféricos 
compensarem a diminuição da actividade tímica, e consequente perda de produção de 
células T naïve. Adultos timectomizados na infância durante cirurgia cardíaca 
correctiva foram agrupados de acordo com presença/ausência de timopoiese e 
comparados com controlos emparelhados por idade. Investigámos particularmente o 
papel da IL-7 no aumento da sobrevivência celular e indução de proliferação de células 
naïve que expressam CD31. 
 
Documentámos manutenção da subpopulação CD31 independentemente do timo, 
sendo a dimensão deste compartimento controlada por mecanismos periféricos, 
incluindo aumento da sobrevivência celular.  
 
Em contraste, observou-se contracção significativa da subpopulação CD31+ nos 
timectomizados sem evidência de timopoiese, associada a perda das respostas à IL-7 
em cultura de células T CD4 naïve purificadas, afectando a sua proliferação e aumento 
da expressão de CD31, efeitos dependentes da via PI3K.  
 
No entanto, mesmo na ausência de timopoiese, as células naïve-Treg estavam 
preservadas, com evidência ex vivo de resposta à IL-7 e aumento, em cultura na 
presença de IL-7, de marcadores de sobrevivência celular e da proliferação dependente 
da via PI3K, mantendo fenótipo naïve e supressor. É de notar que adultos submetidos 
a timectomia completa não evidenciaram aumento da prevalência de autoimunidade 
ou alergia/sensibilizações IgE-mediadas, embora se documentasse maior 
autoreactividade IgG contra um grupo de antigénios ligados a doenças autoimunes. 
 xiv 
 
Em conclusão, demonstrámos pela primeira vez que a IL-7 contribui para a 
manutenção das células naïve-Treg independentemente do timo. Revelámos ainda que 
a reconstitutição do compartimento CD4 naïve mediada pela IL-7 depende da 
manutenção de timopoiese, com implicações para o uso clínico desta via na promoção 
da reconstituição imunológica. 
 
Palavras Chave: 
Células T CD4 naïve; Células T reguladoras; IL-7; Timo; Timectomia.   
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RESUMO EXTENSO 
 
O timo é um orgão linfóide primário, essencial para o desenvolvimento das células T. 
As células T CD4 são exportadas para a periferia com fenótipo naïve, mantendo-se este 
processo activo até pelo menos à sexta década de vida, conforme demonstrado pela 
quantificação nos linfócitos circulantes do ADN epissomal resultante dos rearranjos de 
genes do receptor das células T (TRECs).  
 
A homeostasia do compartimento T CD4 naïve resulta de um equilíbrio dinâmico entre 
o output tímico e mecanismos na periferia que visam contrariar o declínio progressivo 
da actividade tímica associado à idade e à morte ou diferenciação das células naïve em 
células de memória/effectoras. O objectivo é manter um número relativamente estável 
de células T CD4 naïve e preservar a diversidade do seu reportório ao longo da vida. 
Esta enorme diversidade resulta de um complexo processo de rearranjo genético intra-
tímico do receptor das células T (TCR), permitindo manter capacidade de resposta a 
novos antigénios e tolerância ao próprio, ao longo da vida. 
 
O principal objectivo deste trabalho foi estudar o impacto da perda de actividade tímica 
na homeostasia das células naïve e a eventual adaptação dos mecanismos 
homeostáticos da periferia. Indivíduos submetidos a timectomia na infância têm sido 
usados como modelo para responder a esta questão. No entanto, os resultados 
descritos são muito heterogéneos relativamente ao impacto da timectomia no 
compartimento naïve no adulto, o que se deve em parte à não avaliação da actividade 
tímica residual, que pode ser devida a tecido tímico ectópico e/ou regeneração tímica. 
Neste trabalho, avaliámos um coorte de adultos submetidos a timectomia na primeira 
infância, em contexto de cirurgia cardíaca correctiva, usando uma metodologia 
inovadora para estimar de forma mais precisa o contributo do output tímico para a 
manutenção do compartimento naïve. Os doentes foram estratificados de acordo com 
a ausência (Thy: n=8) ou presença (Thy: n=14) de timopoiese, com base nos 
respectivos relatórios cirúrgicos e no output tímico, estimado pela quantificação de 
sjTREC/ml. Foi feito um estudo transversal destes indivíduos, com mediana de 21 anos 
post-timectomia, em comparação com controlos (n=20), com distribuição semelhante 
por idade e sexo. 
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Observámos que nos indivíduos timectomizados com persistência de actividade tímica 
(Thy), o compartimento CD4 naïve estava mantido (frequência de células CD4 naïve no 
total de CD4 e número absoluto), e apresentava diversidade de TCR semelhante aos 
controlos. A análise do ratio sj/β TREC, que permite estimar a proliferação intra-tímica, 
revelou nestes indivíduos valores semelhantes aos controlos, sugerindo uma 
regeneração tímica post-timectomia. Estes dados reforçam a vantagem de priveligiar 
uma atitute conservadora, sempre que possível, em cirurgias correctivas cardíacas, 
evitando a timectomia total, em particular após o primeiro ano de vida. 
 
Em contraste, os indivíduos timectomizados sem evidência de timopoiese (Thy) 
apresentavam uma contração marcada do compartimento CD4 naïve. Nestes 
indivíduos, a análise da expressão de um conjunto de genes relacionados com a 
regulação da quiescência/proliferação nas células T CD4 naïve, revelou um aumento da 
expressão de DUSP-6, que codifica uma fosfatase que aumenta o limiar de activação do 
TCR. No entanto, a resposta in vitro das células T CD4 naïve purificadas à estimulação 
por via do TCR e a sua consequente diferenciação em células de memória não revelou 
alterações, sendo assim pouco plausível que esta seja uma via preferencial de 
preservação do compartimento CD4 naïve na ausência de timopoiese. 
 
O compartimento CD4 naïve contém dois subsets definidos pela expressão/ausência de 
CD31, tendo sido demonstrado pelo nosso grupo que a IL-7 induz proliferação 
preferencial das células CD31+, onde se incluem as células recentemente emigradas do 
timo (RTE). 
 
Em ambos os coortes de indivíduos submetidos a timectomia, o subset CD31 estava 
mantido, independentemente do seu grau de timopoiese. Esta manutenção associava-
se ao aumento da proliferação das células CD4 naïve CD31 e da sua sobrevivência, 
estimada pela expressão de Bcl-2. Estes resultados sugerem que a homeostasia do 
subset CD31, é controlada de forma rigorosa por mecanismos da periferia, 
provavelmente, como previamente sugerido, por interações de baixa afinidade com 
péptidos do próprio apresentados no contexto de HLA. Os nossos dados são ainda 
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suportados por estudos anteriores que mostraram a manutenção do subset CD31 
durante o envelhecimento, independentemente do declínio do output tímico. 
 
No que respeita ao subset CD31+, observámos a sua diminuição apenas nos 
timectomizados sem timopoiese activa. Esta diminuição verificou-se apesar das 
respostas homeostáticas, documentadas ex vivo, com aumento da proliferação e da 
expressão de Bcl-2. Subsequentemente questionámos se estas respostas eram 
mediadas por IL-7. Para este efeito, estudámos as respostas in vitro de células CD4 
naïve purificadas de indivíduos timectomizados e saudáveis em cultura com IL-7 e IL-
2 (controlo). 
  
A IL-7 induz proliferação selectiva das células CD31+ e mantém a expressão deste 
marcador, pela via de sinalização PI3K. Em paralelo, a sinalização pela IL-7 também 
promove o aumento da sobrevivência celular, induzindo o aumento da expressão de 
Bcl-2 por mecanismos independentes do PI3K. Em cultura com IL-7, o aumento da 
expressão de Bcl-2, estava preservado nos compartimentos CD31+/CD31 de 
indivíduos timectomizados e saudáveis. No entanto, os indivíduos sem timopoiese não 
apresentaram aumentos significativos da proliferação das células CD4 naïve ou da 
intensidade de expressão de CD31. Com base nestes achados, concluimos que as 
respostas das células CD4 naïve à IL-7, mediadas pela sinalização pela via PI3K, estão 
dependentes da manutenção de actividade tímica.  
 
No timo tem origem uma linhagem de células T com função reguladora (Treg) e 
caracterizadas pela expressão de FoxP3, que são exportadas com fenótipo naïve (naïve-
Tregs). Este subset mantém um reportório diversificado no sangue periférico e é 
considerado fundamental para a prevenção de autoimunidade, alergia e contenção das 
respostas imunes. O conhecimento sobre a homeostasia das naïve-Treg é escasso. 
Assim, questionámos o impacto do declínio da timopoiese na manutenção do subset 
naïve-Treg. Observámos que os indivíduos sem timopoiese, mantinham as células 
naïve-Treg, apesar da contracção do subset naïve sem expressão de FoxP3 (naïve-
Tconv). As células naïve-Treg apresentavam uma frequência de células a proliferar ex 
vivo superior à das naïve-Tconv, quer em timectomizados quer em saudáveis, 
contrariando a quiescência atribuída na literatura a esta população e levando-nos a 
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investigar os mecanismos envolvidos. Dada a elevada expressão do receptor para a IL-
2 (CD25) e baixa expressão do receptor para a IL-7 (CD127) nas naïve-Treg não se 
antecipava um papel importante para a IL-7 na sua homeostasia. No entanto, reunimos 
evidência ex vivo do papel da IL-7 nomeadamente: 1) aumento de pSTAT5 ex vivo, 
indicador de sinalização pela IL-7, nas naïve-Treg em comparação com as naïve-Tconv 
e populações de memória; 2) recuperação da expressão de CD127 nas naïve-Treg após 
cultura de células CD4 naïve em privação de IL-7. Adicionalmente, verificámos que as 
células naïve-Treg proliferavam em cultura com IL-7, mantendo o fenótipo naïve e 
função reguladora. Em comparação com culturas com IL-2, a IL-7 induzia níveis mais 
elevados de expressão de Bcl-2 e frequências superiores de células a proliferar. O 
aumento na proliferação em resposta à IL-7 foi inclusivamente superior nas naïve-Treg, 
quando comparadas com as naïve -Tconv, sendo igualmente abolido pela inibição 
específica da via PI3K/mTor.  
 
Os dados reunidos suportam assim, pela primeira vez, o papel da IL-7 na manutenção 
das células naïve-Treg em indivíduos saudáveis. 
 
Os estudos anteriores não têm sido conclusivos no que respeita ao eventual aumento 
de frequência de manifestações clínicas de alergia e/ou autoimunidade após 
timectomia na infância. Tendo acesso a um grupo de indivíduos com idade homogénia 
e rigorosamente estratificados por grau de timopoiese, questionámos se a preservação 
do compartimento naïve-Treg poderia contribuir para evitar o aumento da incidência 
de doenças autoimunes e/ou alérgicas. A avaliação clínica de ambos os coortes de 
timectomizados (Thy e Thy) não revelou aumento da prevalência de doença alérgica 
ou autoimune. Quantificámos ainda, em indivíduos sem timopoiese (n=7), a expressão 
de anticorpos específicos para um painel alargado de 128 autoantigénios. Apesar de 
não encontrarmos diferenças na autoreactividade IgG, IgM, IgA, ou IgE que 
permitissem a diferenciação entre coortes; identificámos um conjunto de antigénios 
para os quais os indivíduos timectomizados tinham autoreactividade IgG 
significativamente aumentada, alguns destes antigénios com correlações clínicas 
descritas em doenças autoimunes. Em paralelo, a avaliação de IgEs específicas para 112 
componentes de aeroalergénios e alergénios alimentares comuns não apresentou 
tendência para aumento de sensibilização IgE-mediada nos indíviduos sem timopoiese.  
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Em resumo, os nossos resultados sugerem que, 21 anos post-timectomia, apesar da 
contração do compartimento CD4 naïve, a preservação de mecanismos de tolerância na 
periferia e, em particular, a manutenção do compartimento naïve-Treg, poderá limitar 
a evolução para manifestações clínicas de autoimunidade e alergia. Por outro lado, a 
longo prazo, a diminuição da proliferação induzida pela IL-7 em células naïve-Tconv 
nos indivíduos sem timopoiese poderá contribuir para a redução da diversidade do 
reportório e eventual aumento do risco infeccioso, bem como da emergência de clones 
autoreactivos.  
 
Um número crescente de crianças, têm sido submetidas a cirurgia cardíaca correctiva 
nos últimos 30 a 40 anos, traduzindo-se numa diminuição significativa da morbilidade 
associada a malformações cardíacas e no aumento da esperança de vida. O seguimento 
futuro destes indivíduos será particularmente informativo relativamente ao risco de 
autoimunidade/alergia e capacidade de resposta a novos antigénios/infecções. 
 
Os resultados deste trabalho têm implicações para a homeostasia do compartimento 
CD4 naïve em saudáveis, em particular ao longo do processo de envelhecimento. 
Revelámos que a manutenção da proliferação homeostática das células T CD4 naïve em 
resposta à IL-7 depende da manutenção da actividade tímica e que esta citocina 
desempenha um papel importante na preservação do compartimento naïve-Treg. Estes 
achados têm potenciais implicações para o desenho e avaliação de terapêuticas 
dirigidas para o eixo IL-7/IL-7R, particularmente em contextos de autoimunidade, 
linfopénia e na reconstituição imunológica após transplante de células estaminais ou 
depleção linfocitária por doença oncológica ou autoimune. Terapêuticas dirigidas à 
preservação/regeneração tímica deverão ser ponderadas neste contexto. 
 
Palavras Chave: 
Células T CD4 naïve; Células T reguladoras; IL-7; Timo; Timectomia.   
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1.1 Homeostasis of naïve CD4 T-cells 
The immune system has evolved to protect the host from pathogenic microbes, that are 
themselves constantly evolving, and to help in the elimination of toxic or allergenic 
agents that contact with body surfaces. Therefore, the ability to discriminate self from 
non-self is obviously critical to ensure efficacy and safety of immune responses. 
An efficient immune system relies on both innate and adaptive responses to overcome 
foreign assaults, with T and B-cells being the main players of the later [1]. T-cells are 
defined by the expression of T-cell receptor (TCR) on their surface, a transmembrane 
heterodimeric protein that binds processed antigens displayed by antigen presenting 
cells (APCs). TCRs are generated upon somatic rearrangement of few hundred 
germline gene elements in the thymus, allowing the formation of millions of different 
antigen receptors, each one with a potentially unique specificity for a different antigen 
[2, 3].  
During their maturation in the thymus, T-cells differentiate into discrete 
subpopulations, each with defined repertoires of effector functions [4-6]. The major 
subsets of T-cells are defined by their selective surface expression of CD4 or CD8. In 
the blood and secondary lymphoid organs, 60-70% of T-cells are CD4+CD8− that 
constitute the cornerstone of adaptive immune response, and are generally designated 
“helper cells” [4, 6, 7].  
Newly generated T-cells continuously replenish the naïve CD4 T-cell compartment [8]. 
This thus represents the long-life reservoir of antigen inexperienced CD4+ T-cells, that 
differentiate into functionally distinct subsets of memory-effector cells upon exposure 
to antigens in the periphery [9-11]. Memory-effector cells acquire specialized 
function/phenotype, depending on the nature of the cytokines present at the site of 
activation [6, 7, 12, 13].  
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1.1.1. Thymus and T-cell development 
 
The thymus is the central organ for T-cell development, which occurs via a multistep 
pathway tightly controlled by the complex thymic environment [5]. Originally 
described by Claudius Galen of Pergamum (130-200 AD), the lymphopoietic function 
of the thymus was only recognized in the XX century [14], although it was still 
considered an evolutionary redundant “lymphocyte graveyard”. In the early 1960’s, 
Jacques Miller’s work on the role of the thymus in mouse lymphocytic leukaemia and 
the impact of neonatal thymectomy in tolerance [15-17] led the way for the recognition 
of the thymus as a non-redundant specialized organ of the immune system, with a 
unique function in the establishment and maintenance of the T-cell pool. 
 
The thymus is found in all vertebrates [18, 19]. Its development in humans closely 
follows that observed in the murine model and in most land mammalian animals [19]. 
In the mouse, the thymic rudiment is first evident on day 11 of gestation, having 
evolved from the endoderm of the third pharyngeal pouch [20]. The human thymus is 
thought to develop from either the third pharyngeal pouch or from both the third and 
fourth pharyngeal pouches [21]. The thymic primordium is colonized by T-cell 
progenitors during the 8th week of gestation, and mature T-cells are observed by the 
12th to 13th week [21-23], already featuring a diverse T-cell repertoire [22]. 
Remarkably, as a primary site for T-cell lymphopoiesis, the thymus is active, not only 
during the foetal stages of development, but also throughout post-natal life with 
variable degrees across age (as reviewed in 1.1.3.1). 
 
The thymus architecture is essentially conserved across species. It consists of distinct 
anatomical compartments which include the subcapsular area, the cortex, the cortico-
medullary junction and an inner medulla [24, 25]. Thymic stroma is very important, as 
it provides the specialized microenvironment that actively supports T-cell 
development, guiding thymocytes across the different anatomical compartments [25]. 
Thymic epithelial cells (TECs) constitute the major component of the stromal 
population, and can be divided into cortical (cTEC) and medullary (mTEC) epithelial 
cells, with different functional, morphological, and antigen presentation capacities [25, 
26]. Thymic stroma also comprises other cell types, including populations of 
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haematopoietic origin, namely dendritic cells (DC), macrophages and B-cells, and other 
populations, like fibroblasts and endothelial cells [27, 28].  
A combination of factors controls thymocytes proliferation, survival and 
differentiation, including stromal cell-derived signals (namely interleukin-7 (IL-7), 
stem cell factor (SCF)) secreted by TEC, Wnt molecules, Hedgehog (an essential 
positive regulator of T-cell progenitor differentiation), and Notch1, amongst others 
[27, 29-31].  
Bone-marrow derived lymphoid progenitor cells, expressing CD34, migrate to the 
thymus to undergo T-cell development [5], as illustrated in the diagram of Figure 1. 
These precursor cells enter the human thymus at the cortico-medullary junction [5, 27] 
and migrate towards the cortical region where proliferation and differentiation are 
initiated, via interactions with the thymic stroma [5].  
Figure 1 Schematic overview of the different developmental stages that characterize human T-cell 
development. HSC: hematopoietic stem cell,  T-S: T-lineage specified progenitor,  T-C: T-cell committed 
progenitor,  ISP4: CD4 immature single positive,  β: rearranged T-cell receptor-β chain,  DP: double 
positive,  αβ  T-cell receptor: αβ positive cell,  NKT: natural killer T-cell,  Treg: regulatory T-cell,  CD8 SP: 
CD8 single positive,  CD4 SP: CD4 single positive,  γδT-cell:  receptor-γδ positive cell. Adapted from [32]. 
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The expression of the CD1a molecule in progenitor cells is strongly associated with the 
commitment to the T-cell lineage, at which stage cells begin to undergo rearrangement 
of their TCR ,  and  loci [33].  Undifferentiated CD34+CD1a+ thymocytes do not 
express either CD4 or CD8 and thus are named double negative (DN). In the cortex 
CD34+CD1a+ thymocytes lose CD34 expression and start to express CD4, thus becoming 
immature CD4 single positive (CD4ISP) cells, that can either become αβ T-cells or γδ T-
cells. The CD4ISP stage is followed by an early double-positive (EDP) stage, in which 
cells express CD4 and the  chain of CD8 [34], followed by double-positive (DP) cells, 
that co-express CD4 and the  and  chains of CD8. During the DP stage the levels of 
CD3 progressively increase and the cells acquire a functional TCR allowing positive and 
negative selection. Following this DP stage, cells differentiate into CD4+ or CD8+ SP T-
cells, mature and exit the thymus [5, 24, 35, 36]  
 
The TCR expressed by the majority of T-cells is a heterodimer composed of α and β 
chains. TCR diversity is generated by random rearrangement of multiple germline 
encoded variable (42 Vα and 47 Vβ segments), diversity (2 Dβ segments), and joining 
(61 Jα and 13 Jβ segments) gene segments, non-germline-encoded N region insertions, 
and α and β chain pairing [37, 38]. D-to-J recombination occurs first in the  chain of 
the TCR [5], followed by V-to-DJ rearrangements leading to the formation of the 
TCR C chain. -selection is the process by which precursor T-cells, with a productive 
rearrangement of the TCR locus, are then selected to undergo further differentiation, 
in the form of TCR rearrangements [32]. Thymocytes harbouring a rearranged TCR 
locus generate a TCR molecule that pairs covalently with the invariant pre-TCR 
(pT), and non-covalently with CD3 signal-transducing molecules, resulting in 
formation of a pre-TCR complex at the cell surface [32]. DP thymocytes proliferate 
extensively and rearrange their TCRα [5, 34]. The subsequent assembly of the  and  
chains results in formation of the -TCR that is expressed on the majority of T-cells.  
 
Developing T-cells undergo a filtering process in the thymus that establishes a 
particular T-cell repertoire for each individual. The TCR diversity that can be generated 
within the thymocytes pool has been estimated to be as large as 1018 /-chain 
combinations [3, 38]. Life or death decisions leading to their selection are mainly 
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dictated by the strength of TCR signalling, upon interaction with peptide/major 
histocompatibility complexes (MHC) complexes, as schematically illustrated in Figure 
2, ultimately resulting in the generation of CD4 or CD8 SP cells, based on MHC-II or 
MHC-I restriction, respectively [2, 3, 5, 39]. These interactions are currently thought to 
important for the peripheral homeostasis of the naïve compartment, by providing tonic 
signals that promote cell survival and low-level homeostatic proliferation [3].   
Figure 2. The affinity model of thymocyte selection. 
According to this model, the affinity of the TCR-peptide/MHC interaction is 
the key determinant of T-cell selection. Thymocytes with intermediate 
affinity for self-peptide/MHC complexes receive a survival signal, undergo 
positive selection, CD4 or CD8 T-cell lineage commitment and maturation to 
become part of the T-cell pool. Adapted from [40] 
Immature CD4+CD8+ DP  T-cells are selected by intermediate/high-affinity 
interaction of the TCR heterodimer with self-peptides complexed with MHC 
antigens expressed on cTECs, a stringent process termed positive selection [3, 39]. 
Positively selected DP thymocytes differentiate into either CD4+ or CD8+ SP T-cells 
depending on their MHC-II or MHC-I restriction, respectively. Most DP cells (around 
98%) cannot recognise any antigen in the context of either MHC-I or MHC-II molecules 
and these cells die rapidly in situ from “neglect” (lack of a TCR signal) [39]. 
Cells that survive positive selection then move to the thymic medulla, where 
thymocytes expressing high-affinity for self-peptide/MHC complexes expressed on 
thymic DCs are deleted and die through apoptosis, a process known as negative 
selection [5]. Hassall's bodies, structures observed in the thymic medulla, are likely the 
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“graveyards” for dead thymocytes [27]. Finally, CD4SP and CD8SP thymocytes with a 
stringently selected TCR repertoire and expressing the naïve-associated marker 
CD45RA exit the thymus and migrate to the periphery, incorporating the naïve T-cell 
pool [5, 27].  
 
A distinct lineage of suppressive CD4+ T-cells, defined by FoxP3 expression is also 
committed in the thymus. These thymus-derived Tregs are thought to be enriched in 
self-reactive TCRs and to be critical for the maintenance of self-tolerance [41]. 
Cumulative evidence supports the existence of different pathways of Treg commitment 
in the human thymus that may occur at different stages of thymocytes differentiation, 
as illustrated in Figure 3 [42]. In parallel with the proposed role of TCR signalling 
strength in human Treg commitment, it has become increasingly clear that common 
gamma chain (γC) cytokines, particularly IL-2 and IL-15, are important mediators of 
lineage stabilization [42].  
 
 
Figure 3. Schematic representation of human Treg development in the thymus. 
DP: double-positive (CD4+CD8+), CD4SP: CD4 single-positive (CD4+CD8), CD8SP: CD8 single-positive 
(CD8+CD4), cTEC: cortical thymic epithelial cell, mTEC: medullary TEC, Mac: macrophage, FOXP3: 
Forkhead box P3, TSLP: thymic stromal lymphopoietin. Adapted from [42] 
 
A variety of T-cell receptor excision circles (TRECs) are formed from the excised DNA 
generated by the rearrangements of the TCR,  and  loci described above [43-48]. As 
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the TCR gene segments are embedded within the TCR locus, the V-to-J 
rearrangements lead to deletion of the  locus from the chromosome [5, 49]. The end-
to-end ligation of the recombination signal sequences flanking the -rec locus and the 
-J locus generates a single TREC containing a signal joint (sj) sequence (sjTREC), as 
illustrated in Figure 4. Coding-joint (cj)TRECs are then produced during the TCR 
rearrangement of V to J gene segments.  
Figure 4 Generation of signal-joint (sj) and coding-
joint cjTRECs. Adapted from [43]. 
TREC levels have been used to assess thymic function, through their quantification in 
peripheral blood using real time PCR technology [50]. This PCR-based assay performed 
in circulating lymphocytes is also currently used in the neonatal screening of major T-
cell defects [51]. The quantification of sjTREC as a measure of thymic output was first 
utilized by Douek et al [43]. As expected, given the gradual loss of thymic function 
during aging, they showed a decreasing number of sjTRECs with age in healthy 
individuals [43].  
However, it is important to note that the measurement of sjTREC concentration as an 
estimate of thymic function requires careful consideration. TRECs are not duplicated 
during mitosis, and are therefore diluted out with each cellular division [45, 52]. 
Because sjTRECs are not replicated during cell division, their levels can also be 
influenced by other events occurring in the periphery, such as cell proliferation and 
differentiation, redistribution, or alterations in cell survival [53]. All of these can lead 
to a dilution of TREC-bearing cells in the periphery. Of note, it has been reported that 
quantification of TRECs/μl is less influenced by proliferation in the periphery than 
quantification of TRECs in a given subpopulation [50, 54]. 
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The level of thymic output has been shown to be primarily determined by the intra-
thymic proliferation of precursor T-cells [55]. A new assay was developed to estimate 
the relative changes in intra-thymic proliferation occurring between the TN and early 
DP stages [56], as represented in Figure 5. This assay quantified sjTRECs, generated at 
the DP stage, and DJTREC created during the DJ rearrangement and organization 
of the TCR locus at the TN stage. The proliferation occurring between these stages can 
thus be estimated by the ratio of sjTREC to TREC (sj/TREC ratio). This marker is not 
influenced by peripheral T-cell homeostasis, given that both types of TREC are equally 
affected by the rates of proliferation and death of peripheral T-cells [50].   
 
 
 
Figure 5: Schematic representation of intra-thymic proliferation occurring between late TN and 
early DP thymocyte differentiation stages and its effects on TREC and sjTREC levels. 
TN: Triple Negative stage; DP: Double Positive stage; SP/RTE: Single Positive/ Recent Thymic Emigrant 
stage. Adapted from [56]. 
 
 
  
1 TREC / T-cell 
Proliferation → 
dilution of TREC 
sjTREC is generated 
after proliferation 
Dilution of sjTRECs and 
TRECs after proliferation 
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1.1.2. Naïve CD4 T-cells as key players in the immune system 
Naïve T-cells have been defined as mature T-cells that have not yet encountered their 
cognate antigen in the periphery. Prior to contact with antigen, CD4 naïve T-cells 
continuously recirculate between blood and secondary lymphoid tissues (SLO), mainly 
the spleen and lymph nodes [57, 58]. High endothelial venules (HEV) serve as the entry 
point into lymph nodes and Peyer's patches, and endothelial cells in these vessels 
express a unique set of ligands that are recognized by homing receptors expressed by 
naïve T-cells [59]. The expression of the chemokine receptor CCR7 and L-selectin 
(CD62L), that engage chemokine CCL21 and vascular addressins in endothelial cells 
respectively, enables this continuous migration, which is a key mechanism in providing 
antigenic surveillance [11, 57, 59].  
Within lymphoid tissues, antigens are presented to T-cells in the form of peptide 
fragments bound to MHC molecules expressed upon specialized APC, in particular DC. 
These cells are strategically positioned within a dense network in the T-cell zones. Once 
naïve cells encounter their cognate antigen/MHC complex, they undergo proliferation 
and differentiation towards a memory phenotype, with inherent migratory and 
functional properties (reviewed in [60]). Clonal selection, upon activation with foreign 
antigen, therefore leads to predictable loss of TCR diversity in the memory 
compartment [61] 
Isoforms of the transmembrane phosphatase CD45 were initially considered the 
crucial markers of naïve and memory T-cells, with naïve cells expressing the CD45RA 
isoform and memory cells expressing CD45RO [62-64]. Presently, distinction between 
naïve and memory subsets no longer relies solely on CD45 isoforms, as both antigen-
primed CD8+ [65, 66] and CD4+ [67-69] T-cells have since been reported to be able to 
re-express CD45RA in humans, in settings of terminal effector differentiation. 
Moreover, it has also been suggested that some thymocytes may egress the thymus 
before switching from CD45RO to CD45RA and only acquire the typical CD45RA+ naïve 
phenotype in the periphery [70]. Other markers associated with lymphocyte 
differentiation, such as co-stimulatory molecules (CD27, CD28) [65, 71] or chemokine 
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receptors (CCR7, CD62L) [71, 72] are currently used to distinguish naïve and memory 
T-cell subsets within the CD4 and CD8 T-cell pools.  
 
Naïve CD4 T-cells are usually seen as a homogeneous population regarding stage of 
maturation and cell differentiation, although their phenotypic and functional variety is 
increasingly recognized [73-77]. Age is an obvious determinant of naïve T-cell biology, 
impacting both on thymic activity and on SLO microenvironment where peripheral 
homeostatic mechanisms operate [78, 79]. The functional properties of naïve CD4 T-
cells change along infancy, with a clear trend to differentiation into a Th2 profile of 
cytokine production in early life [80, 81]. Additionally, thymic generated functional 
populations, that are hardly found beyond the first decade of life have been described 
with a yet unclear role in immunity, as illustrated by the IL-8 producing subset [74, 76]. 
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1.1.3. Mechanisms involved in the maintenance of the naïve CD4 T-
cell compartment throughout life 
The size of circulating naïve T-cell pool remains relatively constant throughout adult 
life, despite continuous environmental antigenic stimulation and the age-associated 
reduction in thymic output [43, 44]. 
It has been suggested that the naïve T-cell pool in mice is almost entirely maintained 
by thymic output [82]. In contrast, the maintenance of human naïve T-cell 
compartment is sustained by dynamic equilibrium between new T-cell generation in 
the thymus and mechanisms operating in the periphery, namely peripheral T-cell 
proliferation, extended survival and death or differentiation into the memory-effector 
compartment [8, 82], as illustrated in Figure 6. In agreement with studies using 
manipulated murine models, the cell-intrinsic properties in terms of turnover, survival 
and threshold for TCR activation are also modulated by a prolonged time-span in 
circulation [11, 83-86]. 
Figure 6. Homeostasis of the naïve CD4 T-cell compartment. 
We will briefly review the contribution of these different mechanisms to the 
homeostasis of the naïve CD4 T-cell compartment. 
Naïve CD4 T-cells
Differentiation into
Memory/Effector/Suppressor
CD4+ T-cell subsets
Thymus
Proliferation
Cell death/Survival
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1.1.3.1. Thymic output  
 
The thymus plays a central role in the generation and maintenance of naïve T-cells 
early in life [87]. Both thymic epithelial cell development defects, namely DiGeorge 
syndrome and FOXN1 deficiency, as well as defects of hematopoietic progenitors, have 
severe clinical impact, which illustrates the non-redundant thymic contribution for the 
establishment of the T-cell compartment [88, 89]. 
 
Despite this, the role of the thymus in T-cell homeostasis after the first years of life was 
neglected for many years, because of the acknowledged age-dependent thymic 
involution [78, 90, 91]. However, there is now clear data supporting life-long thymic 
activity [43, 92]. Particularly, the thymus is known to be active until at least the sixth 
decade of life [43]. Moreover, data from patients with different clinical conditions 
associated to T-cell depletion, such as human immunodeficiency virus (HIV) infection 
[44, 93], and chemotherapy/bone-marrow transplantation [94-99] have confirmed 
that the thymus is still capable of producing new T-cells in these settings, which might 
be relevant to the reconstitution of immune function.  
 
The rate of thymic involution has been differently estimated [100], and this 
heterogeneity of results is possibly influenced by the methods used, namely histology 
versus measurement of thymic output by TREC quantification [50]. This information 
may be complemented with imaging studies, although these are difficult to perform in 
adults and usually lack functional correlation [101]. Some authors consider that after 
a peak of thymic output, thymus involution starts at the age of 1 year and thymic output 
decreases at a rate of approximately 3% per year until young adulthood, and a rate of 
1% per year thereafter [100]. The speed of involution changes during mid-life and 
leads to a strongly reduced involution afterwards [100, 102]. Other authors consider 
that thymic output only begins to decrease in early adulthood and continues to further 
decline with aging [103].  
 
The assessment of the relative contribution of thymic output versus peripheral 
expansion to naïve T-cell homeostasis requires markers able to distinguish the so 
called Recent Thymic Emigrants (RTEs) from naïve T-cells that have undergone post-
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thymic proliferation. High expression of CD31 has been suggested to identify RTEs, but 
its use alone is not sufficient [43, 104, 105]. Work from our Laboratory has shown that 
CD31 expression may be maintained upon homeostatic proliferation in the periphery 
[106] and therefore although, the CD31+ naïve CD4 T-cell subset include the RTEs,
there is a large population of CD31+ naïve cells that are not RTEs [61, 104, 106]. Protein 
tyrosine kinase 7 (PTK7) was also described as a novel marker of human CD4 RTEs 
[75]. The authors showed that a fraction of the CD31+ naïve CD4 subset expresses PTK7 
and that the frequency of PTK7+ cells within the naïve subset decreases progressively 
with age [75], however not all RTEs are likely to express this marker [75, 107]. 
1.1.3.2. Cell-Proliferation – 2 main conductors:  IL-7 and low-
affinity self-peptide/MHC interactions 
Although thymic involution progressively limits the replenishment of the peripheral 
naïve T-cell pool by RTEs, the size of the naïve pool only slowly declines in aging 
humans [43, 104, 108, 109]. TREC numbers among CD4 T-cells decrease 50-100 times 
during aging [43, 44], while absolute numbers of naïve CD4 T-cells, as characterized by 
the expression of CD45RA, decrease only by a factor of 2 or 3 with age [108, 109]. 
Additionally, several in silico studies suggest that thymic output per se is insufficient to 
guarantee the size of the peripheral naïve T-cell compartment without a major 
contribution of cell proliferation in the periphery [82, 83, 87, 110-113]. Overall, these 
data support that peripheral post-thymic T-cell proliferation must contribute to the 
maintenance of the naïve T-cell pool, implying that naïve T-cells are able to proliferate 
in the periphery whilst retaining their phenotypic and functional properties [105, 114]. 
The naïve CD4 T-cell compartment has been shown to comprise two subsets with 
distinct proliferative histories in the periphery, that can be distinguished by the 
expression of the platelet endothelial cell adhesion molecule-1 (PECAM-1 or CD31) 
[73]. Of note, both CD31+ and CD31 naïve CD4 T-cells express surface markers of 
naivety, such as CD45RA, CD27 and CD62L, and may secrete IL-2, in the absence of 
significant effector cytokine production after polyclonal stimulation [73]. In addition, 
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both CD31+/CD31 naïve CD4 T-cells are able to differentiate into memory-effector 
cells upon encounter with antigen [73].   
 
The absolute numbers, as well as the frequency of CD31+ naïve CD4 T-cells in human 
peripheral blood decrease with aging, in parallel with the decline in their TREC content 
[61, 73, 104, 115]. Of note, whereas in cord blood 90-95% of CD45RA+ CD4 T-cells 
express CD31, the majority of the cells lack CD31 expression in the elderly [61]. In 
accordance with their phenotypic proximity to thymocytes, which also express CD31 
[116], the sjTREC content of CD31+ naïve CD4 T-cells is only slightly reduced compared 
with thymocytes, supporting that this subset contains RTEs.  
 
In contrast, the absolute numbers of CD31 naïve CD4 T-cells remain relatively 
constant throughout adult life despite thymic involution [61, 73, 104, 115]. The 
proportion of CD31 cells within the naïve CD4+ T-cell population increases with age, 
allowing the maintenance of naïve T-cell numbers in the elderly through peripheral 
expansion [61, 73, 108, 109, 115, 117]. The markedly reduced sjTREC content of CD31  
naïve CD4 T-cells strongly implies peripheral proliferation in the 
generation/maintenance of this subset [61].  
 
The homeostatic proliferation of naïve T-cells is dependent on TCR interaction with 
self-peptide/MHC complexes plus IL-7 signalling [61, 105, 118-124]. The peripheral 
expansion/survival in CD31+ compartment is thought to be mainly mediated by IL-7, 
whereas the CD31 subset is thought to mainly proliferate in response to TCR 
stimulation by low-affinity self-peptide/MHC [73, 105], as illustrated in Figure 7. 
 
IL-7, a C cytokine, is mainly produced by non-lymphoid cells within stromal cells in the 
bone-marrow and SLO, and epithelial cells in the thymus and gut [10, 125-128]. IL-7 
has been described as a non-redundant cytokine in the development of T-cells in mice 
and humans [129-132], as well as being essential for the survival and proliferation of 
naïve and memory T-cells in the periphery [114, 133-136].  
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Figure 7. Post-thymic proliferation of human naïve CD4 T-cells. 
IL-7 signalling appears to be tightly regulated by the expression of the α-chain of its 
receptor (IL-7Rα, CD127). The expression of IL-7Rα on lymphocytes varies according 
to the stage of development or activation [137]. IL-7 itself [138, 139], other γC cytokines 
[138, 140] and TCR stimulation [118, 139, 141] down-modulate IL-7Rα expression, 
which is up-regulated in the absence of its cognate cytokine [138, 139]. IL-7 induces 
several pro-survival pathways, particularly through the modulation of the expression 
of Bcl-2 family members [142-144], in addition to promoting cell proliferation, growth 
and metabolic activity [141, 145-149].  
IL-7 signal transduction involves different pathways, as illustrated in Figure 8. Ligation 
of IL-7 to IL-7Rα induces the hetero-dimerization of IL-7Rα with the γC [150], and 
consequent activation of the receptor-associated Janus kinases (JAK) -1 and -3 [151]. 
JAK1 and JAK3, respectively associated with the γC chain and IL-7Rα, phosphorylate 
each other and then IL-7Rα, creating docking sites for the signal transducers and 
activators of transcription (STAT) factors, such as STAT1, -3 and -5 [152-154]. STAT5, 
the most relevant STAT in IL-7-induced signalling, comprises two isoforms: STAT5a 
and STAT5b [155], that are phosphorylated by JAK1/3. The STAT5 signalling pathway 
promotes cell survival through the modulation of Bcl-2 family members, up-regulating 
the expression of anti-apoptotic proteins Bcl-2 and Bcl-xL and down-regulating the 
pro-apoptotic proteins Bax and Bad [156-158]. STAT5 signalling also leads to the 
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inhibition of protein kinase C θ (PKCθ), and subsequently to the down-modulation of 
the cyclin-dependent kinase inhibitor p27kip1, inducing cell cycle entry [159]. 
 
 
 
 
Figure 8.  IL-7 signal transduction 
pathways. The main IL-7R pathways — 
through JAK1/JAK3 and then STAT5 and 
STAT5b or through PI3K and AKT — 
and some of their key downstream 
targets involved in naïve T-cell 
homeostasis are depicted.  
Adapted from  Takada et al 2009 [9]  
 
 
 
The phosphoinositide 3-kinase (PI3K) pathway is central in IL-7 signal transduction, 
playing a key role in the regulation of cell survival, growth, metabolism and 
proliferation [160]. The major substrate of PI3K is Akt, a serine/threonine kinase 
[161]. Activation of PI3K by growth factors or cytokines induces the recruitment of Akt 
to the plasma membrane, where it becomes fully activated [162]. The substrates of Akt 
include several molecules that impact on cell survival and proliferation, such as pro- 
and anti-apoptotic Bcl-2 family members, caspases and forkhead transcription factors 
[163]. Akt inactivates the fork head transcription factor FOXO3a through 
phosphorylation, which leads to the down-regulation of the pro-apoptotic protein Bim 
[164]. The PI3K pathway is also required for the IL-7-induced increase of GLUT1 
expression, a key glucose transporter in T-cells, thus promoting glucose uptake and 
metabolic activity [146, 149].  
 
TREC content within CD31+ naïve CD4+ T-cells was reported to decrease slightly with 
age [104] and following IL-7 administration in humans [165]. Furthermore, the 
absolute numbers of CD31+ naïve CD4 T-cells in the elderly are higher than those 
estimated by the assessment of thymic output through the quantification of TREC 
levels [43]. Hence the CD31+ naïve CD4 T-cell subset appears to undergo post-thymic 
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proliferation, which is likely induced by a TCR-independent mechanism, driven by 
homeostatic cues, such as γC cytokines [105]. Results from our Laboratory showed, for 
the first time, that IL-7 plays a role in the maintenance of CD31+ naïve CD4 T-cells 
during adult life [106], preferentially driving the proliferation of the CD31+ naïve CD4 
T-cells, while sustaining their expression of CD31 [106].
Other authors have shown a preferential ability of RTEs to proliferate in response to 
IL-7 [75]. RTEs have been shown to proliferate in response to IL-7 in an antigen-
independent manner, more efficiently than naïve T-cells from adult peripheral blood 
[85, 166, 167], which is in agreement with the higher proliferation of naïve CD4 T-cells 
expressing PTK7 in response to IL-7 [75]. The ability of IL-7 to promote the 
homeostatic proliferation of RTEs has been proposed to allow the maintenance of the 
peripheral naïve CD4 T-cell pool whilst preserving a diverse TCR repertoire [166].  
CD31 is a trans-membrane glycoprotein from the immunoglobulin super-family which 
is expressed by a variety of cell types, including endothelial cells, platelets, monocytes, 
neutrophils and T-cells [168-170]. CD31 has been shown to be required for the trans-
endothelial migration of neutrophils and monocytes [171], hence it might play a role 
on the migration of CD31+ naïve T-cells into SLO [73], a proposed site for homeostatic 
proliferation of naïve T-cells [172]. Furthermore, CD31 engagement has been shown to 
inhibit TCR-mediated signal transduction via immune-receptor tyrosine-based 
inhibitory motifs (ITIMs), present in its cytoplasmic domain [169], raising the 
hypothesis that CD31 might hamper peripheral proliferation of CD31+ naïve CD4 T-
cells upon TCR triggering with self-peptide/MHC complexes [105]. 
As mentioned above, the term naïve CD4 T-cells derives from the assumption that these 
are antigen-inexperienced T-cells when they egress from the thymus until they are 
primed by foreign antigen and differentiate into memory/effector CD4 T-cells. During 
recent years, a substantial number of studies have highlighted the importance of 
continuous low-affinity contact with MHC-II peptides for naïve CD4 T-cells, promoting 
their survival and low-level homeostatic proliferation [121, 122, 173-179]. 
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According to experimental studies, the peptides presented by MHC-II in a non-
immunogenic fashion could be derived from self-antigens, related to those displayed 
in the thymus. In this scenario [174, 175, 178, 179], naïve CD4 T-cell proliferation could 
be regarded as a peripheral positive selection of CD4+ T-cells, in which their repertoire 
is shaped/restricted to those cells selected to undergo peripheral post-thymic 
proliferation, as illustrated in Figure 9. Of note, a role for exogenous antigens cannot 
be ruled out in these processes. 
 
Figure 9. Post-thymic proliferation 
of human naïve CD4 T-cells. RTEs 
emigrate from the thymus and are 
incorporated into the pool of CD31+ 
naïve CD4 T-cells, with high TREC 
content. Some CD31+ naïve CD4 T-
cells undergo peripheral postthymic 
selection; CD31 naïve CD4 T-cells are 
induced and maintain the size of the 
naïve CD4 T-cell pool. On cognate 
interaction with foreign antigens, both 
subsets can differentiate directly into 
memory/effector CD4 T-cells.  
Adapted from[105] 
 
 
The expression of CD31 in both cord blood and adult naïve CD4 T-cells has been shown 
to be down-regulated upon activation with anti-CD3+IL-2 [180]. However, this overt 
TCR activation also leads to the differentiation into a CD45RO+CD62L memory 
phenotype [180]. Thus, it has been proposed that the CD31 naïve CD4 T-cell subset 
could result from TCR triggering by low-affinity antigens, thus inducing the loss of 
CD31 without affecting the overall naïve phenotype [61, 73].  
 
Moreover, CD31 naïve CD4 T-cells have been shown to express higher levels of the 
anti-apoptotic BFL1/A1 than their CD31+ counterparts [61]. This marker is specifically 
induced by TCR, but not cytokines like IL-4, IL-7 and IL-15 stimulation, pointing to an 
involvement of TCR signalling in the generation and/or maintenance of the CD31 
naïve CD4 subset. These data have raised the possibility that the non-immunogenic 
signals triggered by self-peptide/MHC complexes, might play a role in the generation 
and/or maintenance of the CD31 naïve CD4 T-cell subset [121, 122, 173, 175-178]. As 
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a result, the proliferation of CD31 naïve CD4 T-cell subset is thought to cause a 
contraction of the naïve TCR repertoire [61, 181, 182]. 
1.1.3.3. Cell survival / death 
The maintenance of the naïve T-cell pool is also thought to depend upon survival 
signals, such as those provided through TCR engagement of self-peptide/MHC 
complexes and by IL-7 [85, 114, 119, 183, 184]. Naïve T-cells moving along HEV’s 
encounter IL-7, self-peptide/MHC complexes and CCR7 ligands, all of which cooperate 
to produce homeostatic survival signals [185].  
As mentioned above, the binding of IL-7 to its receptor induces several signalling 
cascades (Figure 8), such as the JAK–STAT and the PI3K pathways, that promote 
lymphocyte survival [10, 186] through the up-regulation of the anti-apoptotic molecule 
Bcl-2 [187].   
The relevance of cell survival pathways is further supported by the progressive loss of 
naïve CD4 T-cells in association with defective Bcl-2 expression in patients with MST1 
deficiency [188]. An increase in the peripheral survival of naïve CD4 T-cells in the 
elderly has been predicted by in silico models, in agreement with experimental data in 
mice [189]. 
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1.1.3.4. Cell differentiation into the memory compartment  
 
The dynamics of the naïve T-cell compartment is also constrained by pressure to 
memory-effector differentiation [8]. It has been suggested that naïve CD4 T-cells may 
adjust their threshold for TCR activation with the length of time in circulation since 
thymus export [11, 83, 190] and with the aging of the individual [190-192]. T-cell 
activation is triggered by a series of steps (Figure 10): an initial interaction between a 
TCR and its cognate peptide/MHC complex presented by a DC (signal 1), followed by 
co-stimulatory signals delivered by the DC, such as those provided through CD28 
(signal 2).  
 
When they encounter their antigen in SLOs, activated CD4 T-cells proliferate rapidly 
and differentiate into memory-effector T helper subsets namely Th1, Th2, Th17, Th9, 
T follicular helper (TFH) cells, depending on the pathogen encountered and initiating 
stimulation signal. Each cell type is distinct in terms of the type of immune response 
provided and cytokine produced [12, 13]. Some conventional naïve CD4 T-cells may 
also up-regulate FoxP3 and differentiate into induced-regulatory T-cells (Tregs) in the 
periphery [77]. 
 
 
Figure 10.  CD4 T-cell recognition of antigen and activation. 
Adapted from Lewis 2011 et al [107] 
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Upon antigen clearance, the expansion of the T-cell population is followed by a 
contraction phase during which most cells perish through apoptosis, although a 
proportion of the expanded population is preserved to ensure long-term protection 
against subsequent antigenic challenge.  Around 5-10% of both CD4 and CD8 T-cells 
persist as memory T-cells which can be broadly subdivided into: central-memory (CM) 
CD4 or CD8 T-cells that express CCR7 and CD45RO and are mainly present in secondary 
lymphoid tissues; and effector-memory (EM) CD4 or CD8 T-cells that also express 
CD45RO but not CCR7 [6, 12].  
Memory T-cells constitute a highly heterogeneous population, differing not only in cell 
surface phenotype, but also in functional ability and history of antigen encounter [4, 6, 
193]. Memory T-cells provide more rapid and effective immunity against previously 
encountered antigens, as they can be activated by lower doses of antigen, and 
accumulate as well as perform effector functions quicker than their naïve counterparts 
upon antigen re-exposure [194-196]. Furthermore, the distinct migratory capacity of 
memory T-cells allows them to enter non-lymphoid tissues, potentially detecting and 
responding to infection earlier on [4, 6, 197]. 
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1.1.4. The uniqueness of FoxP3+ regulatory T-cells within the naïve 
compartment  
 
The human naïve CD4 T-cell compartment comprises a population of thymus-
generated naïve-like cells expressing FoxP3 (naïve-Tregs) that continuously replenish 
the pool of fully-suppressive activated Tregs expressing memory markers [42, 77, 198-
202].  
 
Tregs maintain tolerance to self and to the environment, and are central players in the 
control of immune responses [41, 77]. Expression of the transcription factor FoxP3, 
considered a master regulator of Treg development and function, is essential for their 
role in the maintenance of dominant tolerance [41]. 
 
Both naïve and activated Tregs possess a fully functional FOXP3 gene, hardly secrete 
cytokines and potently suppress proliferation [77]. Naïve-Tregs have been considered 
resting/quiescent population in steady-state conditions in non-lymphopenic 
individuals, in opposition to the activated memory-Tregs [77]. In addition to thymus-
derived Tregs, the peripheral Treg compartment includes a peripheral population 
converted from conventional CD25FoxP3 CD4 T-cell precursors, particularly in the 
gut mucosa and inflammatory tissue sites, likely via a transforming growth factor beta 
(TGF-)-dependent mechanism (peripheral or induced Tregs).  
 
Despite extensive research on Treg development using murine models in the past 20 
years, many questions remain unanswered regarding the mechanisms involved in the 
commitment to the Treg lineage in the thymus [42, 201, 203]. The mechanisms 
governing naïve-Treg homeostasis, in parallel with age-associated thymic involution, 
also remain largely unknown [202]. The investigation of naïve-Treg homeostasis has 
been hampered by the difficulty in clearly identifying this subset in murine models 
[204]. 
 
A distinct homeostasis of the naïve-Treg and conventional naïve (naïve-Tconv) CD4 T-
cell compartments have been suggested by a longitudinal study that showed naïve-
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Treg preservation up to 1 year post-thymectomy [205], although long-term data are 
lacking.  
In the thymus, increased affinity-TCR engagement is required for initiation of the Treg 
cell differentiation program and induction of Foxp3 expression [42, 206]. As a 
consequence, Tregs exported to the periphery exhibit a TCR repertoire skewed 
towards self-recognition [207, 208]. Naïve-Tregs are thus likely to display high-affinity 
for self-peptides, and to rapidly differentiate into memory-Tregs upon TCR-stimulation 
[42, 77, 198-200, 202]. Thus, self-peptide/MHC stimulation is likely to result in loss of 
their naïve phenotype. Of note, the maintenance of murine naïve-like FoxP3+ CD4 T-
cells was recently demonstrated to be dependent of TCR-driven signals [209]. 
On the other hand, in terms of the contribution of cytokine-driven proliferation, naïve-
Tregs express low levels of receptors for the main homeostatic cytokines. CD25, the α-
chain of the IL-2 receptor, is expressed at only intermediate/dim levels [77], 
questioning whether naïve-Tregs, like their memory counterparts, depend on IL-2 
[202]. Moreover, Tregs per se typically express low levels of IL-7Rα, and there are 
controversial reports on the IL-7 impact on human and murine Tregs [210-214].  
Overall, the mechanisms involved in the homeostasis of human naïve-Tregs remain 
largely unclear. 
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1.2 Clinical models to study naïve CD4 T-cell homeostasis 
 
1.2.1. Immune reconstitution settings 
 
Lymphopenic settings, such as the drastic reductions of peripheral T-cell numbers 
observed following chemotherapy [215], bone-marrow transplantation [94, 97, 216, 
217], HIV infection [44, 218, 219], or increasingly used lymphocyte-depleting therapies 
in autoimmunity [220] provide important clinical scenarios to investigate the 
mechanisms of homeostatic responses, e.g. cytokine-induced proliferation, to restore 
the size of the T-cell pool. 
 
As previously detailed, IL-7 is a key player in T-cell homeostasis, and is essential for T-
cell development in humans [114, 129-136]. This has provided a rationale for the 
consideration of IL-7 as a therapeutic agent in a variety of settings, particularly in the 
improvement of immune reconstitution in lymphopenia and following hematopoietic 
stem cell transplantation (HSCT) or lymphocyte depletion in the context of 
autoimmune disease or malignancy [124, 221, 222].  
 
The first clinical trial using recombinant human (rh)IL-7 in humans was performed 
with lymphopenic patients with non-lymphoid cancer that was refractory to standard 
therapy [165]. Phase I/II clinical trials performed in lymphopenic cancer patients have 
reported that rhIL-7 administration induces T-cell survival and cycling in vivo, 
increasing CD4 and CD8 T-cell numbers [165, 223, 224], with preferential expansion of 
the naïve subsets [165, 223, 224]. Of note, the absolute numbers of CD31+ naïve CD4 T-
cells, were increased following rhIL-7 administration, leading to the generation of a 
diverse TCR repertoire even in older individuals [165, 224]. These effects of rhIL-7 on 
naïve T-cell numbers and repertoire diversity seem to be due to increased proliferation 
of RTEs rather than augmented thymic output, since they are age-independent and no 
thymic enlargement was observed [165]. These observations, however, do not 
preclude a potential effect of rhIL-7 therapy in thymic output.  
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The safety and efficacy of IL-7 administration to HIV-1-infected subjects have been 
evaluated in a phase I/IIa trial, in which rhIL-7 was administrated to HIV-1 infected 
patients presenting persistently low CD4 T-cell counts, despite virological suppression, 
under combination antiretroviral therapy (ART-Discordants) [225]. IL-7 therapy was 
associated with a significant increase in circulating naïve and memory CD4 and CD8 T-
cells, while maintaining their functional profile and cytokine production in response to 
HIV antigen [225]. In addition, in a randomized placebo-controlled dose escalation trial 
of 3 weekly doses of rhIL-7 in ART-treated HIV-infected patients, with low CD4 T-cell 
counts and undetectable plasma HIV levels, CD4 increases of predominantly naïve and 
central-memory T-cells were brisk and lasted up to 1 year [226]. Of note, IL-7 seemed 
to increase thymic output and tended to improve the TCR repertoire in patients with 
low TCR diversity [226]. Thus, these initial human trials suggested that IL-7 therapy 
may improve T-cell recovery and function in the context of ART-treated HIV-1 
infection. However, recently it has been debated the putative inefficacy of IL-7 in 
purging the HIV reservoirs during ART, as it was shown to enhance residual levels of 
viral production and induce proliferation of latently infected cells. These data question 
the possible role of IL-7 as a suitable therapeutic strategy for HIV eradication [227] 
Systemic administration of rhL-7 to bone-marrow transplant recipients has also been 
shown to increase thymopoiesis and improve immune function following bone-
marrow transplantation [228-231]. The increase in naïve CD4 T-cell compartment size 
and TCR diversity was reported in a phase I trial of rhIL-7 in recipients of T-cell 
depleted allo-HSCTs, which was considered very promising, particularly in younger 
patients [232, 233]. IL-7Rα expression was shown to be down-regulated during 
continued IL-7 administration, which might constitute a negative feed-back loop that 
hinders uncontrolled T-cell expansion thus preventing the development of 
lymphoproliferative disorders in response to IL-7 [165, 221]. 
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1.2.2. Thymectomy as a privileged model to study naïve CD4 
homeostasis 
 
 
The importance of thymus in immunity was first recognized in murine models. It was 
observed that neonatal thymectomy resulted in severe immunodeficiency mainly 
affecting cell-mediated immune responses [234]. Importantly, in rodents, as thymic 
maturity at birth differs across species, the impact of thymectomy is also 
heterogeneous. In some strains, neonatal thymectomy causes severe 
immunodeficiency [234, 235], whereas thymectomy at 2-4 days after birth leads to 
autoimmune disease, associated with a decrease in regulatory T-cell number [236, 
237].  
 
Children born with congenital cardiac defects frequently require corrective cardiac 
surgery in infancy. In order to increase exposure of the surgical field and reduce the 
risk of bleeding, surgeons frequently need to perform partial or complete thymectomy 
during those procedures. The value of these thymectomized individuals as a model to 
study the homeostasis of T-cells has been long recognized [238].  
 
Several groups have analysed the impact of thymectomy on T-cell subpopulations in 
thymectomized individuals [76, 238-250]. A decrease in CD4 and CD8 T-cells was 
reported as compared to healthy subjects [238, 239, 242, 245], mainly affecting the 
naïve T-cell pool [238-240, 242, 245-247].  
 
Of note, few studies have addressed specifically the long-term impact of thymectomy 
in the homeostasis of the naïve CD4 T-cell compartment and their results are highly 
heterogeneous [76, 243-245, 247]. Recently, there were reports on the restoration of 
T-cell compartment, including naïve CD4 T-cell counts, beyond 5 years post-cardiac 
surgery upon complete thymectomy performed in the first 4 months of life [76, 243]. 
This was found in more than 75% of the thymectomized individuals and was 
accompanied by a restoration of TREC levels and of the size of the CD31+ naïve CD4 T-
cell compartment [76, 243].  
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The recovery of the naïve CD4 T-cell compartment was attributed to thymic tissue 
regeneration, which is thought to be more effective when thymectomy is performed in 
younger ages [76, 243]. In these studies, the longitudinal data are limited to few 
patients, namely 3 individuals, in whom naïve CD4 T-cell counts and TREC levels do 
not support the restoration of the naïve compartment at an individual level [243].  
Most studies in the literature do not provide information on the extent of the 
thymectomy performed [239, 245, 248, 249], or exclude the presence of residual 
thymus [239, 245, 249]. Given the fact that younger individuals are more likely to 
undergo incomplete thymectomy [245, 250], the interpretation of the heterogeneous 
results on the impact of thymectomy in the naïve CD4 T-cell compartment, would 
benefit from a strict (sequential) quantification of the remaining thymic activity. Of 
note, the existence of ectopic thymus is very frequent in humans [251]. 
The investigation of putative compensatory mechanisms on thymectomized 
individuals has revealed an increase in the proliferation of naïve CD4 T-cells in the 
patients with contracted naïve CD4 T-cell subset [242]. This was associated with 
shorter telomeres in the total CD4 T-cell compartment 18 years post-thymectomy, 
although this decrease was not significant, as compared to age-matched controls [247]. 
Moreover, higher turnover of naïve CD4 T-cells was found to be inversely correlated 
with the size of the CD31+ pool [245]. Gent et al, reported a transient increase in the 
frequency of Ki-67+ cells within the naïve CD4 T-cells, that was no longer detectable 5 
years post-thymectomy and restoration of the naïve CD4 T-cell compartment size 
[243].  
Importantly, no differences were reported between thymectomized and controls in the 
levels of STAT5 phosphorylation within CD8 and CD4 T-cells upon stimulation with 
rhIL-2 or rhIL-7, indicating that responsiveness to homeostatic cytokines such as IL-2 
or IL-7 is not impaired following thymectomy [245].  
Despite their young age, a subgroup of adults submitted to thymectomy in infancy 
presented particularly marked alterations in the T-cell compartment, similar to those 
usually found in individuals older than 75 years [245]. They featured marked loss of 
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naïve CD4 and CD8 T-cells, with accumulation of oligoclonal memory cells and high 
plasma levels of the pro-inflammatory cytokines IL-1β, IL-8, and eotaxin [245]. 
Notably, the TCR spectratyping profile of sorted CD4 and CD8 T-cells from these 
individuals revealed modest impact on the CD4 repertoire, and marked reduction of 
diversity of CD8 T-cells [245, 247].  
 
It has also been reported that CMV infection may have an important role in the 
heterogeneity of alterations observed upon thymectomy [245]. Thymectomy or CMV 
seropositivity alone appeared to have per se an effect on the contraction of the naïve T-
cell compartment, although this was less marked than both combined [245]. 
 
The profound imbalance between naïve and memory T-cell frequencies, loss of T-cell 
repertoire diversity and evidence of inflammation, are typically associated with 
immune-senescence and are reminiscent of the immune risk phenotype, defined by 
gerontologists as a cluster of immune parameters that are predictive of early all-cause 
mortality in the elderly [252, 253].  
 
The long-term impact of thymectomy remain debatable. Concerns about the 
consequences of early thymectomy for immune function in later life have been rising, 
as corrective cardiac surgery in infancy has become routinely practised for the last 3 
to 4 decades [247]. The vast majority of the short- or long-term studies did not show 
an increase in the infectious risk [239, 248, 254, 255]. Of note, one research group 
reported partial immunodeficiency in humans after thymectomy [238], and another 
study has shown increased frequency of infections, without increased severity [242]. 
In a recently reported 18 years’ follow-up study upon thymectomy below 6 months of 
age, the authors present clinical data on 11 patients showing increased frequency of 
recurrent respiratory infections and severe infections requiring admission, although 
the thymectomized individuals are not compared with a prospective/longitudinal 
cohort of controls, which may alter data interpretation [247].  
 
The risk of allergy/autoimmunity is also a concern in these patients, given the central 
role of thymic-derived regulatory T-cells in the prevention/control of both. The impact 
of thymectomy on the pool of regulatory T-cells has been scarcely investigated, 
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although data available point to the maintenance of the proportion of circulating 
regulatory T-cells, although with decreased cell counts [240, 245, 247, 254]. In the 
studies with clinical information available, no increase in clinical manifestations of 
autoimmunity [239, 240, 242, 247, 248] or increased levels of autoantibodies [239, 
240, 242, 249] have been found.  
Importantly, most individuals included in these studies were children and adults below 
the 4th decade of life. Immunological and clinical check-ups of thymectomized patients 
may therefore be advised to monitor the development of an immune risk phenotype 
and potentially related clinical manifestations. Premature immune-senescence after 
thymectomy may be of clinical relevance as the patients get older, possibly increasing 
the incidence of diseases of the elderly, such as infectious complications, reduced 
response to vaccines, atherosclerosis, neurodegenerative disorders and malignancies. 
Thymectomy is, thus, expected to have an impact on immunity later in life, which could 
be particularly critical in case the patients developed a lymphopenic condition that 
required reconstitution of the immune function [256]. 
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Aim and Work Plan 
 
CD4 T-cells play a central role in the complex puzzle of the human immune system, 
being at the intersection of innate and adaptive immune responses. The naïve CD4 T-
cell compartment can be considered the lifelong reservoir of cells with a diverse 
repertoire, maintaining ability to mount specific responses to new antigens and 
providing continuous replenishment of the memory-effector compartments. 
Moreover, the diversity of naïve regulatory (FoxP3+) CD4 T-cells is thought to be crucial 
to ensure the preservation of tolerance to self.  
 
Naïve CD4 T-cells are generated in the thymus and significantly expand in the 
periphery to establish the naïve CD4 T-cell compartment. They are maintained 
throughout life via a combination of thymic output and peripheral expansion/survival, 
as well as death/differentiation into the memory-effector compartment. The 
peripheral expansion/survival is thought to be mediated by both homeostatic 
cytokines, particularly IL-7, and low affinity self-peptide/MHC interactions with TCR, 
which are likely to have distinct impacts on cell diversity/function. 
 
The main objective of this thesis is to investigate the interplay of these different 
mechanisms operating in the homeostasis of the naïve CD4 T-cell compartment.  
 
For this purpose, a cohort of adults thymectomized in early infancy was organized. 
Patients were strictly stratified according to degree of residual thymic activity, based 
on surgery report on the degree of thymectomy performed and estimative of thymic 
output at the time of our evaluation. Two groups were generated, based on evidence of 
complete absence of thymic activity or not, and compared with age-matched healthy 
subjects. 
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The following specific questions were addressed: 
 
1) How is the naïve CD4 T-cell compartment maintained in the absence of thymic 
output? 
We asked whether partial/total thymectomy would be associated with distinct long-
term impacts on size, quality or TCR diversity of the naïve CD4 T-cell compartment. We 
hypothesized that in the absence of thymic output, thymectomized individuals would 
adjust their threshold for TCR activation of naïve CD4 T-cells and subsequent 
differentiation into memory phenotype. Moreover, we investigated the possibility that 
thymectomy could also be associated with an altered response of the naïve CD4 T-cell 
compartment to IL-7, in terms of proliferation and/or survival. These results are 
included in chapter 3.1 
 
2) How is the subset of naïve regulatory (Foxp3+) T-cells maintained? 
Research on human regulatory T-cell homeostasis has been particularly scarce, despite 
its lifelong relevance in the maintenance of tolerance and therapeutic potential. Our 
first aim was to compare the ability of individuals submitted to complete thymectomy 
to preserve naïve regulatory versus naïve conventional CD4 T-cell subsets, in order to 
evaluate the requirement of thymic output to the long-term maintenance of naïve 
regulatory T-cells. We next investigated the impact of homeostatic cytokines, IL-7 and 
IL-2, on naïve-Treg compartment. These results are included in chapter 3.2 
 
3) Is the complete thymectomy performed early in infancy associated with an 
increase in clinical and subclinical markers of autoimmunity and allergy? 
We hypothesized that in the absence of thymic output, the contraction of naïve T-cell 
repertoire and the pressure to differentiate into memory phenotype would favour the 
emergence of autoreactive clones, leading to increased/dysregulated production of 
autoantibodies. An extensive evaluation of the reactivity to self and/or to innocuous 
allergens in patients submitted to complete thymectomy aimed to reveal a possible 
tendency to autoimmunity and/or allergy, and evaluate the central role of thymus in 
the establishment and lifelong maintenance of tolerance. These results are included in 
chapter 3.3. 
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3.1.1. Abstract  
 
Naïve CD4 T-cell maintenance is critical for immune competence. We investigated here 
the fine-tuning of homeostatic mechanisms of the naïve compartment to counteract the 
loss of de novo CD4 T-cell generation. Adults thymectomized in early childhood during 
corrective cardiac surgery were grouped based on presence or absence of 
thymopoiesis and compared with age-matched controls. We found that the 
preservation of the CD31 subset was independent of the thymus and that its size is 
tightly controlled by peripheral mechanisms, including prolonged cell survival as 
attested by Bcl-2 levels. Conversely, a significant contraction of the CD31+ naïve subset 
was observed in the absence of thymic activity. This was associated with impaired 
PI3K-dependent responses of purified naïve CD4 T-cells to IL-7, namely in vitro 
proliferation and up-regulation of CD31 expression, which likely potentiated the 
decline in recent thymic emigrants. Additionally, we found no apparent constraint in 
the differentiation of naïve cells into the memory compartment in individuals 
completely lacking thymic activity despite upregulation of DUSP6, a phosphatase 
associated with increased TCR threshold. Of note, thymectomized individuals featuring 
some degree of thymopoiesis were able to preserve the size and diversity of the naïve 
CD4 compartment, further arguing against complete thymectomy in infancy. Overall, 
our data suggest that robust peripheral mechanisms ensure the homeostasis of CD31 
naïve CD4 pool and point to the requirement of continuous thymic activity to the 
maintenance of IL-7–driven homeostatic proliferation of CD31+ naïve CD4 T-cells, 
which is essential to secure T-cell diversity throughout life. 
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3.1.2. Introduction 
 
Long-term preservation of the naïve CD4 T-cell pool is vital to ensure immunity to 
foreign antigens and to maintain peripheral tolerance (1, 2). Naïve CD4 T-cells are 
preserved throughout life due to a dynamic balance between thymic generation, and 
peripheral proliferation, survival, death, or differentiation into memory/effector cells 
(1, 3). 
 
The thymus is known to be functional up to the sixth decade of life, even though an age-
dependent decline in thymic activity occurs (4). Thymic output can be estimated 
through the quantification of TCR rearrangement circles (TRECs), which are excision 
by-products generated during T-cell development in the thymus (4). These episomal 
DNA fragments are progressively diluted with cell division in the periphery (5), being 
thus enriched in recent thymic emigrant cells (RTEs). Aging is associated with a 
progressive reduction in TREC levels (4). This decline is much more striking than the 
one observed in naïve CD4 T-cell counts, indicating that the loss of cell replenishment 
due to thymic involution is complemented by peripheral dilution due to cell 
proliferation (4, 6-8). In fact, in contrast to mice, the establishment and maintenance 
of the human naïve CD4 T-cell compartment is currently thought to significantly rely 
on post-thymic T-cell proliferation (3, 9, 10). Several in silico studies suggest that 
thymic output per se is insufficient to guarantee the size of the peripheral naïve T-cell 
compartment without a major contribution of cell proliferation in the periphery (3, 9, 
10). This homeostatic proliferation is driven by self-peptide/MHC interaction and/or 
cytokines, namely IL-7 (9, 11, 12).  
 
IL-7 is essential for thymopoiesis and plays a key role in peripheral naïve T-cell survival 
through the induction of Bcl-2 (11, 13). In addition, IL-7 induces low-level naïve T-cell 
proliferation (11, 13), which is particularly important in lymphopenic clinical settings 
(11, 13). In steady-state conditions, this homeostatic proliferation within the naïve CD4 
T-cell compartment is mainly restricted to the subset expressing CD31 (Platelet 
endothelial cell adhesion molecule, PECAM-1) (14), a population that includes the 
RTEs and is thought to have a broadly diverse TCR repertoire (12). We have also shown 
that IL-7 increases the levels of expression of CD31 in this subset (14). The biological 
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significance of CD31 expression is still debatable, though it has been suggested that it 
may limit TCR-mediated naïve CD4 T-cell responses through inhibitory signalling 
ascribed to its cytoplasmic immune-receptor tyrosine-base inhibitory motifs (ITIMS) 
(15). In agreement, the homeostatic proliferation of CD31 naïve CD4 T-cells is thought 
to be mainly mediated by low-affinity self-peptide/MHC interactions (16). Of note, 
CD31 expression is lost after TCR stimulation of naïve CD4 T-cells (2, 17-19).   
 
There are few studies on human naïve CD4 T-cell homeostasis, and the interplay 
between peripheral mechanisms and the age-associated decline in thymic output 
remains unclear (3, 9, 10). Adults thymectomized early in infancy due to corrective 
cardiac surgery provide a unique setting to address this issue (20-27). Using this 
clinical model, we show here that thymic activity is required to ensure IL-7-mediated 
peripheral homeostatic proliferation, whereas the homeostasis of the CD31 
compartment is preserved in the absence of thymic activity. 
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3.1.3. Material and Methods 
 
Study design  
Blood was collected from 22 adult patients submitted to thymectomy during corrective 
cardiac surgery in early childhood, and 20 age-matched healthy controls. All subjects 
gave written informed consent for blood sampling and processing. The study was 
approved by the Ethical Boards of Faculdade de Medicina da Universidade de Lisboa, 
Centro Hospitalar Lisboa Norte, and Hospital de Santa Cruz, Portugal. 
 
Cell isolation and cell culture  
PBMC (Peripheral blood mononuclear cells) were isolated from freshly-collected 
heparinized blood via Ficoll-Paque PLUS (GE Healthcare, Uppsala, Sweden). Naïve CD4 
T-cells were subsequently purified by negative selection (purity >96%, StemCell 
Technologies, Grenoble, France). Purified naïve CD4 T-cells were cultured at 1x106 
cells/ml with either IL-7 (10ng/ml; R&D Systems, Minneapolis, MN) or IL-2 (20IU/ml; 
NIH/AIDS Research and Reference Program, Division of AIDS, NIAID, Hoffman-La 
Roche), for up to 13 days (d), with media replacement at d3 and d7, as we have 
previously described (14, 28).  
 
Flow-cytometry  
Ex vivo phenotypic analysis was performed in freshly-collected whole blood using an 
eight-colour staining protocol and a panel of monoclonal antibodies previously 
described (28). Purified naïve CD4 T-cells were surface stained ex vivo and upon 
culture, followed by intracellular staining using eBioscience FoxP3 kit (eBioscience, 
San Diego, CA), as described (28). At least 150,000 events were acquired for each 
sample on a BD LSRFortessa (BD Biosciences, San Jose, CA). Data were analysed using 
FlowJo software (TreeStar, Ashland, OR) after doublet exclusion. Results are presented 
as proportion of a cell population or as mean fluorescence intensity (MFI) of a given 
marker within the specified population.  
 
TCR threshold  
Purified untouched naïve CD4 T-cells were cultured at 1x106 cells/ml (25000 
cells/well) and stimulated with increasing concentrations of beads coated with anti-
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CD3 and anti-CD28 monoclonal antibodies (Dynabeads, Thermo Fischer Scientific). In 
agreement with a previously reported protocol (29), antibody against CD40L (clone 
89-76, BD Bioscience) was added to the culture media to improve the staining. After 
6h, cells were collected and surface stained, as described (28), for the marker of cell 
differentiation (CD45RO) and the additional activation marker (CD69).  
 
TREC quantification  
Signal joint (sj) and DβJβ TREC analyses were conducted as described (5, 30). Briefly, 
multiplex PCR amplification for sjTREC, DJ1TRECs (D1-J1.1 to 1.6) or DJ2TRECs 
(D2-J2.1 to 2.7), together with the CD3 chain was performed in triplicate on lysed 
PBMC. TREC and CD3 quantifications were then performed using a LightCycler™ in 
independent experiments, with the same first-round serial dilution standard curve. 
This highly sensitive nested quantitative PCR assay allowed detection of one copy in 
105 cells for any excision circle. The sj/TREC ratio, 
(sjTREC/105cells/(DJ1TRECs/105cells+DJ2TRECs/105cells)), was calculated as 
described (30). 
 
mRNA quantification 
Total RNA was extracted from purified naïve CD4 T-cells using Quick-RNA MicroPrep 
(Zymo Research Corporation, Irvine, USA). cDNA was synthesized from 50ng of RNA 
(SuperScript III Reverse Transcriptase, Thermo Fischer Scientific), and used to 
quantify the expression levels of KLF2, FOXP1, P21, BIM, DUSP4, and DUSP6 in 
duplicates, using TaqMan Gene Expression Assays on a ViiA7 Sequence Detection 
system (both from Thermo Fischer Scientific). Results are expressed as ΔCT 
normalized to the medium CT levels of GAPDH and HPRT. 
 
TCR Spectratyping analysis 
Total RNA was extracted from 105 to 106 cells with RNeasy kit (Qiagen, MD, USA), and 
first strand cDNA synthesized from 1-2µg of RNA (SuperScript III) using an equivolume 
mixture of random hexamers and oligo (dT). Amplification of the TCRVβ CDR3 was 
performed using primers specific for each TRBV family, and a common TRCB reverse 
primer (31); followed by a run-off reaction that extends each different PCR product 
with a second TRCB FAM labeled primer; and a third step, in which each different 
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fluorescent TRBV-TRBC PCR fragment was separated using a capillary electrophoresis 
based DNA automated sequencer. Data were collected and analyzed with GeneMapper 
v4.0 (Thermo Fischer Scientific) for size and fluorescence intensity determination. 
 
Statistical analysis  
Statistical analysis was performed with Graph Prism Version 5.01 (GraphPad Software, 
San Diego, CA). The following tests were used for analyzing epidemiological data and 
results from ex vivo studies as appropriate: Wilcoxon-Signed Rank/paired T-test for 
pairwise comparisons; unpaired T-test/Mann-Whitney for unpaired comparisons; for 
Gaussian and non-Gaussian distribution respectively. Cultures were analyzed using 
one-way ANOVA (Kruskal-Wallis Test). Results were expressed as median 
(interquartile range or range when n<4). P-values <0.05 were considered significant.  
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3.1.4. Results 
 
Evidence of thymus activity in adults thymectomized during the first year of life 
 
We studied a cohort of 22 adults submitted to thymectomy in early childhood during 
corrective cardiac surgery, and 20 age-matched healthy controls (Table 1 and 
Supplementary Table 1). Of note, the thymic function is relatively stable in healthy 
individuals during the age-period spanned (4). The thymectomized patients were 
stratified into two groups according to evidence of residual thymic activity (Table 1 
and Supplementary Table 1). No thymic activity (Thy) strictly refers to cases with 
surgical reports of complete thymus removal and levels of sjTRECs clearly below the 
lower level found in controls (P<0.0001, Figure 1A), as we previously reported (28).  
 
Table 1. Clinical-epidemiological characteristics of cohorts 
 healthy Thya ØThya 
Number (male/female) 20 (8/12) 14 (6/8) 7 (5/3) 
Age, years 22 [18-29] 25 [18-30] 23 [20-27] 
Age at thymectomy, months NA 8 [1-60] 21 [12-72] 
Total lymphocytes/l 2408 [1430-3502] 2219 [1230-3400] 2005 [934-2618]* 
% T-cells (CD3+) 72.7 [50.2-79.0] 70.5 [57.3-82.7] 66.6 [42.7-71.2]*;# 
% CD4 T-cells 39.9 [31.2-60.0] 41.0 [33.8-55.3] 42.7 [20.20-46.4] 
Serum IL-7b, pg/ml 15.0 [6.5-23.3] 12.8 [5.3-16.2]* 14.8 [8.3-19.8] 
NA indicates not applicable. Results are shown as median and range in brackets; *, ** P-value <0.05 and 
0.01, respectively, in comparison with healthy; #, ##, P-value <0.05 and 0.01, respectively, in comparison 
with Thy. a Thymectomy was performed during reconstructive cardiac surgery to facilitate surgical 
access to the heart and great vessels; patients with syndromatic cardiopathy were excluded (e.g. 
Trisomy 21, Velocardiofacial or DiGeorge Syndrome); individuals were not treated with drugs known to 
influence the immune system; ØThy - No thymic activity based on surgical reports of complete thymus 
removal and levels of sjTRECs clearly below the lower level found in controls;  Thy - some degree of 
thymic activity attested by sjTREC levels within the range of age-matched controls. b Serum IL-7 levels 
were quantified using Human IL-7 Quantikine HS ELISA kit (R&D Systems). 
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Individuals with some degree of thymic activity (Thy) featured sjTREC levels within 
the range of age-matched controls, though significantly lower (P=0.0061, Figure 1A).  
 
 
Figure 1. Naïve CD4 T-cell compartment in adults thymectomized early in life.  
(A) Quantification of sjTREC levels in PBMCs from thymectomized patients without (Thy), or with 
evidence of thymic activity (Thy), and in age-matched healthy individuals. (B) Contour plots illustrating 
CD45RO and CCR7 analysis within circulating CD4 T-cells of representative individuals from the 3 
cohorts; graphs show naïve CD4 T-cell frequency (top) and counts (bottom). (C) sj/ TREC ratio 
quantified in PBMCs from Thy and healthy individuals. Each dot represents one individual, bars 
represent median, and P-values are shown. 
 
Interestingly, these two groups showed almost no overlap between age at thymectomy, 
which was performed during the first year of life in all Thy cases except two, and later 
on in all Thy patients (Supplementary Table 1). A previous study also found an 
association between preservation of thymic activity and younger age at thymectomy, 
which was attributed to loss of thymus regenerative capacity in children older than 
eighteen months-old (24, 32). It is also noteworthy that complete thymic tissue 
removal is more likely to occur after the first year of life due to the surgical procedures 
required for the type of cardiac defects (Supplementary Table 1), as well as due to age-
related anatomic specificities (21) Of note, individuals with syndromatic cardiac 
defects were not included (Supplementary Table 1).  
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In agreement with complete lack of thymic activity, the Thy group featured decreases 
in naïve CD4 T-cell frequency and absolute numbers, that were statistically significant 
not only in comparison with healthy individuals (P=0.0012 and P=0.0006 respectively, 
Figure 1B), but also with Thy (P=0.0041 and P=0.0019 respectively, Figure 1B). These 
cells featured a truly naïve phenotype based on an extensive panel of naïve markers 
and lack of expression of molecules associated with a memory phenotype, as we have 
previously reported (28). 
 
On the other hand, Thy patients showed no reduction in lymphocyte counts (Table 1), 
and maintained the naïve CD4 T-cell compartment (Figure 1B). In order to estimate 
their effective thymic output, we quantified the sj/βTREC ratio, which reflects the 
number of proliferation cycles undergone by precursor T-cells during their intra-
thymic differentiation, and directly correlates with thymic activity (30). We observed 
similar levels of sj/βTREC ratio in Thy and age-matched healthy individuals (Figure 
1C). Together with close to normal sjTREC contents, this observation supports a major 
contribution of thymic recovery to the maintenance of the size of naïve CD4 T-cell 
compartment upon partial thymectomy.  
 
We further assessed the impact of the degree of thymectomy on the structural diversity 
of naïve CD4 T-cells by spectratyping analysis of their TCR repertoire. The distribution 
of the CDR3 lengths within each different Vβ family is considered to reflect the overall 
sequence diversity (33). A diverse polyclonal TCR repertoire is associated with a 
Gaussian distribution of CDR3 lengths, whereas skewed TCR repertoires feature a 
reduced number of peaks. A relatively preserved TCR diversity was observed in Thy 
patients as compared to age-matched controls (P=0.2620), supporting that their 
degree of thymic activity was sufficient to ensure the preservation of the quality of the 
naïve CD4 T-cell compartment (Figure 2A and 2B). Patients with no thymic activity 
exhibited higher numbers of non-polyclonal Gaussian families than both Thy 
(P<0.0001) and healthy individuals (P=0.0001), as shown in Figure 2.  
 
Of note, these differences between the two thymectomized cohorts could not be 
attributed to a distinct prevalence of CMV infection, since a similar proportion of 
individuals with IgG seropositivity against CMV was observed in Thy and Thy cohorts 
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(Supplementary Table 1). Moreover, the contraction of the naïve CD4 T-cell 
compartment in Thy individuals was not restricted to those CMV+, as previously 
reported (21).  
 
Figure 2. Spectratyping analysis of naïve CD4 T-cell diversity in adults thymectomized 
early in life. CD3 length distribution within each of the 22 V families of purified naïve CD4 T-cells 
analyzed by spectratyping: (A) Illustrative examples from thymectomized patients without (right, 
Thy1 in Supplemental Table 1), and with evidence of thymic activity (middle, Thy6 in Supplemental 
Table 1), as well as age-matched healthy (left) individuals; (B) Proportion of the illustrated patterns 
within each V family in the three cohorts (Thy, bottom, n=7; Thy, middle, n=6; healthy, top, n=12). 
 
 
Overall, peripheral homeostatic mechanisms were unable to prevent the contraction of 
the naïve CD4 T-cell compartment upon complete thymus removal in infancy, whereas 
the maintenance of some degree of thymic activity allowed preservation of naïve CD4 
T-cells with a diverse TCR repertoire into adulthood.  
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Lack of thymic activity does not associate with increased threshold for TCR-
activation of naïve CD4 T-cells  
 
The maintenance of naïve T-cells is also determined by the rate of their differentiation 
into memory-effector cells. Of note, both central- and effector-memory CD4 T-cell 
counts in individuals lacking thymic activity were found to be similar to those in age-
matched healthy controls (Figure 3A).  Therefore, we assessed the expression of a 
panel of genes known to be involved in the regulation of cell quiescence and/or of the 
threshold for TCR-mediated cell activation in purified naïve CD4 T-cells from 
thymectomized and healthy individuals (Figure 3B). No alterations were found in the 
expression levels of the following genes: krüppel-like factor 2 (KLF-2) (34); the 
transcription factor FOXP1 (35); CDKN1A (encoding the cyclin-dependent kinase 
inhibitor p21cip1/waf) (36); the pro-apoptotic Bcl-2 family member BIM (37); and the 
dual-specificity protein phosphatase DUSP4 (38). However, individuals with no thymic 
activity featured significantly higher DUSP6 transcript levels than controls, an increase 
not observed in those with some preservation of thymopoiesis (Figure 3B).  
 
Figure 3. Maintenance of naïve CD4 T-cell quiescence upon thymectomy.  (A) Absolute 
numbers of circulating central-memory (CD45RO+CCR7+), and effector-memory (CD45RO+CCR7) cells 
in thymectomized patients without (Thy), and with evidence of thymic activity (Thy), as well as age-
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matched healthy individuals. (B) mRNA expression levels of genes involved in cell cycle or maintenance 
of naïve phenotype quantified in purified naïve CD4 T-cells from the three cohorts; ΔCT normalized to 
the medium CT levels of GAPDH and HPRT are shown; numbers below the graph indicate the total 
number of samples tested and those with levels above the detection threshold of the respective gene. 
(C) Purified naïve CD4 T-cells from Thy and healthy individuals were stimulated (6h) with increasing 
concentrations of beads coated with anti-CD3 and anti-CD28 monoclonal antibodies with dot-plots 
illustrating the up-regulation of the activation markers CD40L and CD69 in one Thy subject, and 
graphs showing frequencies of CD69+CD40L cells (left), CD69+CD40L+ cells (middle), and CD3 MFI 
(right); each dot represents one individual, lines connect means, and the two cohorts were compared 
with 2-way ANOVA. Bars represent median and interquartile range. P<0.05 are shown. 
 
DUSP6 is highly specific for ERKs, leading to reduction of ERK activity that is critical for 
efficient TCR-signalling (38, 39). Therefore, high DUSP6 levels might be associated with 
an increase in the threshold for TCR-induced activation in Thy. To test this 
possibility, we performed a dose-response TCR stimulation of purified naïve CD4 T-
cells, and quantified the up-regulation of the activation markers CD40L and CD69, in 
parallel with the down-regulation of CD3 expression and induction of the memory 
marker CD45RO. Contrarily to our expectation, individuals completely lacking thymic 
activity responded to TCR stimulation as efficiently as healthy subjects (Figure 3C).  
 
In conclusion, we found no apparent constraint in the differentiation of naïve CD4 T-
cells into the memory compartment in individuals completely lacking thymic activity.  
 
 
Preservation of the CD31 compartment of CD4 naïve T-cells in the absence of 
thymic activity 
 
Next, we investigated the contribution of peripheral cell-survival and cell-cycling to the 
homeostasis of the CD31+ and CD31 naïve CD4 T-cell subsets according to the degree 
of thymic activity.  
 
The CD31+ compartment was preserved in Thy patients (Figure 4A and 4B). 
Conversely, it was significantly contracted in the Thy cohort, both in frequency 
(Figure 4A) and absolute counts (Figure 4B), as expected in the absence of thymic 
activity (3, 20). Importantly, despite the marked naïve CD4 T-cell lymphopenia, Thy 
featured preserved CD31– naïve CD4 T-cell counts (Figure 4B). This finding adds to 
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previous data on aged individuals reporting preservation of the CD31– compartment in 
parallel with the progressive decline of CD31+ cell counts (40), and argues in favor of 
the robustness of the homeostasis of CD31– naïve CD4 T-cells in individuals lacking 
thymic activity.   
 
Figure 4. Homeostasis of the CD31+ and CD31 subsets of naïve CD4 T-cells upon 
thymectomy. (A) Frequency of CD31+ cells within naïve CD4 T-cells in thymectomized patients without 
(Thy), and with evidence of thymic activity (Thy), as well as age-matched healthy individuals. (B) 
Absolute numbers of CD31+ and CD31 naïve CD4 T-cells in the three cohorts. (C-D) Bcl-2 MFI within 
naïve CD4 T-cells (C), and within the CD31+ and CD31 subsets (D) with the overlay histogram 
illustrating Bcl-2 expression within CD31+ and CD31 naïve CD4 T-cells in Thy, Thy and healthy 
individuals (numbers indicate Bcl-2 MFI). (E-F) Frequency of cycling cells (Ki-67+) within naïve CD4 T-
cells (E) and within the CD31+ and CD31 subsets (F) in the three cohorts. In scatter graphs each dot 
represents one individual, and bars represent median; bar graphs show median and interquartile range; 
P-values are shown. 
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The expression levels of the survival marker Bcl-2 were up-regulated in both 
thymectomized cohorts as compared to healthy controls (Thy: P=0.0187; Thy: 
P=0.0487; Figure 4C), suggesting increased naïve CD4 T-cell survival irrespectively of 
the presence of thymic activity that persisted for more than 20 years post-thymectomy 
(Table 1). This increase was observed in both CD31+ and CD31– naïve T-cells (Figure 
4D). Of note, we found that the CD31– compartment featured significantly higher Bcl-2 
MFI than CD31+ cells both in healthy and Thy individuals, a difference that was 
attenuated in Thy (Figure 4D).  
 
Regarding proliferation, a significant increase in the frequency of cycling cells within 
total naïve CD4 T-cells was found only in Thy (P<0.0001 to healthy, P=0.0007 to Thy; 
Figure 4E). The proportion of Ki-67+ cells was significantly higher in the CD31– than in 
the CD31+ compartment in both healthy individuals and in Thy patients (Figure 4F). 
Nevertheless, its relative contribution to the pool of proliferating naïve CD4 T-cells is 
minor (<1%), given the large overrepresentation of CD31+ cells in these individuals 
(Figure 4A). On the other hand, Thy individuals featured an increase in the relative 
representation of the CD31– subset, associated with the loss of CD31+ cells (Figure 4A), 
in parallel with a significant increase in the frequency of cycling cells irrespective of 
CD31 expression (CD31– subset: P<0.0001 to healthy; P=0.0048 to Thy; CD31+ subset: 
P<0.0001 to healthy; P<0.0001 to Thy; Figure 4F).  
 
Thus, we showed that the CD31– naïve CD4 T-cell compartment was maintained in the 
absence of thymic output, in association with both expanded cell survival and 
increased proliferation.  
 
 
Naïve CD4 T-cells feature reduced proliferative response to IL-7 in vitro in the 
absence of thymic activity in vivo 
 
Cytokine-driven homeostatic mechanisms are crucial for naïve CD4 T-cell 
maintenance, and IL-7 is considered the key cytokine in these processes (13). 
Therefore, we hypothesized that naïve CD4 T-cells adjust their intrinsic ability to 
respond to IL-7 in order to counteract the decline in thymic output. Thus, we 
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investigated the impact of IL-7 on purified naïve CD4 T-cells, using a 13d culture 
system previously optimized in our laboratory (14, 28). We found comparable ex vivo 
levels of IL-7R-chain (CD127) expression within naïve CD4 T-cells in healthy and 
thymectomized individuals, irrespective of the degree of thymopoiesis (Figure 5A), and 
others have shown that the proximal signalling through the IL-7 receptor is preserved 
in adults thymectomized in infancy, as assessed by STAT5 phosphorylation upon short-
term stimulation with IL-7 (20).  
 
 
Figure 5. Impact of thymectomy on naïve CD4 T-cell ability to respond to IL-7. Purified naïve 
CD4 T-cells from thymectomized individuals without (Thy) or with evidence of thymic activity (Thy), 
and age-matched healthy controls were cultured for 13d with IL-7 or IL-2. (A) Illustrative contour-plots 
from one individual of each cohort showing maintenance of naïve phenotype (CD45RA+) and down-
regulation of IL-7R upon culture with IL-7, but not with IL-2; graph shows CD127 MFI within the CD31+ 
and CD31- compartments ex vivo (d) and upon culture with IL-2 or IL-7 in the three cohorts. (B) 
Overlay histogram illustrating Bcl-2 expression within CD31+ and CD31 naïve CD4 T-cells in one Thy 
patient ex vivo (d) and upon culture; graph shows the MFI fold change to d of Bcl-2 expression level 
in CD31+ and CD31 naïve CD4 T-cells upon culture with IL-7 or IL-2 in the three cohorts. Bars represent 
median and interquartile range. The down-regulation of CD127 and the up-regulation of Bcl-2 in 
response to IL-7 in all the cell populations evaluated were statistically significant as compared to both 
d and IL-2 (P<0.05), and no significant differences were found between d and IL-2 (P>0.05). 
 
As illustrated in Figure 5A, the cells preserved their naïve phenotype upon culture with 
either IL-7 or IL-2, including those from Thy individuals. The expected IL-7-mediated 
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down-regulation of CD127 expression (14, 41) was comparable in all individuals, and, 
therefore, independent of the degree of thymic activity (Figure 5A). Of note, no changes 
occurred in the control culture condition with IL-2 (Figure 5A). Additionally, the up-
regulation of CD25 and CD95 by IL-7 (14, 42) was also similar in all cohorts, both in the 
CD31+ and CD31 compartments (data not shown).  
 
An important physiological role of IL-7 relies on Bcl-2 induction (43). We found a clear 
up-regulation of Bcl-2 expression, in both CD31+ and CD31 subsets in cultures with IL-
7 in all thymectomized individuals, which was not observed with IL-2 (Figure 5B).  
 
We then investigated the proliferative response of naïve CD4 T-cells using the cell-
cycling marker Ki-67, which we have shown to be the best approach to reveal low-level 
IL-7-driven proliferation (14). Unexpectedly, we found that in contrast to healthy and 
Thy cohorts, Thy featured no significant increase in the frequency of cycling cells in 
response to IL-7, as compared to both ex vivo and cultures with IL-2 (Figure 6A and 
6B). Naïve CD4 T-cell recovery per well was significantly higher upon culture with IL-
7 than IL-2 in healthy (fold change 1.07[0.86-1.54] vs 0.79[0.51-1.63]; P=0.0137) and 
Thy (fold change 1.15[0.16-1.55] vs 0.65[0.06-1.32]; P=0.0259), but not in Thy (fold 
change 0.87[0.65-1.77] vs 0.54[0.34-1.66]; P=0.2234). The cell recovery upon culture 
with IL-7 was significantly lower in Thy as compared to healthy individuals 
(P=0.0236). 
 
We have previously shown that the IL-7-induced proliferation was restricted to the 
CD31+ subset in healthy subjects (14), which was confirmed here (Figure 6B). Notably, 
a similar profile was observed in Thy individuals, in striking contrast with patients 
lacking thymic activity (Figure 6B).    
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Figure 6. Impact of thymectomy on naïve CD4 T-cell ability to proliferate in vitro in 
response to IL-7. Purified naïve CD4 T-cells from thymectomized patients without (Thy) or with 
evidence of thymic activity (Thy), and from age-matched healthy controls were cultured for 13d with IL-
7 or IL-2.  (A) Frequency of cycling cells (Ki-67+) within total naïve CD4 T-cells ex vivo (d) and upon 
culture with IL-7 or IL-2. (B) Contour-plots illustrate the analysis of Ki-67 versus CD31 in representative 
Thy, Thy and healthy individuals, and graph shows the frequency of CD31+ cells within Ki-67+ cells. (C) 
Illustrative contour-plots of the analysis of PTK7 versus CD31 or Ki-67 within naïve CD4 T-cells cultured 
with IL-7. (D) Frequency of PTK7 ex vivo (d) and upon culture with IL-7. (E) Levels of expression of 
CD31 (MFI) within the CD31+ compartment ex vivo (d) and upon culture with IL-7 or IL-2. Each dot 
represents one individual, and bars represent median; P-values comparing conditions within cohorts (A, 
C, D) and between cohorts (B) are shown.   
 
Naïve CD4 T-cells expressing protein tyrosine kinase 7 (PTK7) have been shown to 
display higher ability to proliferate in response to IL-7 (44). In spite of the very low 
(<1%) frequencies of PTK7+ cells within naïve CD31+ CD4 T-cells ex vivo, we 
demonstrated, in cultures with IL-7 from healthy individuals, that PTK7+ cells 
expressed the highest levels of CD31 and were all cycling (Figure 6C), leading to an 
increase in their overall frequency at the end of the culture (Figure 6D). The same 
pattern of response was observed in individuals with evidence of some degree of 
thymic activity (Figure 6C and 6D). In contrast, Thy cases featured cycling cells in 
both CD31+ and CD31 naïve CD4 T-cell compartments (Figure 6B), and no expansion 
of PTK7+ cells (Figure 6C and 6D).  
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We have also previously shown that IL-7 up-regulates the levels of expression of CD31 
within the CD31+ naïve CD4 T-cell subset in a PI3K-dependent manner (14, 28). Of note, 
the Thy cohort reached significantly lower levels of up-regulation of CD31 MFI within 
the CD31+ subset in response to IL-7, as compared to healthy (P=0.0035), despite 
featuring comparable ex vivo levels (P=0.1052) (Figure 6E). Moreover, the up-
regulation of CD31 MFI was also significantly lower in Thy than in Thy (P=0.0177) 
individuals, although the latter featured significantly higher ex vivo levels of CD31 MFI 
within the CD31+ subset (P=0.0177) (Figure 6E). These findings suggest that naïve CD4 
T-cells from Thy patients lost the ability to respond to IL-7 through the PI3K 
pathway, in agreement with their impaired proliferation. Conversely, they preserved 
the ability to up-regulate Bcl-2 in response to IL-7, which we have shown previously 
that is not PI3K-dependent (14, 28).  
 
Altogether, these data showed that the ability of naïve CD4 T-cells to proliferate and 
upregulate CD31 in response to IL-7 was impaired in individuals completely lacking 
thymic activity 
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3.1.5. Discussion 
 
We investigated here mechanisms of peripheral naïve CD4 T-cell homeostasis in adults 
with different degrees of thymus impairment since early infancy. We found that the 
size of the CD31– compartment was similar in healthy and thymectomized subjects, 
supporting the existence of thymus-independent homeostasis, possibly driven by self-
peptide/MHC. On the other hand, proliferation mediated by IL-7, the main homeostatic 
cytokine, was severely impaired in the absence of thymopoiesis.  
 
Thymectomy performed during corrective cardiac surgery in infancy is widely 
recognized as a powerful model to investigate the thymus contribution to naïve T-cell 
maintenance beyond the establishment of the T-cell compartment. Nevertheless, a 
wide heterogeneity of findings has been reported (22-26, 32, 45-48). Our study focused 
on adults thymectomized during infancy/early childhood within a relatively narrow 
age range, which were grouped according to absence (Thy) or presence (Thy) of 
thymopoiesis based on circulating sjTRECs/μl (5). Our molecular strategy to 
stringently rule out the existence of thymic output in thymectomized patients 
overcomes the limitations of other approaches based solely on surgical reports (21, 23, 
32, 45-47) and/or thoracic imaging (21, 32, 46, 49), which may have neglected thymic 
regeneration or ectopic thymus (50). 
 
Of note, after the exclusion of the thymectomized patients lacking thymic activity, we 
found that both size and diversity of the naïve CD4 T-cell compartment were preserved 
to a median of 21y post-thymectomy. This likely occurred through both peripheral 
mechanisms and thymus regeneration, as supported by our finding of sj/βTREC ratios 
in Thy patients within the range of healthy age-matched controls. These data 
strengthen the recommendation to avoid complete thymectomy during cardiac 
surgery (45, 51), which is particularly relevant after the first year of life given the 
observed association between younger age at thymectomy and thymic recovery (24, 
32).  
 
The thymus provides a unique environment to generate a diverse TCR-repertoire (52). 
This process that involves genomic recombination and gene editing at the individual 
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cell level (53), imposes major challenges to the quantification of TCR diversity, 
particularly when sample availability is limited (53-58), leading us to opt for a standard 
approach using spectratyping. To our knowledge, there is only one study assessing the 
diversity of purified naïve CD4 T-cells from 3 thymectomized children/adolescents 
that reported conservation of the spectratyping profiles (25). We showed here that the 
diversity of the TCR repertoire within the naïve CD4 T-cell compartment was 
preserved in thymectomized individuals with some degree of remaining thymic 
activity, and significantly contracted in patients completely lacking thymopoiesis. This 
profile of premature immune senescence (21, 22, 47, 59) is likely to have clinical 
implications not yet evaluated, since successful corrective cardiac surgery in young 
children only became a routine practice 3 decades ago, precluding extended follow-up 
studies (46, 60).  
 
Of note, patients lacking thymic activity featured no major change of the transcript 
levels of genes involved in cell quiescence and survival of naïve CD4 T-cells, except for 
the significant increase in DUSP6. This phosphatase enhances the TCR activation 
threshold by decreasing ERK phosphorylation (39). However, no significant change 
was observed in the activation of purified naïve CD4 T-cells, suggesting that this 
pathway does not limit their purging into the memory-effector pool in completely 
thymectomized patients. Accordingly, they featured an increase in cycling cells within 
the CD31 subset that is thought to mainly proliferate in response to TCR stimulation 
by low-affinity self-peptide/MHC (2, 18).  
 
We showed here that the maintenance of the CD31– subset is independent of thymic 
output, and that robust peripheral mechanisms ensure the homeostasis of this 
population. This is in agreement with the CD31 preservation that others have 
reported during age-associated thymic involution (12, 40). Our study revealed that, 
even in healthy young adults, the levels of the pro-survival molecule Bcl-2 were 
significantly higher in CD31– than in CD31+ naïve CD4 T-cells, emphasizing the 
contribution of anti-apoptotic pathways for the homeostasis of the CD31– subset (61).  
 
IL-7 is known to play a crucial role in naïve CD4 T-cell homeostasis, not only by 
enhancing thymopoiesis (62, 63), but also through the peripheral induction of survival 
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and proliferation (14, 28, 57, 64). Our data support the notion that in the absence of 
thymopoiesis there is a significant impairment in the peripheral responses to IL-7 that 
are PI3K-dependent, namely proliferation and CD31 up-regulation, whereas Bcl-2 
induction, which does not rely on this pathway, is preserved.   
 
Functional heterogeneity within naïve CD4 T-cells may result from the maturation 
process that RTEs undergo in the periphery, which may vary throughout life (65-67). 
It is expectable that cells with privileged response to IL-7 are more abundant in the 
first years of life, when accelerated growth and constant exposure to new antigens 
demand for peripheral expansion to ensure continuous replenishment of the naïve 
compartment. IL-7-induced proliferation is known to be higher in mature single 
positive thymocytes than peripheral T-cells (28, 67), and in cord blood than adult naïve 
CD4 T-cells (14). Moreover, it is plausible that in elderly an impaired ability of 
circulating naïve CD4 T-cells to proliferate in response to IL-7 contributes to their 
decline, in parallel with thymic involution (40).  
 
Our data suggest a scenario where proliferative responses to IL-7 would be favored in 
a narrow window of time upon thymic egress, which has important implications to the 
therapeutic use of IL-7 in clinical settings known to be associated with thymic injury, 
namely HIV/AIDS (68, 69) and chemotherapy (70, 71). Therefore, the requirement for 
ongoing thymopoiesis questions the suggested benefit of IL-7 therapy in the recovery 
of lymphopenia in thymectomized individuals (21).  
 
In conclusion, our investigation of the interplay of thymic output and peripheral 
mechanisms to the maintenance of the naïve CD4 T-cell compartment uncovered the 
need for continued thymic activity to the IL-7-driven peripheral proliferation of naïve 
CD4 T-cells. These findings are of particular relevance for lymphopenic clinical settings 
and aging, demanding the appraisal of thymus targeting strategies in order to maximize 
the peripheral effect of IL-7. 
  
Results | IL-7-induced proliferation of human naïve CD4 T-cells requires maintenance of thymic activity 
85 
Acknowledgments 
We thank the sample donors for their collaboration, as well as Rita Tendeiro, Helena 
Nunes-Cabaço, Maria Conceição Pereira-Santos, Ana Serra-Caetano, Russell B. Foxall, 
Ana R. Pires and Ana Isabel Pinheiro for technical assistance and discussion of the 
results.  
 
Funding 
This work was supported by Fundação para a Ciência e Tecnologia (FCT; 
POCI2010/IC/83068/2007 to RMMV; PTDC/SAU-MIC/109786/2009 to AES), and 
Gulbenkian Foundation (P132532/2013 to AES). SLS, ASA, and PM received FCT 
scholarships.  
 
Author contributions 
SLS, ASA, JTB, RMMV, and AES designed the study; SLS, ASA, PM, DL and RC performed 
research; SLS. MA, and RA collected clinical data; AES supervised the study; SLS and 
AES wrote the paper.  
 
Competing interests 
The authors declare that they have no competing interests.  
 
 
  
Living without thymus: lessons from adults thymectomized in early infancy 
86 
3.1.6. References 
 
1. Appay, V., and D. Sauce. 2014. Naive T cells: the crux of cellular immune aging? 
Exp Gerontol 54: 90-93. 
2. Kohler, S., and A. Thiel. 2009. Life after the thymus: CD31+ and CD31- human 
naive CD4+ T-cell subsets. Blood 113: 769-774. 
3. den Braber, I., T. Mugwagwa, N. Vrisekoop, L. Westera, R. Mogling, A. B. de Boer, 
N. Willems, E. H. Schrijver, G. Spierenburg, K. Gaiser, E. Mul, S. A. Otto, A. F. 
Ruiter, M. T. Ackermans, F. Miedema, J. A. Borghans, R. J. de Boer, and K. 
Tesselaar. 2012. Maintenance of peripheral naive T cells is sustained by thymus 
output in mice but not humans. Immunity 36: 288-297. 
4. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, 
M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, B. D. Jamieson, J. A. Zack, L. 
J. Picker, and R. A. Koup. 1998. Changes in thymic function with age and during 
the treatment of HIV infection. Nature 396: 690-695. 
5. Dion, M. L., R. P. Sekaly, and R. Cheynier. 2007. Estimating thymic function 
through quantification of T-cell receptor excision circles. Methods Mol Biol 380: 
197-213. 
6. Zhang, L., S. R. Lewin, M. Markowitz, H. H. Lin, E. Skulsky, R. Karanicolas, Y. He, 
X. Jin, S. Tuttleton, M. Vesanen, H. Spiegel, R. Kost, J. van Lunzen, H. J. Stellbrink, 
S. Wolinsky, W. Borkowsky, P. Palumbo, L. G. Kostrikis, and D. D. Ho. 1999. 
Measuring recent thymic emigrants in blood of normal and HIV-1-infected 
individuals before and after effective therapy. J Exp Med 190: 725-732. 
7. Utsuyama, M., K. Hirokawa, C. Kurashima, M. Fukayama, T. Inamatsu, K. Suzuki, 
W. Hashimoto, and K. Sato. 1992. Differential age-change in the numbers of 
CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech 
Ageing Dev 63: 57-68. 
8. Stulnig, T., C. Maczek, G. Bock, O. Majdic, and G. Wick. 1995. Reference intervals 
for human peripheral blood lymphocyte subpopulations from 'healthy' young 
and aged subjects. Int Arch Allergy Immunol 108: 205-210. 
9. Pekalski, M. L., R. C. Ferreira, R. M. Coulson, A. J. Cutler, H. Guo, D. J. Smyth, K. 
Downes, C. A. Dendrou, X. Castro Dopico, L. Esposito, G. Coleman, H. E. Stevens, 
S. Nutland, N. M. Walker, C. Guy, D. B. Dunger, C. Wallace, T. I. Tree, J. A. Todd, 
Results | IL-7-induced proliferation of human naïve CD4 T-cells requires maintenance of thymic activity 
87 
and L. S. Wicker. 2013. Postthymic expansion in human CD4 naive T cells 
defined by expression of functional high-affinity IL-2 receptors. J Immunol 190: 
2554-2566. 
10. Westera, L., V. van Hoeven, J. Drylewicz, G. Spierenburg, J. F. van Velzen, R. J. de 
Boer, K. Tesselaar, and J. A. Borghans. 2015. Lymphocyte maintenance during 
healthy aging requires no substantial alterations in cellular turnover. Aging Cell 
14: 219-227. 
11. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 
2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. 
Proc Natl Acad Sci U S A 98: 8732-8737. 
12. Kohler, S., U. Wagner, M. Pierer, S. Kimmig, B. Oppmann, B. Mowes, K. Julke, C. 
Romagnani, and A. Thiel. 2005. Post-thymic in vivo proliferation of naive CD4+ 
T cells constrains the TCR repertoire in healthy human adults. Eur J Immunol 
35: 1987-1994. 
13. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to 
peripheral T cell maintenance. J Immunol 174: 6571-6576. 
14. Azevedo, R. I., M. V. Soares, J. T. Barata, R. Tendeiro, A. Serra-Caetano, R. M. 
Victorino, and A. E. Sousa. 2009. IL-7 sustains CD31 expression in human naive 
CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent 
manner. Blood 113: 2999-3007. 
15. Newton-Nash, D. K., and P. J. Newman. 1999. A new role for platelet-endothelial 
cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal 
transduction. J Immunol 163: 682-688. 
16. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands 
mediating positive selection in the thymus control T cell survival and 
homeostatic proliferation in the periphery. Immunity 11: 173-181. 
17. Torimoto, Y., D. M. Rothstein, N. H. Dang, S. F. Schlossman, and C. Morimoto. 
1992. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, 
unaltered by state of activation. J Immunol 148: 388-396. 
18. Kimmig, S., G. K. Przybylski, C. A. Schmidt, K. Laurisch, B. Mowes, A. Radbruch, 
and A. Thiel. 2002. Two subsets of naive T helper cells with distinct T cell 
receptor excision circle content in human adult peripheral blood. J Exp Med 195: 
789-794. 
Living without thymus: lessons from adults thymectomized in early infancy 
88 
19. Demeure, C. E., D. G. Byun, L. P. Yang, N. Vezzio, and G. Delespesse. 1996. CD31 
(PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation 
into Th1 or Th2 effector cells. Immunology 88: 110-115. 
20. Sauce, D., M. Larsen, S. Fastenackels, A. Roux, G. Gorochov, C. Katlama, D. Sidi, J. 
Sibony-Prat, and V. Appay. 2012. Lymphopenia-driven homeostatic regulation 
of naive T cells in elderly and thymectomized young adults. J Immunol 189: 
5541-5548. 
21. Sauce, D., M. Larsen, S. Fastenackels, A. Duperrier, M. Keller, B. Grubeck-
Loebenstein, C. Ferrand, P. Debre, D. Sidi, and V. Appay. 2009. Evidence of 
premature immune aging in patients thymectomized during early childhood. J 
Clin Invest 119: 3070-3078. 
22. Prelog, M., M. Keller, R. Geiger, A. Brandstatter, R. Wurzner, U. Schweigmann, M. 
Zlamy, L. B. Zimmerhackl, and B. Grubeck-Loebenstein. 2009. Thymectomy in 
early childhood: significant alterations of the CD4(+)CD45RA(+)CD62L(+) T cell 
compartment in later life. Clin Immunol 130: 123-132. 
23. Eysteinsdottir, J. H., J. Freysdottir, I. Skaftadottir, H. Helgason, A. Haraldsson, and 
H. M. Ogmundsdottir. 2009. Vbeta usage and T regulatory cells in children 
following partial or total thymectomy after open heart surgery in infancy. Scand 
J Immunol 69: 162-168. 
24. van Gent, R., A. W. Schadenberg, S. A. Otto, R. A. Nievelstein, G. T. Sieswerda, F. 
Haas, F. Miedema, K. Tesselaar, N. J. Jansen, and J. A. Borghans. 2011. Long-term 
restoration of the human T-cell compartment after thymectomy during infancy: 
a role for thymic regeneration? Blood 118: 627-634. 
25. Halnon, N. J., P. Cooper, D. Y. Chen, M. I. Boechat, and C. H. Uittenbogaart. 2011. 
Immune dysregulation after cardiothoracic surgery and incidental 
thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis. 
Clin Dev Immunol 2011: 915864. 
26. Halnon, N. J., B. Jamieson, M. Plunkett, C. M. Kitchen, T. Pham, and P. Krogstad. 
2005. Thymic function and impaired maintenance of peripheral T cell 
populations in children with congenital heart disease and surgical thymectomy. 
Pediatr Res 57: 42-48. 
27. Gudmundsdottir, J., S. Oskarsdottir, G. Skogberg, S. Lindgren, V. Lundberg, M. 
Berglund, A. C. Lundell, H. Berggren, A. Fasth, E. Telemo, and O. Ekwall. 2016. 
Results | IL-7-induced proliferation of human naïve CD4 T-cells requires maintenance of thymic activity 
89 
Early thymectomy leads to premature immunologic ageing: An 18-year follow-
up. J Allergy Clin Immunol. 
28. Silva, S. L., A. S. Albuquerque, A. Serra-Caetano, R. B. Foxall, A. R. Pires, P. Matoso, 
S. M. Fernandes, J. Ferreira, R. Cheynier, R. M. Victorino, I. Caramalho, J. T. Barata, 
and A. E. Sousa. 2016. Human naive regulatory T-cells feature high steady-state 
turnover and are maintained by IL-7. Oncotarget. 
29. Chattopadhyay, P. K., J. Yu, and M. Roederer. 2005. A live-cell assay to detect 
antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med 11: 1113-
1117. 
30. Dion, M. L., J. F. Poulin, R. Bordi, M. Sylvestre, R. Corsini, N. Kettaf, A. Dalloul, M. 
R. Boulassel, P. Debre, J. P. Routy, Z. Grossman, R. P. Sekaly, and R. Cheynier. 
2004. HIV infection rapidly induces and maintains a substantial suppression of 
thymocyte proliferation. Immunity 21: 757-768. 
31. Albuquerque, A. S., J. G. Marques, S. L. Silva, D. Ligeiro, B. H. Devlin, J. Dutrieux, 
R. Cheynier, C. Pignata, R. M. Victorino, M. L. Markert, and A. E. Sousa. 2012. 
Human FOXN1-deficiency is associated with alphabeta double-negative and 
FoxP3+ T-cell expansions that are distinctly modulated upon thymic 
transplantation. PLoS One 7: e37042. 
32. van den Broek, T., E. M. Delemarre, W. J. Janssen, R. A. Nievelstein, J. C. Broen, K. 
Tesselaar, J. A. Borghans, E. E. Nieuwenhuis, B. J. Prakken, M. Mokry, N. J. Jansen, 
and F. van Wijk. 2016. Neonatal thymectomy reveals differentiation and 
plasticity within human naive T cells. J Clin Invest 126: 1126-1136. 
33. Pannetier, C., J. Even, and P. Kourilsky. 1995. T-cell repertoire diversity and 
clonal expansions in normal and clinical samples. Immunol Today 16: 176-181. 
34. Kuo, C. T., M. L. Veselits, and J. M. Leiden. 1997. LKLF: A transcriptional regulator 
of single-positive T cell quiescence and survival. Science 277: 1986-1990. 
35. Feng, X., H. Wang, H. Takata, T. J. Day, J. Willen, and H. Hu. 2011. Transcription 
factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive 
T cells. Nat Immunol 12: 544-550. 
36. Khanna, A. K., M. Plummer, V. Nilakantan, and G. M. Pieper. 2005. Recombinant 
p21 protein inhibits lymphocyte proliferation and transcription factors. J 
Immunol 174: 7610-7617. 
Living without thymus: lessons from adults thymectomized in early infancy 
90 
37. Tsukamoto, H., G. E. Huston, J. Dibble, D. K. Duso, and S. L. Swain. 2010. Bim 
dictates naive CD4 T cell lifespan and the development of age-associated 
functional defects. J Immunol 185: 4535-4544. 
38. Huang, C. Y., and T. H. Tan. 2012. DUSPs, to MAP kinases and beyond. Cell Biosci 
2: 24. 
39. Li, G., M. Yu, W. W. Lee, M. Tsang, E. Krishnan, C. M. Weyand, and J. J. Goronzy. 
2012. Decline in miR-181a expression with age impairs T cell receptor 
sensitivity by increasing DUSP6 activity. Nat Med 18: 1518-1524. 
40. Kilpatrick, R. D., T. Rickabaugh, L. E. Hultin, P. Hultin, M. A. Hausner, R. Detels, J. 
Phair, and B. D. Jamieson. 2008. Homeostasis of the naive CD4+ T cell 
compartment during aging. J Immunol 180: 1499-1507. 
41. Park, J. H., Q. Yu, B. Erman, J. S. Appelbaum, D. Montoya-Durango, H. L. Grimes, 
and A. Singer. 2004. Suppression of IL7Ralpha transcription by IL-7 and other 
prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell 
survival. Immunity 21: 289-302. 
42. Kinter, A. L., E. J. Godbout, J. P. McNally, I. Sereti, G. A. Roby, M. A. O'Shea, and A. 
S. Fauci. 2008. The Common gamma-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 
Induce the Expression of Programmed Death-1 and Its Ligands. Journal of 
Immunology 181: 6738-6746. 
43. Hassan, J., and D. J. Reen. 1998. IL-7 promotes the survival and maturation but 
not differentiation of human post-thymic CD4(+) T cells. European Journal of 
Immunology 28: 3057-3065. 
44. Haines, C. J., T. D. Giffon, L. S. Lu, X. Lu, M. Tessier-Lavigne, D. T. Ross, and D. B. 
Lewis. 2009. Human CD4+ T cell recent thymic emigrants are identified by 
protein tyrosine kinase 7 and have reduced immune function. J Exp Med 206: 
275-285. 
45. Kurobe, H., T. Tominaga, M. Sugano, Y. Hayabuchi, Y. Egawa, Y. Takahama, and 
T. Kitagawa. 2013. Complete but not partial thymectomy in early infancy 
reduces T-cell-mediated immune response: three-year tracing study after 
pediatric cardiac surgery. J Thorac Cardiovasc Surg 145: 656-662, 662 e651-
652; discussion 662. 
46. Prelog, M., C. Wilk, M. Keller, T. Karall, D. Orth, R. Geiger, G. Walder, G. Laufer, M. 
Cottogni, B. Zimmerhackl Lothar, J. Stein, B. Grubeck-Loebenstein, and R. 
Results | IL-7-induced proliferation of human naïve CD4 T-cells requires maintenance of thymic activity 
91 
Wuerzner. 2008. Diminished response to tick-borne encephalitis vaccination in 
thymectomized children. Vaccine 26: 595-600. 
47. Mancebo, E., J. Clemente, J. Sanchez, J. Ruiz-Contreras, P. De Pablos, S. Cortezon, 
E. Romo, E. Paz-Artal, and L. M. Allende. 2008. Longitudinal analysis of immune 
function in the first 3 years of life in thymectomized neonates during cardiac 
surgery. Clin Exp Immunol 154: 375-383. 
48. Eysteinsdottir, J. H., J. Freysdottir, A. Haraldsson, J. Stefansdottir, I. Skaftadottir, 
H. Helgason, and H. M. Ogmundsdottir. 2004. The influence of partial or total 
thymectomy during open heart surgery in infants on the immune function later 
in life. Clin Exp Immunol 136: 349-355. 
49. Kamali, K., M. Ghahartars, and A. A. Amirghofran. 2014. Evaluation of thymic 
changes after median sternotomy in children. Iran J Med Sci 39: 289-292. 
50. Sanei, B., S. A. Tabatabie, H. Bigdelian, S. M. Hashemi, A. H. Davarpanah, H. R. 
Jafari, and M. H. Sanei. 2015. Distribution of mediastinal ectopic thymic tissue in 
patients without thymic disease. Adv Biomed Res 4: 18. 
51. Sauce, D., and V. Appay. 2011. Altered thymic activity in early life: how does it 
affect the immune system in young adults? Curr Opin Immunol 23: 543-548. 
52. Carpenter, A. C., and R. Bosselut. 2010. Decision checkpoints in the thymus. Nat 
Immunol 11: 666-673. 
53. Attaf, M., E. Huseby, and A. K. Sewell. 2015. alphabeta T cell receptors as 
predictors of health and disease. Cell Mol Immunol 12: 391-399. 
54. Naylor, K., G. Li, A. N. Vallejo, W. W. Lee, K. Koetz, E. Bryl, J. Witkowski, J. 
Fulbright, C. M. Weyand, and J. J. Goronzy. 2005. The influence of age on T cell 
generation and TCR diversity. J Immunol 174: 7446-7452. 
55. Goronzy, J. J., W. W. Lee, and C. M. Weyand. 2007. Aging and T-cell diversity. Exp 
Gerontol 42: 400-406. 
56. Qi, Q., Y. Liu, Y. Cheng, J. Glanville, D. Zhang, J. Y. Lee, R. A. Olshen, C. M. Weyand, 
S. D. Boyd, and J. J. Goronzy. 2014. Diversity and clonal selection in the human 
T-cell repertoire. Proc Natl Acad Sci U S A 111: 13139-13144. 
57. Parker, R., J. Dutrieux, S. Beq, B. Lemercier, S. Rozlan, V. Fabre-Mersseman, M. 
Rancez, C. Gommet, B. Assouline, I. Rance, A. Lim, M. Morre, and R. Cheynier. 
2010. Interleukin-7 treatment counteracts IFN-alpha therapy-induced 
Living without thymus: lessons from adults thymectomized in early infancy 
92 
lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in 
SIV-infected rhesus macaques. Blood 116: 5589-5599. 
58. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky. 
1999. A direct estimate of the human alphabeta T cell receptor diversity. Science 
286: 958-961. 
59. Zlamy, M., and M. Prelog. 2009. Thymectomy in early childhood: a model for 
premature T cell immunosenescence? Rejuvenation Res 12: 249-258. 
60. Brearley, S., T. A. Gentle, M. I. Baynham, K. D. Roberts, L. D. Abrams, and R. A. 
Thompson. 1987. Immunodeficiency following neonatal thymectomy in man. 
Clin Exp Immunol 70: 322-327. 
61. Duszczyszyn, D. A., J. L. Williams, H. Mason, Y. Lapierre, J. Antel, and D. G. 
Haegert. 2010. Thymic involution and proliferative T-cell responses in multiple 
sclerosis. J Neuroimmunol 221: 73-80. 
62. van Lent, A. U., W. Dontje, M. Nagasawa, R. Siamari, A. Q. Bakker, S. M. Pouw, K. 
A. Maijoor, K. Weijer, J. J. Cornelissen, B. Blom, J. P. Di Santo, H. Spits, and N. 
Legrand. 2009. IL-7 enhances thymic human T cell development in "human 
immune system" Rag2-/-IL-2Rgammac-/- mice without affecting peripheral T 
cell homeostasis. J Immunol 183: 7645-7655. 
63. Okamoto, Y., D. C. Douek, R. D. McFarland, and R. A. Koup. 2002. Effects of 
exogenous interleukin-7 on human thymus function. Blood 99: 2851-2858. 
64. Barata, J. T., A. Silva, J. G. Brandao, L. M. Nadler, A. A. Cardoso, and V. A. 
Boussiotis. 2004. Activation of PI3K is indispensable for interleukin 7-mediated 
viability, proliferation, glucose use, and growth of T cell acute lymphoblastic 
leukemia cells. J Exp Med 200: 659-669. 
65. Gibbons, D., P. Fleming, A. Virasami, M. L. Michel, N. J. Sebire, K. Costeloe, R. Carr, 
N. Klein, and A. Hayday. 2014. Interleukin-8 (CXCL8) production is a signatory 
T cell effector function of human newborn infants. Nat Med 20: 1206-1210. 
66. Lewis, D. B., C. Haines, and D. Ross. 2011. Protein tyrosine kinase 7: a novel 
surface marker for human recent thymic emigrants with potential clinical 
utility. J Perinatol 31 Suppl 1: S72-81. 
67. Okazaki, H., M. Ito, T. Sudo, M. Hattori, S. Kano, Y. Katsura, and N. Minato. 1989. 
IL-7 promotes thymocyte proliferation and maintains immunocompetent 
Results | IL-7-induced proliferation of human naïve CD4 T-cells requires maintenance of thymic activity 
93 
thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: 
synergism with IL-2. J Immunol 143: 2917-2922. 
68. Levy, Y., C. Lacabaratz, L. Weiss, J. P. Viard, C. Goujard, J. D. Lelievre, F. Boue, J. M. 
Molina, C. Rouzioux, V. Avettand-Fenoel, T. Croughs, S. Beq, R. Thiebaut, G. 
Chene, M. Morre, and J. F. Delfraissy. 2009. Enhanced T cell recovery in HIV-1-
infected adults through IL-7 treatment. J Clin Invest 119: 997-1007. 
69. Sereti, I., R. M. Dunham, J. Spritzler, E. Aga, M. A. Proschan, K. Medvik, C. A. 
Battaglia, A. L. Landay, S. Pahwa, M. A. Fischl, D. M. Asmuth, A. R. Tenorio, J. D. 
Altman, L. Fox, S. Moir, A. Malaspina, M. Morre, R. Buffet, G. Silvestri, M. M. 
Lederman, and A. S. Team. 2009. IL-7 administration drives T cell-cycle entry 
and expansion in HIV-1 infection. Blood 113: 6304-6314. 
70. Rosenberg, S. A., C. Sportes, M. Ahmadzadeh, T. J. Fry, L. T. Ngo, S. L. Schwarz, M. 
Stetler-Stevenson, K. E. Morton, S. A. Mavroukakis, M. Morre, R. Buffet, C. L. 
Mackall, and R. E. Gress. 2006. IL-7 administration to humans leads to expansion 
of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J 
Immunother 29: 313-319. 
71. Sportes, C., F. T. Hakim, S. A. Memon, H. Zhang, K. S. Chua, M. R. Brown, T. A. 
Fleisher, M. C. Krumlauf, R. R. Babb, C. K. Chow, T. J. Fry, J. Engels, R. Buffet, M. 
Morre, R. J. Amato, D. J. Venzon, R. Korngold, A. Pecora, R. E. Gress, and C. L. 
Mackall. 2008. Administration of rhIL-7 in humans increases in vivo TCR 
repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 
205: 1701-1714. 
 
  
Living	without	thymus:	lessons	from	adults	thymectomized	in	early	infancy	
94	
3.1.7. Supplemental	Data	
	
	
Results | Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7 
95 
3.2 Human naïve regulatory T-cells feature high steady-state 
turnover and are maintained by IL-7 
 
 
Susana L. Silva*,  Adriana S. Albuquerque*,  Ana Serra-Caetano,   Russell B. Foxall,   Ana R. 
Pires,  Paula Matoso, Susana M. Fernandes, João Ferreira, Rémi Cheynier, Rui M. M. 
Victorino,,  Iris Caramalho,  João T. Barata,  and Ana E. Sousa 
 
‡SLS and ASA contributed equally to this study 
 
*Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 
Portugal. 
†Serviço de Imunoalergologia, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, 
Portugal. 
§Clínica Universitária Medicina II, Hospital de Santa Maria, Centro Hospitalar Lisboa 
Norte, Portugal. 
¶Infection Immunity and Inflammation Department, Institut Cochin, INSERM U1016-
CNRS UMR8104-Université Paris Descartes, France. 
 
 
Keywords 
Human Regulatory T-cells, Naïve Regulatory T-cells, Regulatory T-cell Homeostasis, 
Thymectomy, IL-7. 
 
 
Published 
Silva, S.L., et al., Human naïve regulatory T-cells feature high steady-state turnover and 
are maintained by IL-7. Oncotarget 2016;15:12163-75 
 
 
Results | Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7 
97 
3.2.1. Abstract 
 
Naïve FoxP3-expressing regulatory T-cells (Tregs) are essential to control immune 
responses via continuous replenishment of the activated-Treg pool with thymus-
committed suppressor cells. The mechanisms underlying naïve-Treg maintenance 
throughout life in face of the age-associated thymic involution remain unclear. We 
found that in adults thymectomized early in infancy the naïve-Treg pool is remarkably 
well preserved, in contrast to conventional naïve CD4 T-cells. Naïve-Tregs featured 
high levels of cycling and pro-survival markers, even in healthy individuals, and 
contrasted with other circulating naïve/memory CD4 T-cell subsets in terms of their 
strong γc-cytokine-dependent signalling, particularly in response to IL-7. Accordingly, 
ex vivo stimulation of naïve-Tregs with IL-7 induced robust cytokine-dependent 
signalling, Bcl-2 expression, and phosphatidylinositol 3-kinase (PI3K)-dependent 
proliferation, whilst preserving naïve phenotype and suppressive capacity. Altogether, 
our data strongly implicate IL-7 in the thymus-independent long-term survival of 
functional naïve-Tregs, and highlight the potential of targeting the IL-7 pathway to 
modulate Tregs in different clinical settings. 
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3.2.2. Introduction 
 
FoxP3-expressing regulatory T-cells (Treg) maintain tolerance to self and to the 
environment, and are central players in the control of immune responses in general 
[1]. Notwithstanding their relevance in limiting immune-mediated pathology, and their 
therapeutic potential, research focused on human Treg homeostasis has been scarce 
[2]. Human Tregs comprise a compartment of thymus-generated naïve-like cells 
(naïve-Tregs) that continuously replenish the pool of fully-suppressive activated Tregs 
expressing memory markers [1-7]. The mechanisms governing naïve-Treg 
homeostasis, in parallel with age-associated thymic involution, remain largely 
unknown. Moreover, the investigation of naïve-Treg homeostasis has been hampered 
by the difficulty in clearly identifying this subset in murine models [8]. 
 
The establishment and maintenance of the human naïve T-cell compartment is known 
to rely on both thymic output and peripheral expansion, with their relative 
contributions still the subject of intense debate. Increasing evidence points to a major 
contribution of peripheral proliferation in order to explain the relatively stable size of 
the naïve compartment in adulthood despite thymic involution [9, 10].  
 
Individuals submitted to total thymectomy in early infancy due to corrective cardiac 
surgery provide an ideal clinical setting to address the peripheral contribution to long-
term maintenance of naïve T-cell subsets. Contraction of the entire naïve compartment 
upon thymectomy has been consistently reported, confirming the central role of the 
thymus [11-14]. Notwithstanding this, distinct homeostasis of the naïve-Treg and 
conventional naïve (naïve-Tconv) CD4 T-cell compartments have been suggested by a 
longitudinal study that showed naïve-Treg preservation up to 1 year post-thymectomy 
[15], although long-term data are lacking.  
 
Peripheral homeostasis of naïve-Tconvs relies upon a slow rate of cell-turnover 
resulting from both cytokine-driven proliferation, and TCR-stimulation by low-affinity 
self-peptides [16]. Additionally, naïve-Tconv homeostasis is known to rely on pro-
survival factors, such as Bcl-2, which are up-regulated by homeostatic cytokines, 
particularly IL-7 [16, 17].  
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Naïve-Tregs are characterized by high-affinity for self-peptides, and by rapidly 
differentiating into memory-Tregs upon TCR-stimulation [1-6]. Thus, MHC-self peptide 
stimulation is likely to result in loss of their naïve phenotype. On the other hand, in 
terms of the contribution of cytokine-driven proliferation, naïve-Tregs express low 
levels of receptors for the main homeostatic cytokines. CD25, the α-chain of the IL-2 
receptor, is expressed at only intermediate/dim levels [1], questioning whether naïve-
Tregs, like their memory counterparts, depend on IL-2 [2]. Moreover, Tregs per se 
typically express low levels of the α-chain of the IL-7 receptor (IL-7Rα), and there are 
controversial reports on the IL-7 impact on human and murine Tregs [18-22].  
 
We investigated here the impact of IL-7 and IL-2 on peripheral naïve-Tregs from blood 
and secondary lymphoid organs (SLO), as well as on mature FoxP3+ thymocytes, and 
provide evidence for a role of IL-7 in human naïve-Treg homeostasis. We show for the 
first time that naïve-Tregs feature much higher levels of the pro-survival molecule Bcl-
2 and significantly higher turnover than naïve-Tconvs in healthy individuals. These 
parameters further increased in the absence of thymic replenishment, ensuring the 
long-term maintenance of the naïve-Treg compartment in total thymectomized 
individuals.  
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3.2.3. Materials and Methods 
 
Study design  
Blood was collected from healthy and age-matched adults thymectomized in infancy 
(Table 1). Complete thymectomy was confirmed based on the corrective cardiac 
surgery report and severely reduced levels of sjTREC. Patients with syndromatic 
cardiopathy were excluded. Circulating naïve-Tregs were further compared to their 
precursors, CD4SP thymocytes, isolated from thymic tissue obtained from children 
during routine corrective cardiac surgery.   
Tonsil tissue and blood collected at the same time from children submitted to 
tonsillectomy were used to study in parallel naïve CD4 T-cells in blood and SLO. All 
subjects/legal guardians gave written informed consent for blood and/or tissue 
sampling. Study was approved by Ethical Boards of Faculty of Medicine of University 
of Lisbon, and from Hospital de Santa Cruz for thymic tissue collection, Portugal. 
 
Cell isolation  
PBMCs were isolated from freshly-collected heparinized blood via Ficoll-Paque PLUS 
(GE Healthcare, Uppsala, Sweden). Total or naïve CD4 T-cells were subsequently 
purified by negative selection (purity >96%, StemCell Technologies, Grenoble, France). 
Naïve-Tregs (CD45RO─CD25highCD127─), naïve-Tconvs (CD45RO─CD25─CD127high), 
and memory-Tregs (CD45RO+CD25highCD127─) were sorted from purified CD4 T-cells 
using a FACSAria (purity >95%; BD Biosciences, San Jose, CA). Tonsillar mononuclear 
cells and thymocytes were recovered using Ficoll-Paque PLUS after mechanical 
dispersion of tonsil and thymic tissue. CD4SP thymocytes were subsequently purified 
as CD3highCD8─CD4+ cells using a FACSAria (purity >97%).  
 
Cell culture  
Purified naïve CD4 T-cells, naïve-Tregs or naïve-Tconvs, were cultured at 1x106 
cells/ml in complete medium as described [17], with either IL-7 (10ng/ml; R&D 
Systems, Minneapolis, MN) or IL-2 (20IU/ml; NIH/AIDS Research and Reference 
Program, Division of AIDS, NIAID, Hoffman-La Roche), for up to 13 days, with media 
replacement at day 3 and day 7. Naïve CD4 T-cell recovery per well was significantly 
higher upon culture with IL-7 than IL-2 (200,615[144,000-262,167] versus 
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95,958[60,063-178,125]; n=16; P=0.0006). In some experiments, anti-IL-2 blocking 
monoclonal antibody (clone 5334, 10µg/ml, R&D Systems) or isotype control IgG1 
(10µg/ml, eBioscience, San Diego, CA) was added to cultures with IL-7. Cultures were 
also performed for 7 days in presence of PI3K inhibitor LY294002 (10µM, Merck 
Biosciences, Nottingham, UK); mTOR inhibitor rapamycin (100nM, Sigma-Aldrich); or 
drug vehicle DMSO (Sigma-Aldrich). For serum deprivation experiments, purified CD4 
T-cells were cultured for 24 hours in medium without AB serum, or with 40% 
autologous serum alone or supplemented with IL-7, IL-2, anti-IL-2 blocking mAb, or 
isotype control.  
 
Flow-cytometry 
Ex vivo phenotypic analysis was performed in freshly-collected whole blood. Eight-
color staining was performed using mAbs listed in Supplementary Table 1. 
Intracellular staining was done using eBioscience FoxP3 kit. At least 150,000 events 
were acquired for each sample on a BD LSRFortessa (BD Biosciences) and data 
analyzed using FlowJo software (TreeStar, Ashland, OR).  Dead cells were excluded 
according to FSC/SSC characteristics and/or LifeDead staining. After lymphogate 
definition, doublets were excluded, and cells analyzed within the mentioned gates. 
 
STAT5 phosphorylation  
pSTAT5 was quantified in whole blood immediately after collection. After surface 
staining, red blood cells were lysed, and cells fixed and permeabilized using 
eBioscience FoxP3 protocol, followed by BD Cytofix and BD Phosflow (BD Biosciences), 
and 1h incubation at 4°C with anti–pSTAT5 mAb and other intracellular markers 
(Supplementary Table 1). pSTAT5 was also quantified upon stimulation of surface 
stained purified CD4 T-cells, with increasing concentrations of recombinant IL-7 
(0.1/1/10/50ng/ml) or IL-2 (2/20/100/200IU/ml) for 15 minutes at 37°C, as 
described [44].  
 
Thymidine analogue 5-ethynyl-2'-deoxy-uridine (EdU) incorporation 
EdU (5µM) was added to cell cultures for 12 hours. Immediately after collection, cells 
were surface and intracellularly stained, resuspension in ice-cold 1% formaldehyde 
(15 minutes), kept on ice on 70% ethanol (10 minutes), and then washed several times 
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in PBS with 0.05% Triton-X100 before detection of EdU-substituted DNA using the 
Click-iT® EdU HCS Assay (Thermo Fischer Scientific) according to manufacturer´s 
instructions.  
 
Cytokine quantification 
Cytokine production at the single-cell level was assessed after 4 hours stimulation with 
PMA+Ionomycin and Brefeldin A, as described [44]. Serum IL-7 levels were quantified 
using Human IL-7 Quantikine HS ELISA kit (R&D Systems) [42].  
 
In vitro suppression assay 
Purified naïve-Tregs were incubated with IL-7, IL-2, or medium alone for 4 hours 
followed by co-culture (ratio 1:1) with autologous naïve-Tconvs labeled with 
carboxyfluorescein succinimidyl ester (CFSE), as described [17], stimulated with plate 
bound anti-CD3 (0.5g/ml, clone OKT3, eBiosciences) in the presence of irradiated 
autologous PBMCs (4000rad). CFSE intensity decline was assessed at d4 by flow-
cytometry; % of suppression of naïve-Tconv proliferation = (% proliferating naïve-
Tconvs plated alone - % proliferating naïve-Tconvs co-cultured with Treg)/ % 
proliferating naïve-Tconvs plated alonex100. 
 
sjTREC quantification 
A highly sensitive nested quantitative PCR assay (detection-limit 1copy/105 cells) was 
used as described [24]. Triplicate multiplex PCR amplification of sjTREC, together with 
the CD3 chain was performed on lysed PBMCs; quantifications were then performed 
using a LightCycler™ in independent experiments, with the same first-round serial 
dilution standard curve.  
 
FOXP3 mRNA quantification 
Total RNA (Zymo Research kits) was used to generate cDNA (Superscript III Reverse 
Transcriptase, Thermo Fischer Scientific). mRNA levels of FOXP3 (primers/probe 
described in [45]), and GAPDH (Taqman Gene Expression Assay) were quantified in 
duplicates  (ViiA 7 Real-Time PCR System, all from Thermo Fischer Scientific) using 
standard curves generated by serial dilutions of cDNA from pooled PBMCs for GAPDH 
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and a plasmid with FOXP3 sequence. Relative copy numbers of FOXP3 were calculated 
upon normalization to GAPDH. 
 
Immunofluorescence staining 
Human tonsils were placed in OCT (VWR, Radnor, PA) and snap-frozen in liquid 
nitrogen. 3μm sections were stained overnight at 4°C using antibodies listed in 
Supplementary Table 1, and DAPI as a nuclear counter stain. Image processing was 
performed using FIJI software. 
 
Statistical analysis  
Statistical analysis was performed with Graph Prism Version 5.01 (GraphPad Software, 
San Diego, CA). The following tests were used: Friedman for variance; Wilcoxon-Signed 
Rank for pairwise comparisons; Mann-Whitney for unpaired comparisons; Spearman’s 
coefficient for correlations. Results were expressed as median [interquartile range or 
range (n<4)]. P-values <0.05 were considered significant. 
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3.2.4. Results  
 
Preservation of the naïve-Treg compartment following thymus removal 
 
Adults submitted to total thymectomy early in life provide a unique setting to 
investigate human naïve compartment homeostasis. However, published studies have 
been hampered by the lack of clear information regarding possible residual thymic 
activity that can result from either ectopic thymus or post-thymectomy regeneration 
[11, 12, 14, 23]. We applied here strict criteria to exclude residual thymic activity based 
on detailed surgical reports and single-joint TCR excision circles (sjTREC) levels clearly 
below the lowest level observed in healthy adults (Table 1).  
 
Table 1. Characterization of the cohorts 
 Healthy Thymectomized 
Number 22 7 
Age, years 21 [18-30] 24 [22-27] 
Age at thymectomy, months NA 23 [12-72] 
sjTRECs/µl 16.6 [4.1-39.3] 0.5 [0.1-1.8]a 
Lymphocytes/l 2413 [1430-3502] 2010 [933-2618] 
% CD4 T-cells 40 [29-52] 43 [23-47] 
% Naïveb in CD4 40 [29-58] 15 [9-49]a 
% FoxP3+ in CD4 2.9 [1.2-5.4] 4.1 [3.0-5.6] 
FoxP3+  cells/L 21 [9-51] 28 [11-39] 
Serum IL-7, pg/ml 15 [7-23] 14 [8-20] 
Data are presented as median with limits in square brackets. 
NA - not applicable. a P<0.0001. b Naïve cells defined as CCR7+CD45RO─. 
 
sjTRECs are by-products of TCR rearrangements during T-cell development that are 
progressively lost as cells divide in the periphery, and thus used to identify recent thymic 
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emigrant cells [24]. Adults, with a median of 21y (18-24.5y) after total thymectomy, were 
compared with age-matched healthy individuals (Table 1). 
 
 
Figure 1. Preservation of the naïve-Treg compartment following thymus removal. 
Circulating naïve-Treg and naïve-Tconv counts; as well as % of cycling-cells, and Bcl-2 MFI within these 
subsets in healthy and thymectomized adults; each symbol represents one individual; bars represent 
median; significant P-values of comparisons within each subset are shown.  
 
We observed a significant decrease in circulating naïve-Tconvs, both in frequency 
within CD4 T-cells (P=0.0042; Supplementary Figure 1A) and absolute numbers 
(P=0.0026; Figure 1), in agreement with previous data from other thymectomized 
cohorts [11-14]. Conversely, the naïve-Treg pool size was preserved, as compared to 
healthy subjects (Figure 1 and Supplementary Figure 1A).  
 
The healthy cohort spanned an age period associated with relatively stable thymic 
function and naïve-Treg numbers [6], and the size of the circulating naïve-Treg pool 
was within the range previously described [4-6].  We sorted naïve-Tregs, and 
confirmed that their FOXP3 mRNA expression levels were comparable to those found 
in memory-Tregs (4526-21104 versus 1540-14363 relative copy numbers, 
respectively, n=3 healthy adults), and much higher than those in naïve-Tconvs (34-115 
relative copy numbers), confirming them as bona fide Tregs [1].  
 
Circulating naïve-Tregs were confirmed to have a truly naïve phenotype both in 
healthy and thymectomized subjects, based on the expression of a panel of naïve 
markers and reduced CD95 expression, as well as expressing Treg function-associated 
markers (CTLA-4, HLA-DR, CD39) at lower levels than memory-Tregs (Figure 1 and 
Supplementary Figure 1B). Although Helios has been proposed as a marker of thymus-
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derived Tregs, we showed that in both cohorts a significant proportion of circulating 
naïve-Tregs lacked Helios expression (Figure 1 and Supplementary Figure 1B), as 
already observed in human mature FoxP3+ CD4 single-positive (CD4SP) thymocytes 
(Supplementary Figure 1C), questioning its usefulness as a marker of thymic-derived 
Tregs [25]. Regarding the CD31+ subset, a population known to be enriched in recent 
thymic emigrants [16], no significant contraction was observed within naïve-Tregs of 
thymectomized, as compared to healthy individuals (P=0.1708, Supplementary Figure 
1B), in contrast to the significant reduction observed within naïve-Tconvs (P=0.0122, 
Supplementary Figure 1B). This finding suggests that distinct homeostatic mechanisms 
are operating in the two naïve compartments upon thymectomy. Interestingly, we have 
previously shown that IL-7 up-regulates CD31 expression [17], further validating the 
importance of investigating the impact of IL-7 on naïve-Tregs, as detailed below.  
 
In order to investigate the mechanisms underlying the preservation of the naïve-Treg 
compartment, we quantified the expression levels of markers of cell survival and cell 
cycling in thymectomized, as compared to healthy individuals. Bcl-2 expression was 
significantly higher, supporting a contribution of increased naïve-Treg survival to their 
maintenance upon thymectomy (P=0.0143; Figure 1). Additionally, significantly higher 
frequencies of cycling-cells, as assessed by Ki-67, were documented (P=0.0009; Figure 
1). The degree of Bcl-2 increase in thymectomized was comparable in the two naïve 
compartments, whereas the increase in Ki-67+ cell frequency was much more striking 
within naïve-Tregs (4-fold) than within naïve-Tconvs (1.7-fold), supporting an 
important contribution of increased cell-turnover to the better preservation of the 
naïve-Treg compartment.  
 
Altogether, our data indicate that naïve-Tregs are preserved in adults submitted to 
total thymectomy in early infancy, mainly through increased homeostatic proliferation. 
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High steady-state turnover of the naïve-Treg compartment  
 
The finding of a preserved naïve-Treg compartment in thymectomized adults 
prompted us to further investigate the mechanisms underlying naïve-Treg 
homeostasis under steady-state conditions in healthy young adults with stable thymic 
output. 
 
We found that naïve-Tregs displayed significantly higher levels of Bcl-2 than both 
naïve-Tconvs and memory-Tregs (Figure 2A), suggesting that enhanced survival plays 
a major role in their maintenance. Therefore, in this respect, naïve-Tregs are distinct 
from memory-Tregs, which have been shown to have a pro-apoptotic profile [1, 4].  
 
 
Figure 2.  High steady-state turnover of the naïve-Treg compartment. (A) Bcl-2 MFI and % of 
cycling-cells, within circulating CD4 T-cell subsets; each dot represents one individual; bars represent 
median; significant P-values are shown.  (B) % of cycling-cells within naïve-Tregs and naïve-Tconvs from 
matched blood and tonsil samples (each symbol represents one child: 2y/open, 6y/grey, and 7y/black).  
 
Additionally, naïve-Tregs featured a much higher in vivo turnover than naïve-Tconvs 
(Figure 2A), with significantly elevated proportion of cycling-cells (2.23%[1.12-4.75] 
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versus 0.17%[0.10-0.29], P<0.0001).  Thus, although naïve-Tregs are frequently 
labeled as “quiescent” as opposed to memory-Tregs, we show here that they featured 
levels of cycling comparable to those found in memory-Tconvs (Figure 2A). 
 
Homeostatic naïve-Tconv proliferation occurs mainly in SLO [16]. We performed a 
parallel study of blood and tonsils, used here as an example of SLO due to ease of access 
to clinical samples. Tonsil naïve-Tregs featured a much higher proportion of cycling-
cells than blood naïve-Tregs (Figure 2B). Notably, the fold-increase in cycling-cells in 
tonsils as compared to blood was much more striking in the naïve-Treg than in the 
naïve-Tconv compartment (4-fold versus 2-fold, respectively). The presence of naïve-
Tregs expressing Ki-67 in tonsil tissue was further confirmed by immunofluorescence 
(Supplementary Figure 2A). Additionally, we showed that naïve-Tregs from freshly-
collected tonsils consistently entered S-phase at higher rates than naïve-Tconvs, as 
estimated by the ex vivo incorporation of 5-ethynyl-2'-deoxy-uridine (Edu), a 
thymidine analogue (Supplementary Figure 2B; 12 hours incubation: naïve-Treg: 1.23-
1.70%; naïve-Tconv: 0.37-0.42%; n=3). Of note, in tonsils, naïve-Tregs featured 
significantly higher proportion of Ki-67+ cells than naïve-Tconvs (Figure 2B), as well as 
Bcl-2 MFI (mean fluorescence intensity; range 2777-3161 versus 1873-1992, n=3, 
respectively).  These results suggest that SLO may provide appropriate niches for 
naïve-Treg homeostatic proliferation.  
Overall, our data show that, in healthy young adults, naïve-Tregs featured markers of 
enhanced survival and increased turnover in comparison to naïve-Tconvs, supporting 
an important contribution of peripheral proliferation to the maintenance of the naïve-
Treg compartment. 
 
 
Ex vivo evidence for ongoing naïve-Treg response to IL-7 
 
Next, we investigated the putative contribution of γc-cytokines to the increased 
turnover and survival of naïve-Tregs. Ex vivo levels of pSTAT5, a downstream marker 
of both IL-7 and IL-2-mediated signalling, were significantly higher in naïve-Treg than 
in naïve-Tconv and memory CD4 subsets, analyzed in freshly-collected whole blood 
from healthy subjects (Figure 3A), irrespectively of the levels of expression of IL-7R 
and IL-2R (Supplementary Figure 1B).  
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Figure 3.  Ex vivo evidence for ongoing naïve-Treg response to IL-7.  (A) Representative 
histogram of ex vivo pSTAT5 levels in circulating naïve-Tregs and naïve-Tconvs, with graph showing 
pSTAT5 MFI within these and counterpart memory CD4 T-cell subsets; comparison of pSTAT5 levels 
only revealed significant differences between naïve-Tregs and all the other subsets (* P<0.05; n=6). (B) 
Analysis of pSTAT5 MFI within gated naïve-Tregs upon in vitro stimulation with increasing 
concentrations of IL-7 or IL-2; each symbol represents one individual. (C) IL-7Rα MFI within naïve-Tregs 
analyzed ex vivo and after 24 hours-culture without serum or supplemented with 40% autologous serum 
alone or with IL-7 (n=6); as well as with IL-2, anti-IL-2 blocking monoclonal antibody, or isotype-control 
(n=3); * P<0.05 as compared to ex vivo levels.  
 
Additionally, we stimulated purified CD4 T-cells with increasing concentrations of IL-
7 or IL-2, and clearly showed that naïve-Tregs responded to both cytokines, in a dose-
dependent manner (Figure 3B and Supplementary Figure 3A). Our data extend 
previous human and murine studies on the ability of Tregs to phosphorylate STAT5 in 
response to IL-7 in vitro [20, 26-28], through the comparison of naïve and memory 
Tregs, as well as their FoxP3 negative counterparts. Since IL-7 signalling induces the 
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down-regulation of its receptor [17], we reasoned that the level of recovery of IL-7R 
expression upon IL-7 deprivation would reflect the extent of ongoing IL-7 signalling in 
vivo. IL-7R expression levels were quantified in purified CD4 T-cells from healthy 
subjects following 24 hours in different culture conditions (Figure 3C and 
Supplementary Figure 3B). Naïve-Tregs featured a significant recovery of IL-7R 
expression in the absence of IL-7 (culture in serum free medium), as compared to ex 
vivo levels, in agreement with a significant ongoing IL-7 response. Notably, IL-7R 
expression was relatively preserved in the presence of autologous serum (IL-7 levels 
range: 15.8-23.5pg/ml). Moreover, the possible contribution of IL-2, either derived 
from serum or produced by cells in culture, was excluded by documenting a lack of 
impact of IL-2 blockade. Addition of exogenous IL-7 (10ng/ml) or IL-2 (20IU/ml) led 
to the expected down-regulation of IL-7R [29].  
 
In conclusion, we showed that naïve-Tregs featured high ex vivo pSTAT5 levels, and 
recovered IL-7Rα expression after IL-7 deprivation, supporting their ongoing response 
to IL-7 in vivo. 
 
 
Preserved naïve phenotype, Treg-markers and suppressive capacity upon naïve-
Treg response to IL-7. 
 
We subsequently investigated the impact of IL-7 on naïve-Treg phenotype and 
suppressive capacity. For this purpose, total naïve CD4 T-cells were purified from 
freshly-collected blood of healthy donors, and cultured for up to 13 days in the 
presence of IL-7 or IL-2, using conditions previously optimized in our laboratory [17]. 
Analysis was performed within naïve-Tregs and naïve-Tconvs defined according to 
their FoxP3 expression, as illustrated in Figure 4A. 
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Figure 4.  Evidence of naïve-Treg response to IL-7 while preserving their naïve and 
suppressive phenotype.  (A) Representative contour-plots of FoxP3 and CD25 expression within total 
naïve CD4 T-cells ex vivo (dØ) and upon 13 day-culture with IL-7 or IL-2. (B) Illustrative histogram 
demonstrating absence of FoxP3 induction in purified naïve-Tconvs following 13 day-culture with IL-7. 
(C) Cell recovery upon 13 day-culture with IL-7 or IL-2 of total naïve CD4 T-cells (n=11), purified naïve-
Tregs (n=3) or purified naïve-Tconvs (n=3); graph shows median and interquartile range or range 
(purified populations). (D-F) Analysis of naïve-Tregs and naïve-Tconvs ex vivo and post-13 day-culture 
of naïve CD4 T-cells with IL-7 or IL-2 showing representative contour-plots of CD31/CD45RA expression 
(D),  and graphs of MFI of CD31 (D), CD25 (E), and IL-7Rα (F); each dot represents one individual; bars 
represent median; comparisons done within each subset; significant P-values are shown. (G) Illustrative 
histograms of CTLA-4, Helios, HLA-DR, CD39, Tim-3, PD-1 and PD-L1 expression within naïve-Tregs and 
naïve-Tconvs ex vivo and post-13 day-culture with IL-7 or IL-2 (one/3-14). (H) IL-2, IL-4, IL-17 and IFN-
γ production after short-term PMA/Ionomycin stimulation ex vivo and post-13 day-culture with IL-7 or 
IL-2 (one/3). (I) Illustrative histograms of CFSE expression within naïve-Tconvs cultured alone or with 
naïve-Tregs pre-incubated with medium alone, IL-7 or IL-2 (numbers represent % of cells that divided 
at least once); graph shows % of suppression of naïve-Tconv proliferation in 3 individuals.   
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We confirmed that FoxP3 was not induced in naïve-Tconvs in the presence of IL-7, 
using sorted naïve-Tconvs cultured alone with IL-7, and showing no increase in FoxP3 
expression either at the protein level, by flow-cytometry (Figure 4B), or at the 
transcriptional level by real-time PCR (ex vivo range 34-115 versus 14-62 FOXP3 
relative copy numbers after 13 day-culture, n=3). FoxP3 induction was also not 
observed in cultures of purified naïve-Tconvs with IL-2 (data not shown). This is in 
agreement with the requirement for TCR stimulation for de novo induction of FoxP3 in 
conventional CD4 T-cells [1].  
 
Importantly, despite the clear impact of both IL-7 and IL-2 on the recovery of naïve-
Tregs in cultures of total naïve CD4 T-cells, neither cytokine was able to maintain sort-
purified naïve-Tregs when they were cultured alone (Figure 4C). This finding revealed 
a requirement for naïve-Tregs to interact with naïve-Tconvs to ensure their survival, 
which was not overcome by the addition of IL-2 (Figure 4C). These data precluded 
purified naïve-Treg culture in isolation.  
 
Of note, the overall proportion of naïve-Tregs within total naïve CD4 T-cells 
significantly increased upon 13 day-culture with IL-7 (from 0.99%[0.60-1.43] to 
2.15%[1.29-3.21], P=0.0048, n=16). This increase was more evident upon culture with 
IL-2 (7.94%[3.65-11.75], P=0.0005), likely due to the reduced impact of IL-2 on naïve-
Tconvs (Figure 4C). 
 
As illustrated in Figure 4D, FoxP3+ cells maintained their naïve phenotype following 13 
day-culture with either IL-7 or IL-2. Our previous work showed that IL-7 increases 
CD31 expression in naïve CD31+ CD4 T-cells [17]. Here, we showed that naïve-Tregs 
cultured in the presence of IL-7 up-regulated CD31 MFI to levels comparable to naïve-
Tconvs (fold-increase: 2.17[1.45-3.69] versus 2.17[1.73-2.46], P=0.4333, respectively; 
Figure 4D). Moreover, naïve-Tregs up-regulated CD25 (fold-increase: 3.85[3.29-6.01], 
Figure 4E), and down-regulated IL-7R (fold-reduction: 0.43[0.23-0.67], Figure 4F) 
upon IL-7 stimulation, although less markedly than naïve-Tconvs (11.54[7.80-14.96], 
P<0.0001 for CD25; and 0.21[0.15-0.27], P=0.0058 for IL-7R expression). These 
findings support an ability of naïve-Tregs to respond to IL-7. 
Living without thymus: lessons from adults thymectomized in early infancy 
114 
The impact of IL-2 on naïve-Tregs followed a similar pattern, albeit significantly less 
striking than that observed for IL-7 (Figure 4D-F). Conversely, in naïve-Tconvs both 
CD25 and CD31 expression levels were unaltered in response to IL-2, whereas IL-7R 
expression increased (Figure 4D-F), possibly due to a dominant effect of IL-7 
deprivation [17, 29].  
 
Concerning Treg function-associated markers, naïve-Treg FoxP3 MFI (ex vivo: 
778[650-1009], n=16) significantly increased upon culture with IL-7 (1166[863-
1522], P=0.0214), and even more so with IL-2 (1229[902-1916], P=0.0280 as 
compared to ex vivo, P=0.0362 as compared to IL-7). Furthermore, we observed a 
sustained or moderate increase in CTLA-4, CD39 and HLA-DR expression upon culture 
with either IL-7 or IL-2 (Figure 4G), suggesting maintenance of regulatory function. 
Additionally, IL-7 induced a major up-regulation of PD-L1, but not PD-1, on both naïve 
subsets (Figure 4G).  
 
Importantly, naïve-Tregs remained unable to produce IL-2, IL-4, IL-17 or IFN- after 13 
day-culture in the presence of IL-7 or IL-2, as evaluated upon further short-term 
stimulation with PMA plus Ionomycin (Figure 4H).  
 
Finally, we asked whether exposure to IL-7 impairs the suppressive capacity of naïve-
Tregs. For this purpose, we sorted naïve-Tregs and compared their suppressive 
capacity upon 4h pre-incubation with culture medium alone or supplemented with IL-
7 or IL-2. We observed that upon treatment with either cytokine, naïve-Tregs 
maintained their ability to suppress autologous naïve-Tconv proliferation in response 
to TCR stimulation (Figure 4I).  
 
Altogether, these results support an ability of naïve-Tregs to respond to IL-7 whilst 
maintaining both their naïve and suppressive phenotype.  
 
IL-7 induced naïve-Treg survival and proliferation  
 
We then asked whether IL-7 induces the expression of markers of survival (Bcl-2) and 
cell cycling (Ki-67) in naïve-Tregs. We observed a clear induction of Bcl-2 expression 
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in naïve-Tregs cultured in the presence of IL-7 (Figure 5A-B), although less marked 
than in naïve-Tconvs (fold-increase: 3.02[2.33-3.72] versus 3.93[3.29-5.05], 
respectively, P<0.0001). Bcl-2 up-regulation in naïve-Tregs was significantly higher 
upon IL-7 stimulation than with IL-2 (Figure 5A-B), using optimal concentrations of 
both cytokines [17]. 
 
 
 
Figure 5.  IL-7 induced naïve-Treg survival and proliferation. (A-D) Analysis of naïve-Tregs 
and naïve-Tconvs ex vivo (dØ) and post 13 day-culture of purified naïve CD4 T-cells with IL-7 or IL-2 or 
IL-7 plus anti-IL-2 blocking monoclonal antibody: (A) Representative contour-plots of Bcl-2 and Ki-67 
expression; graphs show Bcl-2 MFI (B) and % of cycling-cells (C), bars represent median; significant P-
values of comparisons within each subset are shown; (D) Contour-plots illustrating the impact of IL-7 
or IL-2 on EdU incorporation by naïve-Tregs (final 12 hours-culture, n=2). (E) Illustrative histograms of 
Bcl-2 and Ki-67 expression within gated FoxP3+ or FoxP3─ cells ex vivo and post 7 day-culture of purified 
CD4SP thymocytes with IL-7 or IL-2 (one/3). (F) Impact of the PI3K-inhibitor (LY294002), mTOR-
inhibitor (rapamycin), or vehicle control (DMSO), on naïve CD4 T-cells upon 7 day-culture with IL-7; 
graphs show % of naïve-Treg and change in cell recovery, Bcl-2 MFI and % of cycling-cells within naïve-
Tregs and naïve-Tconvs, as compared to ex vivo levels; each color represents one individual.  
 
Additionally, IL-7 induced cycling of naïve-Tregs (Figure 5A and 5C). The proportion of 
cells expressing Ki-67 (21.06%[9.62-40.40]) was higher than that observed within 
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naïve-Tconvs (13.92%[5.11-17.63], P=0.0186), and within naïve-Tregs cultured with 
IL-2 (7.31%[1.74-9.35], P=0.0019). These findings are even more striking considering 
the much higher IL-7R expression levels on naïve-Tconvs (Supplementary Figure 1B). 
We further showed that IL-7 was superior to IL-2 in promoting naïve-Treg entry into 
cell-cycle, via assessment of the frequency of EdU-incorporating cells in the last 12 
hours of the culture (Figure 5D).  
 
Proliferative studies using CFSE-labeled cells were not performed, as we have 
previously demonstrated that this approach does not reproducibly reveal cytokine-
mediated proliferation of naïve CD4 T-cells [17].  
 
Importantly, as shown in Figure 5A, IL-7 induction of Bcl-2 and cell cycling was 
unaltered in the presence of an anti-IL-2 blocking monoclonal antibody, thus 
supporting a major role for IL-7 in the maintenance of naïve-Treg homeostasis 
independently of IL-2. 
 
Human FoxP3+CD4SP thymocytes were already able to proliferate in culture, and to 
up-regulate Bcl-2 in response to IL-7 (Figure 5E), in agreement with our previous data 
showing an increase of pSTAT5 in FoxP3+ thymocytes upon stimulation with IL-7 [30].  
 
Finally, we investigated whether the signalling pathways involved in IL-7 response 
differed between naïve-Tregs and naïve-Tconvs. IL-7 signalling uses both JAK3/STAT5 
and PI3K/Akt pathways to promote T-cell survival and proliferation [17]. We have 
previously demonstrated that IL-7-mediated naïve CD4 T-cell proliferation, but not 
Bcl-2 up-regulation, critically depends upon PI3K activity [17]. On the other hand, Treg 
metabolism is known to rely on mammalian target of rapamycin (mTOR) [2]. To 
investigate the relative importance of these pathways, we added the cell permeable 
PI3K-specific inhibitor (LY294002) or mTOR inhibitor (rapamycin) to naïve CD4 T-
cells cultured with IL-7 or IL-2. A 7 day-culture assay was selected to avoid possible 
deleterious impact of long-term exposure to the inhibitors, and was found to be 
sufficient to reveal Bcl-2 and Ki-67 induction albeit at lower levels than after 13 days 
culture (Figure 5F). Inhibition of the PI3K pathway led to a major decrease in naïve-
Treg recovery and proliferation upon stimulation with IL-7. Conversely, Bcl-2 
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expression was not significantly altered. Similar trends were observed upon mTOR 
inhibition, supporting its participation in the signalling cascade leading to 
proliferation. Moreover, the addition of these inhibitors to IL-2 stimulated cultures 
generated comparable profiles in naïve-Tregs, indicating that these pathways are 
utilized by both cytokines (data not shown).  
 
Overall, our in vitro data reveal that both IL-7 and IL-2 are able to promote proliferation 
of naïve-Tregs via activation of PI3K/mTOR signalling, and that IL-7 promotes the 
survival and proliferation of FoxP3+ mature thymocytes and circulating naïve-Tregs. 
. 
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3.2.5. Discussion  
 
Naïve-Tregs are thymus-committed regulatory T-cells with a high degree of self-
reactivity that continuously replenish the activated memory-Treg pool. Our finding of 
a preserved naïve-Treg compartment in adults submitted to total thymectomy in 
infancy support the relevance of peripheral mechanisms to ensure naïve-Treg 
homeostasis. We further showed that in steady-state conditions human naïve-Treg 
homeostasis occurs through a combination of high turnover rate and extended survival 
mediated by IL-7 and/or IL-2, based on the following evidence: 1) higher levels of the 
pro-survival molecule Bcl-2 and proportion of cycling-cells than naïve-Tconvs in both 
blood and tonsils; 2) the highest ex vivo levels of pSTAT5 as compared to other 
naïve/memory CD4 T-cell subsets, which further increases, in a dose-dependent 
manner, following IL-7 or IL-2 stimulation; 3) recovery of IL-7Rα expression upon IL-
7 deprivation, consistent with an ongoing in vivo response to IL-7; 4) response to IL-7 
and IL-2 in culture indicated by up-regulation of Bcl-2, and induction of PI3K/mTOR-
mediated proliferation; and 5) maintenance of naïve and suppressive phenotype upon 
exposure to IL-7. Additionally, we showed that naïve-Treg precursors, namely 
FoxP3+CD4SP thymocytes, already proliferate and up-regulate Bcl-2 in response to IL-
7 stimulation in vitro.  
 
Thus, our results challenge the assumption that naïve-Tregs are a quiescent population 
in steady-state conditions in non-lymphopenic individuals [1]. Human naïve-Tregs 
have been shown to feature a functional and molecular profile partially overlapping 
with both memory-Tregs and naïve-Tconvs [1, 4, 6]. Regarding their homeostasis, as 
for the memory compartment we found a much higher cell-turnover in naïve-Tregs 
than in naïve-Tconvs, suggesting an intrinsic propensity of Tregs to enter cell cycle. On 
the other hand, in agreement with their naïve character, naïve-Treg turnover was 
lower and Bcl-2 levels higher than in their memory counterparts. Additionally, similar 
pathways were apparently operating in response to IL-7 in naïve-Tregs and naïve-
Tconvs.  
 
In fact, we revealed here, for the first time, a role for IL-7 in naïve-Treg survival and 
homeostatic proliferation. These findings are particularly relevant for understanding 
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the impact of IL-7/IL-7Rα polymorphisms on autoimmunity [31], and the mechanisms 
underlying Treg expansion in lymphopenic settings, with implications for the 
therapeutic use of IL-7.  
 
Our data do not exclude the contribution of self-peptide/MHC stimulation to the naïve-
Treg proliferation, which may be particularly important given their enrichment in self-
antigen reactivities [6]. However, TCR stimulation of naïve-Tregs has been associated 
with rapid acquisition of a memory phenotype, with the potential risk of contraction of 
the naïve compartment [1, 4]. Of note, the maintenance of murine naïve-like FoxP3+ 
CD4 T-cells was recently demonstrated to be independent of TCR-driven signals [32].  
 
Importantly, we showed that naïve-Treg proliferation in response to IL-7 or IL-2 was 
associated with preservation of the naïve-like phenotype, in parallel with the 
maintenance or even increase of regulatory markers. We further showed that prior 
exposure of naïve-Tregs to IL-7 did not impair their suppressive capacity.  
 
IL-7, like IL-2, is known to induce PD-1 and PD-L1 on Tconvs [33] and Tregs [20]. Our 
observations extended these reports, by showing that IL-7 up-regulated PD-L1, but not 
PD-1, on both naïve-Tregs and naïve-Tconvs. These results suggest that IL-7 
contributes not only to T-cell homeostasis, but also to the containment of 
immunopathology, by up-regulating the inhibitory molecule PD-L1 on naïve CD4 T-
cells, irrespective of their FoxP3 status. On the other hand, this may have implications 
for tumor immunity, given the clinically relevant suppression of tumor specific 
responses mediated by the PD-1/PD-L1 pathway [34]. 
 
SLO are an important source of IL-7 [10, 17]. Our results from tonsil tissue, using both 
flow-cytometry and immunofluorescence, confirmed a high local naïve-Treg turnover, 
suggesting that SLO contain appropriate niches for naïve-Treg homeostasis. 
Nevertheless, more detailed studies are required to decipher the topography of naïve-
Tregs in SLO, as well as the contribution of their possible interactions with IL-7-
producing stromal reticular cells, dendritic cells or IL-2-producing memory T-cells.  
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Our data argue for the sufficiency of peripheral proliferation and survival to achieve 
long-term maintenance of the naïve-Treg compartment even in the absence of thymic 
output. These results in adults expand upon a recent report describing preservation of 
naïve-Treg counts during short-term follow-up of children submitted to total 
thymectomy in early infancy [15].  
 
Although a previous study showed a reduction of naïve-Treg frequency within total 
Tregs [13], this was not related to an actual contraction of naïve-Tregs upon 
thymectomy, but rather to the relatively high frequency of total Tregs, as also observed 
in our study (Table I; proportion of naïve-Tregs within total Treg compartment: 
11.60%[9.08-18.00] in thymectomized versus 14.85%[12.05-23.95] in healthy 
subjects, P=0.3776).  
 
The increase in naïve-Treg cycling in thymectomized adults was more likely mediated 
by IL-7 than by self-peptide/MHC interaction, given the conserved frequency of CD31+ 
cells, which are typically lost following TCR stimulation [16], and maintained by IL-7 
[17]. We further showed that the CD31+ subset of naïve-Tregs was preferentially 
expanded by IL-7 in vitro, in agreement with our previous data generated with total 
naïve CD4 T-cells [17]. Adults thymectomized in infancy feature an unexpectedly low 
prevalence of autoimmune diseases and allergy [12] , which may be related to the 
maintenance of the broadly-reactive naïve-Treg pool.  
 
To our knowledge, there are no published data specifically addressing the changes in 
the naïve-Treg compartment in individuals receiving IL-7 therapy. Nevertheless, an 
increase in total Treg numbers was documented in clinical trials, although the 
expansion of the Tconv compartment was much higher, leading to maintenance [35, 
36] or a relative decrease [37-39] in Treg proportions. In agreement with our in vitro 
data, naïve-Treg expansion was reported upon IL-2 therapy [28, 40, 41].  
In severe lymphopenic settings associated with elevated serum IL-7 levels, such as HIV 
infection [42], there is an apparent preservation of circulating naïve-Tregs [43], raising 
the possibility that these cells are responding to IL-7. We did not find a correlation 
between the size of the naïve-Treg compartment and IL-7 serum levels in either our 
thymectomized individuals or the study population as a whole, which may be due to 
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the narrow range of IL-7 levels (Table 1). Our data are also relevant in other 
lymphopenic settings, particularly in the context of immune reconstitution following 
hematopoietic stem cell transplantation, where IL-7-driven proliferation of naïve-
Tregs may help to control graft versus host disease. Our results support a model in 
which the increased availability of IL-7 in lymphopenic settings may contribute to the 
expansion of the naïve-Treg compartment, thereby helping prevent immunopathology 
in the context of a constrained TCR repertoire.  
 
In conclusion, naïve-Tregs feature high turnover in healthy adults, which further 
increases to compensate the loss of thymic replenishment upon total thymectomy. 
Moreover, our data reveal a role for IL-7 in naïve-Treg maintenance, both through up-
regulation of the survival molecule Bcl-2 and induction of PI3K/mTOR-mediated 
proliferation. Clinical use and evaluation of therapies targeting the IL-7 pathway 
should take into account the contribution of IL-7 to naïve-Treg homeostasis.  
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3.2.7.  Supplementary Data 
 
 
Supplementary Figure 1. Imbalances of CD4 T-cell subsets in adults submitted to total 
thymectomy in infancy. (A) Frequency of naïve-Tconv, naïve-Treg, mem-Treg, and mem-Tconv 
within circulating CD4+ T-cells in thymectomized and age-matched healthy subjects; each dot represents 
one individual; comparisons performed for each subset between the two cohorts; significant P-values 
are shown. (B) Subset phenotype (numbers of thymectomized and healthy, respectively, shown in 
brackets): FoxP3 (7/22), CTLA-4 (6/21), HLA-DR (7/22), CD39 (7/22), CD25 (6/21), CCR7 (7/21), CD95 
(7/21), Helios (5/17), CD31 (7/16), and IL-7Rα (6/16); subsets within naïve and memory, as well as 
within Treg and Tconv compartments were compared; bars represent median and range; significant P-
values are shown: * P<0.05, ** P<0.005, *** P<0.001. (C) CD25, IL-7Rα and Helios, within FoxP3+ (CD4SP-
Treg) and FoxP3 (CD4SP-Tconv) CD4SP thymocytes from three children (1, 3, and 9m-old); bars 
represent median and range; % of mature CD4SP thymocytes (CD45RAbright) lacking Helios expression 
varied between 4.5% and 19.6%.  
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Supplementary Figure 2. Naïve-Treg proliferation in the human tonsil. (A) Illustrative 
immunofluorescence analysis of regulatory T-cells in human tonsil showing naïve (CD3+CD45RO) and 
memory (CD3+CD45RO+) FoxP3+ Treg in the top; and proliferating (Ki-67+) naïve-Treg (CD45RO
FoxP3+) and memory-Treg (CD45RO+FoxP3+) in the bottom; DAPI was used to counter-stain nuclei. 
Illustrative images of single stainings, merged image, as well as the control staining in the absence of the 
primary antibodies are shown (resolution: 1024x1024; insert magnification: 200x, scale bar: 2.409 
pixels/µm; length shown: 60µm); images were acquired using a Zeiss LSM710 microscope (Zeiss, 
Oberkochen, Germany) with a dry objective Plan-Apochromat with a numerical aperture of 0.8. (B) 
Contour-plots illustrating proportion of tonsillar naïve-Tregs and naïve-Tconvs incorporating EdU upon 
12h-culture of freshly-isolated CD4 T-cells. 
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Supplementary Figure 3.  Ex vivo evidence of naïve-Treg response to IL-7. (A) IL-7 and IL-2 
dose-dependent induction of pSTAT5 following 15min in vitro stimulation of purified CD4 T-cells; 
graphs show pSTAT5 MFI fold change in relation to non-stimulated cells in the gated CD4 T-cell subsets 
in three individuals; bars represent median with range. (B) IL-7Rα modulation in CD4 T-cell subsets 
according to exposure to IL-7 or IL-2; purified CD4 T-cells were cultured for 24h in the absence of IL-
7/IL-2 (no serum), or with 40% autologous serum either alone or further supplemented with: IL-7 
(10ng/ml), IL-2 (20IU/mL), anti-IL-2 blocking mAb (10µg/mL), or isotype-control (IgG1, 10µg/mL); 
graphs show the IL-7Rα MFI within gated CD4 T-cell subsets ex vivo and post-culture, in six (left-hand 
graphs) and three (right-hand graphs) individuals; bars represent median with interquartile range (left-
hand graphs; significant P-values are shown: *P<0.05) or median with range (right-hand graphs).  
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Supplementary Table 1. Antibodies used in Flow-Cytometry and Immunofluorescence 
Antibodies for Flow Cytometry 
Antibody Fluorochrome Clone Source 
CD3 PerCP-Cy5.5/eFluor450 OKT3 eBioscience a 
CD3 APC UCHT1 eBioscience 
CD3 V500 UCHT1 BD Bioscience b 
CD4 PE/PerCP-Cy5.5/PE-Cy7/APC RPA-T4 eBioscience 
CD4 V500 RPA-T4 BD Bioscience 
CD11c FITC 3.9 eBioscience 
CD14 FITC 61D3 eBioscience 
CD19 FITC HIB19 eBioscience 
CD123 FITC 6H6 eBioscience 
CD45RA FITC/PerCP-Cy5.5/APC HI100 eBioscience 
CD45RA eFluor450 2D1 eBioscience 
CD45RA PE-Cy7 L48 BD Bioscience 
CD45RO FITC/PerCP eFluor710/APC-H7 UCHL1 eBioscience 
CCR7 FITC 150503 R&D Systems c 
CCR7 PE 3D12 R&D Systems 
CD25 PE-Cy7 2A3 BD Bioscience 
CD27 PE/PE-Cy7 O323 eBioscience 
CD31 PE/APC WM-59 eBioscience 
CD39 FITC/APC eBioA1 eBioscience 
CD95 PE-Cy7 DX2 eBioscience 
CD127 Alexa Fluor660/APC eFluor780 eBioRDR5 eBioscience 
HLA-DR FITC L243 BD Bioscience 
HLA-DR V500 G46.6 BD Bioscience 
PD-1 FITC MIH-4 eBioscience 
PD-L1 APC BIH1 eBioscience 
FoxP3 PE/PerCP-Cy5.5/eFluor450 PCH101 eBioscience 
CTLA-4 PE BNI3 BD Bioscience 
Helios Alexa Fluor488 22F6 Biolegend d 
Ki-67 FITC/PE/PerCP-Cy5.5/Alexa Fluor647 B56 BD Bioscience 
Bcl-2 FITC 124 DAKO e 
IL-2 Brilliant violet421 MQ1-17H12 Biolegend 
IL-4 APC 8D4-8 eBioscience 
IL-17A PerCP-Cy5.5 eBio64DEC17 eBioscience 
IFN- PE-Cy7 4S.B3 eBioscience 
pSTAT5 PerCP-Cy5.5 47/pY694 BD Bioscience 
LIVE/DEAD APC-Cy7 - Thermo Fischer Scientific f 
Primary Antibodies for Immunofluorescence 
Antigen Species/isotype Clone Source 
FoxP3 Mouse/IgG1 236/E7 eBioscience 
FoxP3 Rat/IgG2a PCH101 eBioscience 
Ki-67 Mouse/IgG1 B56 BD Bioscience 
CD45RO Mouse/IgG2a UCHL1 eBioscience 
CD3 Rabbit/NA Polyclonal Abcam g 
Secondary Antibodies for Immunofluorescence 
Specificity Species Fluorochrome Source 
Mouse IgG1 Goat Alexa Fluor 488 Thermo Fischer Scientific 
Mouse IgG2a Goat Alexa Fluor 546 Thermo Fischer Scientific 
Rabbit Goat Alexa Fluor 647 Thermo Fischer Scientific 
Rat Goat Alexa Fluor 488 Thermo Fischer Scientific 
Mouse IgG1 Goat Alexa Fluor 555 Thermo Fischer Scientific 
Mouse IgG2a Goat Alexa Fluor 633 Thermo Fischer Scientific 
a eBioscience, San Diego, CA; b BD Bioscience, San Jose, CA; c R&D Systems, Minneapolis, MN; d Biolegend, 
San Diego, CA; e DAKO, Glostrup, Denmark; f Thermo Fischer Scientific, Walthan, MA; g Abcam, Cambridge, 
UK. NA- Not Applicable 
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3.3.1. Manuscript  
 
To the Editor  
The thymus is essential to the establishment of the “peripheral” T-cell compartment 
before birth and during the accelerated somatic growth of childhood, and contributes 
to its continuous replenishment until at least the sixth decade of life[1]. Thymus 
removal early in infancy during corrective cardiac surgery is, therefore, associated with 
marked contraction of the naïve T-cell subset, as well as with the presence of markers 
of premature immune senescence as a result of homeostatic naïve T-cell 
proliferation[1]. This is thought to occur mainly in response to self and environmental 
antigens, raising the question whether early thymectomy leads to an increased risk of 
autoimmunity and/or allergic disease. The few studies available are not conclusive, in 
part due to cohort heterogeneity regarding length of follow-up post-thymectomy and 
degree of residual thymic activity[1-3]. Notably, thymic recovery has been reported in 
some individuals[4].  
 
Autoimmunity and allergy are controlled by a subset of regulatory CD4 T-cells (Tregs), 
defined by FoxP3 expression. Tregs generated in the thymus are particularly 
implicated in the maintenance of self-tolerance. They egress from the thymus with a 
naïve phenotype (naïve-Tregs), and continuously replenish the fully-suppressor 
memory-Treg compartment throughout life. We recently reported that naïve-Tregs are 
preserved in adults more than 18y (median 21y) after complete thymectomy early in 
infancy, in contrast with the marked contraction of conventional naïve CD4 T-cells[5]. 
Importantly, in contrast to others[2, 3], we specifically excluded individuals with 
evidence of remaining thymic activity, based on sjTREC quantification[5]. Naïve-Treg 
preservation was also found in a cohort of recently thymectomized children[6].  
 
We hypothesized that the maintenance of naïve-Tregs limits the development of 
autoimmunity and/or allergy likely associated with the skewed conventional T-cell 
repertoire upon thymectomy. We applied an extensive structured questionnaire to 
assess clinical manifestations of autoimmunity and allergy, in parallel with the 
evaluation of serum reactivity to large panels of autoantigens and allergen 
components, to our cohort of complete thymectomized adults[5] and age-matched 
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individuals (Table 1, see supplementary methods in this article's Online Repository at 
www.jacionline.org). 
 
In spite of the very low naïve CD4 and CD8 T-cell counts (Table 1), we found no 
autoimmune manifestations. Therefore, it is possible that Treg preservation, with 
evidence of suppressive phenotype based on FoxP3, CTLA-4 and CD39 expression 
levels (Table 1), may contribute to maintain self-tolerance.  
 
In order to reveal a possible subclinical increase in IgG, IgM, IgA and/or IgE 
autoreactivity, we took advantage of autoantigen array-based technology[7], an 
emergent approach with high sensitivity for early and large-scale autoantibody 
identification (see supplementary methods in this article's Online Repository at 
www.jacionline.org). We compared the complete thymectomized adults with 7 
representative controls (Table 1). By fitting a linear model to the normalized data, we 
did not find significant differences in serum IgG, IgM, IgA and IgE reactivity between 
cohorts (P>0.05); moreover, clustering analysis showed a clear inability to correctly 
assign thymectomized and controls (Figure 1, and see Table E1 and  in this article's 
Online Repository at www.jacionline.org).  
 
Regarding IgG reactivity, we identified 18 autoantibodies with increased expression 
within thymectomized (P<0.05, before multiple testing correction), and for which we 
obtained better clustering of samples according to their cohort of origin (Fig 1). Their 
targets included nuclear antigens (Sp100, chromatin, histone H1, ribophosphoprotein 
P1, SmD2, SmD3, TIF1gamma, Sm), cytoplasmic/membrane proteins (mitochondrial 
antigen, tissue transglutaminase, liver cytosolic 1 antigen, sphingomyelin), cell matrix 
proteins (fibronectin), glomeruli-specific proteins (glomerular basement membrane) 
and circulating proteins (complement C3a, complement C4, complement C8, factor D). 
Interestingly, these are common autoantigens identified in systemic lupus 
erythematosus (SLE) patients[7], some of them with high specificity, such as SmD 
proteins.   
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Previous studies in SLE patients revealed the association of particular IgG 
autoantibody clusters with overall disease activity and lupus nephritis, one of which 
was partially reproduced in our thymectomized cohort (Figure 1, right; glomerular 
basement membrane/chromatin antibodies). Additionally, a cluster combining IgG 
autoantibodies to liver cytosolic antigen 1/mitochondrial antigen/tissue 
transglutaminase, antigens clearly associated with autoimmune liver disease[8], was 
also found in our thymectomized adults (Fig 1). 
Figure 1. IgG autoantibody profiles  Heatmap (left) of serum IgG autoantibody reactivities in adults 
thymectomized early in infancy (T) and controls (C) clustered by autoantigen (listed in Table E1 in this 
article's Online Repository at www.jacionline.org) and subject group. Reactivity intensity was 
normalized and log2-transformed, and 121 autoantibodies meeting minimal net fluorescence intensity 
requirements are presented. Heatmap (right) of the 18 autoantibodies with higher expression in 
thymectomized as compared to control individuals (P-value<0.05). Key color bar corresponds to 
quantified reactivity. 
Recent data recall attention for a role of IgE reactivity against self-peptides in 
autoimmunity[9]. Using the same panel of antigens, we were able to identify IgE 
reactivity to a relatively small number of antigens in both cohorts (a median of 34 per 
individual in thymectomized versus 31 in controls in a total of 125 included in the array, 
P>0.05). There were 4 IgE autoantibodies, not previously reported[9], for which we
observed different levels of reactivity between thymectomized and control individuals 
(P<0.05, before multiple testing correction), although without a coherent trend 
between the two cohorts, in contrast to IgG (see Fig E2 in this article's Online 
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Repository at www.jacionline.org). These findings reinforce the need for further 
investigation on IgE autoreactivity[9].  
 
Regarding allergy, we found no significant differences in the prevalence of clinical 
manifestations (Table 1). Allergic rhinitis was the most frequent disease in both 
cohorts, as expected in young adulthood. In order to expose a putative increase in the 
frequency of IgE sensitizations (sIgE) upon complete thymectomy, we used a 
microarray with a large panel of allergen components (Table 1 and see supplementary 
methods in this article's Online Repository at www.jacionline.org). There were no 
differences in serum total IgE between thymectomized and controls (data not shown), 
and atopy was documented only in individuals with rhinitis (Table 1). The microarray 
revealed positive sIgE in patients with allergic disease, in agreement with their clinical 
manifestations (Table 1). Our findings suggest that thymectomy in early age has no 
major impact on the degree of sensitization.   
 
Cohorts of adults submitted to thymectomy in infancy are expanding due to 
generalization of the access to early corrective/palliative cardiac surgery. 
Nevertheless, the eldest individuals are still in the fourth decade of life. Our finding of 
increased subclinical IgG autoreactivity against antigens with relevant clinical 
associations, stress the importance of extended patient follow-up to ultimately reveal 
whether peripheral tolerance will be able to limit overt progression towards 
autoimmune disease.  
 
Overall, our study, that was strictly designed to include only adults without evidence 
of thymic activity upon thymus removal in infancy, revealed no increase in 
clinical/subclinical manifestations of allergy or in autoimmune diseases, in parallel 
with the preservation of the Treg compartment and contraction of the conventional 
naïve T-cell pool.  
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3.3.3. Supplemental Data 
 
Supplemental Table E1. Sequence of antigens whose IgG reactivities are represented in 
heatmap for IgG autoreactivity (Fig 1). 
Sequence of antigens interested in heatmap for IgG autoreactivity (top-down order) 
1 SNRNP-A 42 TNFa 82 A100 
2 Histone H2A 43 Factor P 83 Collagen III 
3 Histone H2B 44 Intrinsic Factor 84 Phophatidylinositol 
4 Ro-52/SSA 45 M2 85 Proteoglycan 
5 Collagen V 46 dsDNA 86 Ribo phasphoprotein P1 
6 PL-7 47 FactorH 87 Heparin 
7 CENP-B 48 Vitronectin 88 gP210 
8 Chromatin 49 Gliadin (IgG) 89 PR3 
9 TPO 50 Muscarinic receptor 90 Sm 
10 Entaktin EDTA 51 complement C8 91 Genomic DNA 
11 PCNA 52 Nucleosome antigen 92 Mi-2 
12 Topoisomerase I 53 Mitochondrial antige 93 LKM1 
13 Scl-70 54 Prothrombin protien 94 SNRNP-68 
14 complement C5 55 complement C3a 95 Decorin-bovine 
15 complement C1q 56 Histone H4 96 Myelin basic protein 
16 Thyroglobulin 57 Vimentin 97 Chondroitin Sulfate  
17 La/SSB 58 PL-12 98 Amyloid 
18 SNRNP-C 59 MPO 99 Collagen I 
19 Elastin 60 Alpha Fodrin (SPTAN1) 100 Nup62 
20 GBM (disso) 61 SmD3 101 FactorD 
21 Histone-total 62 SmD 102 Sphingomyelin 
22 Histone H3 63 SRP54 103 Collagen II 
23 BPI 64 Glycated Albumin 104 Fibrinogen IV 
24 AGTR1 65 alpha-actinin 105 Myosin 
25 complement C3 66 DGPS 106 TTG 
26 complement C9 67 Nucleolin 107 β2-glycoprotein I 
27 T1F1 GAMMA 68 SNRNP-BB' 108 LC1 
28 POLB 69 MDA5 109 PM/Scl-100 
29 PM/Scl-75 70 GP2 110 Jo-1 
30 KU (P70/P80) 71 Cytochrome C 111 AQP4 
31 Histone H1 72 ssRNA 112 Peroxiredoxin 1 
32 FactorB 73 Hemocyanin 113 complement C6 
33 Collagen IV 74 Ribo phasphoprotein P2 114 ssDNA 
34 complement C7 75 Laminin 115 CRP antigen 
35 CENP-A 76 Heperan Sulfate 116 Sm/RNP 
36 Aggrecan 77 Ribo phasphoprotein P0 117 Fibrinogen S 
37 Collagen VI 78 SmD2 118 β2-microglobulin 
38 Cardolipin 79 Fibronectin 119 Heparan HSPG 
39 SmD1 80 SP100 120 Matrigel 
40 complement C4 81 Ro-60/SSA 121 EBNA1 
41 complement C3b     
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Supplemental Figure E1 – IgA and IgM autoantibody profiles. Heatmaps of serum IgA (left) 
and IgM (right) autoantibody reactivities in adults thymectomized early in infancy (T) and controls (C), 
clustered by autoantigen and subject group. Reactivity intensities were normalized and log2-
transformed; 121 IgA and 122 IgM autoantibodies meeting minimal net fluorescence intensity 
requirements are presented. Key color bars correspond to quantified reactivity. 
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T5C2T1 T4 T6 T2 C7 C3 C5 C1 T3 C4 T7C6 T4 T2 T1T5C3 C7 C4 C1 C5 C2 T7 T6 T3 C6
Supplemental Figure E2. IgE autoantibody 
profiles. Heatmaps of serum IgE autoantibody 
reactivities in adults thymectomized early in 
infancy (T) and controls (C) clustered by 
autoantigen and subject group. Reactivity 
intensity was normalized and log2-transformed, 
and 100 IgE autoantibodies meeting minimal net 
fluorescence intensity requirements are 
presented in the heat map on the left. The heat 
map on the right shows IgE autoantibody profiles 
to 4 IgE autoantibodies distinctly expressed in 
thymectomized individuals (P<0.05, before 
multiple testing correction). Key color bars 
correspond to quantified reactivity. 
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Online Repository : Supplemental Methods 
 
Study Design 
A cohort of 7 adults submitted to thymectomy early in infancy, that we previously 
reported[1], was included in this study. Patients were thymectomized during 
corrective cardiac surgery for no syndromatic cardiopathy and complete thymectomy 
was confirmed based on the surgical report and severely reduced levels of sjTREC/μl. 
Thymectomized individuals were compared with age-matched controls (Table 1). Both 
cohorts were screened for clinical manifestations of autoimmunity and allergy. Blood 
was collected for ex vivo immune-phenotypic analysis and serum samples were stored 
at -80ºC. All subjects gave written informed consent for blood sampling. The study was 
approved by the Ethical Boards of Faculdade de Medicina da Universidade de Lisboa, 
Centro Hospitalar Lisboa Norte, and Hospital de Santa Cruz, Portugal. 
 
Clinical evaluation of allergy and autoimmunity 
An extensive structured questionnaire was applied to all individuals by the same 
investigator. Thymectomized and controls were inquired regarding previous diagnosis 
and clinical signs/symptoms of autoimmune or allergic diseases, namely rhinitis, 
asthma, eczema and food allergy. Modules of ISAAC Questionnaire validated for 
Portuguese speaking adults were included in this evaluation[2, 3]. 
 
Flow-cytometry 
Ex vivo phenotypic analysis was performed in freshly-collected whole blood. Eight-
color staining was performed using the following anti-human Abs, clones in brackets: 
CD3-eFluor450 (OKT3), CD8-eFluor 780 (RPA-T8), CD38-PE (HB7), CD45RO- APC-
H7/APC (UCHL1), CD39-APC (eBioA1), FOXP3-eFluor450 (PCH101), HLA-DR PerCP 
eFluor 710 (L243), all from eBioscience, San Diego, CA; CD4-V500 (RPA-T4), CTLA-4-
PE (BNI3) from BD Biosciences, San Jose, CA; CCR7-FITC (150503) R&D Systems, 
Minneapolis, MN. Intracellular staining was done using eBioscience FoxP3 kit. At least 
150,000 events were acquired for each sample on a BD LSRFortessa (BD Biosciences) 
and data analysed using FlowJo software (TreeStar, Ashland, OR). Total cell numbers 
were calculated by multiplying the percentage of each population within total 
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lymphocytes by the peripheral blood lymphocyte count obtained at the clinical 
laboratory on the day of sampling. 
 
sjTREC quantification 
A highly sensitive nested quantitative PCR assay (detection-limit 1 copy/105 cells) was 
used as described[1, 4]. Triplicate multiplex PCR amplification of sjTREC, together with 
the CD3 chain was performed on lysed PBMCs; quantifications were then performed 
using a LightCycler™ in independent experiments, with the same first-round serial 
dilution standard curve.  
 
ImmunoCAP Phadiatop®  
ImmunoCAP Phadiatop® (TermoFischer scientific, Waltham, MA) was used to assess 
the presence of IgE antibodies in the serum to a balanced mixture of relevant 
environmental allergens. Results were expressed as positive or negative, indicating the 
patient is atopic/non-atopic, respectively. ImmunoCAP Phadiatop® was performed 
according to manufacturer´s instructions.  
 
Microarray for IgE sensitization 
ImmunoCAP ISAC® (TermoFischer scientific), a miniaturized immunoassay platform 
was used to assess serum specific IgE (sIgE) to 112 allergen components from 51 
aeroallergen or food sources. The purified, natural or recombinant allergen 
components are spotted in triplets and covalently immobilized on a polymer-coated 
slide. IgE antibodies in the sample bound to the immobilized allergen components are 
detected by a second fluorescence-labelled anti-IgE antibody. Fluorescence is 
measured with a laser scanner and results are evaluated using Phadia Microarray 
Image Analysis (MIA) software, on a semiquantitative basis. IgE values are presented 
in arbitrary units called ISAC standardized units (from 0.3 to 100 ISU). Values of >0.3 
ISU were considered positive. All individuals were evaluated in the same day. 
ImmunoCap ISAC® was performed according to manufacturer´s instructions.  
 
Autoantigen microarrays 
Autoantigen microarrays were used to detect IgG/IgM or IgA/IgE autoantibodies in 
serum to a panels of 125 autoantigens as previously described[5]. A complete list of 
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the probes used and their sources is available from the authors on request. The same 
chip was used to test all individuals for each isotype. The samples were treated with 
DNAse I, diluted 1:50, and incubated with autoantigen arrays. The autoantibodies were 
detected in parallel arrays, with Cy3-labelled anti-human IgG and Cy5-labelled anti-
human IgM (Jackson ImmunoResearch, West Grove, PA, USA), or Cy3-labeled anti-
human IgA (Jackson ImmunoResearch) and TRITC-conjugated anti-human IgE 
(ThermoFisher Scientific) for imaging. Fluorescence was quantified using GenePix 
4400A scanner with appropriate laser wavelengths and generated Tiff images. Genepix 
Pro 7.0 software was used to analyse the image and create the Gene Pix Results (GPR) 
file. The net fluorescence intensities were normalized using purified human 
IgG/IgM/IgA/gE spotted onto each array. Data obtained from duplicate spots were 
averaged. Signal-to-noise ratio (SNR) is used as a quantitative measure of the ability to 
resolve true signal from background noise. A higher SNR indicates higher signal over 
background noise.  SNR equal or bigger than 3 are considered true signal from 
background noise.Normalized profiles of antigen-microarrays were log2 transformed. 
Using ggplots package[6] we have generated non-supervised hierarquical clustering 
heatmaps of the Euclidean distance matrix estimated from serum autoantibody 
reactivities. 
 
Statistical analysis 
Statistical analysis for epidemiological, clinical and flow-cytometry data, was 
performed with Graph Prism Version 5.01. Unpaired T-test or Mann-Whitney were 
used as appropriate; P-values <0.05 were considered significant.  
To identify autoantigens with significantly different reactivity between controls and 
thymectomized patients, significance analysis of antigen-microarrays was performed 
using R statistical environment[7] and Limma package[8].  
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Conclusion and Future Perspectives 
The thymus is the central organ for T-cell production that continuously replenishes the 
periphery with newly generated naïve CD4 T-cells [1]. The naïve compartment 
represents the lifelong reservoir of T-cells with a diverse repertoire ensuring ability to 
mount specific responses to new antigens [2-4]. Moreover, it includes a distinct lineage 
of cells with suppressor functions that expresses FoxP3 (naïve-Tregs) and are enriched 
in self-reactivities, thus considered essential to prevent autoimmunity [5, 6] 
In spite of the continuous environment antigenic stimulation, and the age-associated 
reduction in thymic output, the size of the human naïve T-cell pool features only a slight 
decline throughout adulthood [7-10]. This is due to a dynamic equilibrium between 
thymic output and homeostatic proliferation of peripheral naïve CD4 T-cells, which 
replace those cells lost by death or conversion into memory-effector cells [3, 4].  
The relative contribution of thymic output and homeostatic proliferation to the 
composition of the naïve CD4 T-cell pool throughout aging remains debatable [1]. It is 
known that human thymus is active until at least the sixth decade of life [7]. However, 
in contrast to mice, the establishment and maintenance of the human naïve CD4 T-cell 
compartment is currently thought to significantly rely on extensive post-thymic T-cell 
proliferation [1, 11-16]. Several in silico studies suggest that thymic output per se is 
insufficient to guarantee the size of the peripheral naïve T-cell compartment without a 
major contribution of cell proliferation in the periphery [1, 11-16].   
The main objective of this work was to investigate the interplay between the different 
mechanisms operating in the homeostasis of the naïve CD4 T-cell compartment. 
Specifically, we investigated the impact of thymus impairment on peripheral 
homeostatic mechanisms and how naïve CD4 T-cells adjust to different degrees of 
thymic impairment. We used as a model adults thymectomized early in infancy, 
stratified according to the actual degree of thymopoiesis.  
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Our major findings are: 
 
a) Adults thymectomized in infancy that featured some degree of actual 
thymopoiesis were able to preserve the size of the naïve CD4 T-cell compartment 
with a conserved spectratyping profile, in association with sj/β TREC ratio within 
the range of age-matched controls, supporting recovery of intra-thymic 
proliferation and of thymic output; 
b) In contrast, those completely lacking thymopoiesis featured a contraction in the 
size and diversity of naïve CD4 T-cell compartment; 
c) Although we documented significantly higher transcriptional levels of DUSP6, a 
gene involved in the fine-tuning of TCR activation threshold, in patients lacking 
thymopoiesis, this was not associated with impairment in the ability of purified 
naïve CD4 T-cells to respond to TCR stimulation and to differentiate into memory 
cells; 
d) The CD31 naïve compartment was maintained independently of the thymus, and 
its size was tightly preserved by peripheral mechanisms;  
e) The maintenance of IL-7-driven homeostatic proliferation of naïve CD4 T-cells 
required continuous thymic output; 
f) Naïve-Treg cells were remarkably well preserved, irrespective of thymectomy;  
g) Naïve-Treg cells were able to up-regulate Bcl-2 and to proliferate in a PI3K-
dependent manner in response to IL-7, whilst preserving their naïve phenotype 
and suppressive capacity; 
h) Patients lacking thymopoiesis featured no clinical autoimmunity or increased 
prevalence of allergy/IgE-sensitizations, although higher levels of IgG against a 
cluster of antigens linked to autoimmune diseases were found using a large array 
of autoantigens.  
 
 
These data add significantly to the current literature and have important clinical 
implications, which are discussed below, in parallel with the future perspectives to 
pursue this work, organized in five major topics.  
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1. Children thymectomized early in infancy provide a unique model to address the
contribution of thymus and peripheral mechanisms to naïve CD4 T-cell homeostasis. 
Thymectomy is widely recognized as a powerful model to investigate the contribution 
of the thymus to the naïve T-cell maintenance beyond the establishment of the T-cell 
compartment.  
Our study features important differences from previous follow-up studies upon 
thymectomy. We only included adults thymectomized within a relatively narrow age 
range in infancy, and patients were evaluated upon a median of 21y post-thymectomy, 
in contrast with studies that include children/adolescents with variable length of time 
post-thymectomy [17-22]. Moreover, thymectomized individuals were grouped 
according to absence (ØThy) or presence (Thy) of thymopoiesis, based on circulating 
sjTRECs/μl [23]. Our molecular strategy to stringently rule out the existence of thymic 
output in thymectomized patients overcomes the limitations of other approaches 
based solely on surgical reports [21, 22, 24-27] and/or thoracic imaging [17, 25-28], 
which may have neglected thymic regeneration or ectopic thymus, which is known to 
be frequent in humans [29].  
There is a wide heterogeneity of findings reported by human studies addressing the 
impact of thymectomy in the naïve T-cell compartment [17, 18, 20-22, 24, 25, 27, 30, 
31]. Our stratification of patients allowed us to reveal that the contraction of the naïve 
CD4 T-cell size and repertoire diversity was observed in the group of patients lacking 
thymopoiesis, in agreement with a premature immune-senescence profile, previously 
reported in some patients [21, 26, 31, 32]. In contrast, thymectomized patients that 
featured some degree of thymopoiesis were able to restore the naïve CD4 T-cell 
compartment, in size and diversity, showing a conserved spectratyping profile. 
Importantly, these thymectomized individuals also featured similar levels of sj/β TREC 
ratios as compared to age-matched controls, supporting the contribution of thymic 
recovery to the maintenance of the naïve CD4 T-cell compartment. Thus, in a long-term 
perspective, our data support the advantages of avoiding complete thymectomy during 
cardiac surgery [24, 33], particularly after the first year of life, given the observed 
association between younger age at thymectomy and thymic recovery [20, 27].  
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We have used spectratyping in our study to assess the diversity of the TCR repertoire 
in naïve CD4 T-cells. In the future, the possibility of using NGS-based techniques, that 
are currently being improved to use in this context [34, 35], may provide a deeper 
characterization of the impact of thymectomy on the repertoire of the naïve T-cell 
compartment. An important question, will be to understand if holes in the repertoire, 
found with spectratyping, correspond to deletions or rather to clonal expansions in the 
periphery [35, 36].  
 
Extending the follow-up of our cohort will also be instrumental, as complete/partial 
thymectomy was performed during corrective cardiac surgery, that has only become 
routinely performed worldwide in infancy for the last 3 to 4 decades.  
 
The extent of thymic regeneration post-thymectomy, and possible dependency on the 
age at thymus removal, also remains under debate [20, 27]. It would be important to 
have long-term longitudinal studies, starting from thymectomy, with sequential 
quantification of thymic activity in correlation with immunological profile. The use of 
imaging techniques directed to the thymus size and activity in that study would also be 
informative. 
 
 
2. The lack of thymic activity has distinct impacts on the CD31+ and CD31 subsets  
 
Our data reveal distinct impacts of the lack of thymus activity on the 2 compartments 
of naïve CD4 T-cells defined according to CD31 expression. This is in agreement with 
previous work from our Laboratory and others, showing their distinct proliferative 
histories, and data supporting that different homeostatic mechanisms are operating in 
these compartments throughout life [2, 37-39].  
 
In the literature, we found no previous data on the homeostasis of the naïve CD31 
compartment upon thymectomy. Interestingly, we observed that this compartment 
was maintained, irrespective of the degree of thymus impairment. Our finding is in 
agreement with the CD31 preservation reported during age-associated thymic 
involution [2, 8] and suggests that peripheral mechanisms are determining the 
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homeostasis of this population. We also observed that even in healthy young adults, 
the levels of expression of the pro-survival molecule Bcl-2 were significantly higher in 
CD31– than in CD31+ naïve CD4 T-cells [40], emphasizing the contribution of the 
survival pathways for the homeostasis of the CD31– subset.  
In contrast, contraction of the naïve CD31+ compartment has been previously reported 
in patients submitted to thymectomy [26, 27, 41]. We reveal that this contraction was 
only significant in individuals lacking thymopoiesis, and occurred despite homeostatic 
responses observed in both thymectomized cohorts, including increase in cell-survival, 
estimated by the expression of the pro-survival molecule Bcl-2, that we showed for the 
first time. 
It has been hypothesized that CD31 might play a role on the trans-endothelial 
migration of CD31+ naïve T-cells into SLO [38], a proposed site for homeostatic 
proliferation of naïve T-cells [42]. Furthermore, CD31 engagement has been shown to 
inhibit TCR-mediated signal transduction [43], raising the hypothesis that CD31 might 
hamper TCR/antigen-driven peripheral proliferation of CD31+ naïve CD4+ T cells [39], 
thus favour cytokine-driven homeostatic proliferation.  
The peripheral expansion/survival in CD31+ compartment is thought to be mainly 
mediated by IL-7, whereas the CD31 subset is thought to mainly proliferate in 
response to TCR stimulation by low-affinity self-peptide/MHC [2, 38, 39]. Here, we also 
reported this pattern in healthy subjects and in thymectomized patients featuring 
some degree of thymopoiesis. Conversely, in thymectomized adults lacking thymic 
activity the functional differences between the two naïve subsets were not apparent, 
in association with a significant impairment of IL-7 driven proliferation in vitro. This 
effacement of functional heterogeneity is in agreement with a recent report [27]. In 
future studies, it would be interesting to address the role of CD31 expression by naïve 
CD4 T-cells and to investigate the pathways that concur with CD31 to modulate naïve 
CD4 T-cell responses in the periphery.  
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3. IL-7-mediated homeostatic proliferation is impaired in the absence of thymic 
activity 
 
We and others have previously shown the preferential role of IL-7 on the homeostasis 
of the CD31+ naïve compartment, not only by enhancing thymopoiesis [44, 45] but also 
through the induction of survival and proliferation in the periphery [37, 46]. In face of 
the contraction of CD31+ compartment upon thymectomy, we thus questioned whether 
thymectomy could be associated with altered homeostatic responses of naïve CD4 T-
cells to IL-7, in addition to the obvious reduction in thymic output. 
 
We showed that IL-7-driven proliferation and up-regulation of CD31 within CD31+ 
naïve CD4 T-cells, which we have previously found to be dependent on signalling via 
PI3K pathway, were significantly impaired in the absence of thymic output [37, 47]. In 
contrast, Bcl-2 up-regulation, thought to be PI3K-independent and mediated by STAT5 
phosphorylation, was preserved in these individuals.  
 
Although based on a limited number of patients, our data support that the absence of 
thymopoiesis significantly impairs PI3K-dependent responses to IL-7. Future studies 
will be important to further dissect the mechanisms underlying this impairment. 
Another interesting question is to identify the possible subpopulation within naïve 
CD31+ cells that is missing or that has lost the/its ability to proliferate in a PI3K-
dependent manner in the absence of thymic activity, which will require new 
phenotypic markers.  
 
These results have implications to different clinical settings in which IL-7/IL-7R axis 
based therapies have been under evaluation, namely in autoimmunity, lymphopenia 
and in immune reconstitution following hematopoietic stem cell transplantation 
(HSCT) or lymphoid depletion in the context of autoimmune disease or malignancy 
[48-53]. Administration of recombinant human (rh)IL-7 was shown to induce 
preferential expansion of naïve CD4 T-cells with a diverse TCR repertoire in 
lymphopenia associated with HIV infection [54, 55] or cancer therapy [48, 49].  Our 
data stress the requirements for continuous thymic output in these settings, in order 
to optimize response in the naïve CD4 compartment. 
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Although IL-7 has been reported to have per se an enhancing effect on thymopoiesis, 
additional therapies targeting the thymus might be considered in order to optimize IL-
7-mediated immune reconstitution. IL-22 [56], human growth hormone [57, 58], and
sex steroid inhibition [59] have been pointed as potential strategies for enhancing 
thymic function, and are currently under evaluation in clinical trials. Many other 
strategies are in preclinical stage of development, including therapies targeting 
thymocytes (IL-12, IL-21, keratinocyte growth factor) and TECs (IGF-1)(reviewed in 
[59]).  
Therapies targeting thymic preservation/regeneration could also be considered in the 
elderly, in order to support an adequate homeostatic post-thymic proliferation and to 
delay the development of an immune-senescence profile. With the increase in life 
expectancy there is a growing number of individuals reaching advanced age with a 
high-risk immunological profile that has been linked to an increased frequency of 
infections, insufficient response to vaccines, autoimmunity and neoplasia, due to a 
decline in immune surveillance [60].   
4. The uniqueness of the naïve regulatory CD4 T-cell compartment
Research on human regulatory T-cell homeostasis has been particularly scarce, despite 
its lifelong relevance in the maintenance of tolerance and therapeutic potential [6] 
Overall, our data provide evidence for an essential role of IL-7 in the maintenance of 
naïve-Tregs. Additionally, we challenge the assumption that naïve-Tregs are a 
quiescent population in steady-state conditions in non-lymphopenic individuals [5], 
given our finding of much higher cell-turnover in naïve-Tregs than naïve-Tconvs. 
Interestingly, we showed increased frequency of cycling naïve-Tregs in the tonsils than 
in blood, using samples from children undergoing routine tonsillectomy. This increase 
is more marked than that observed comparing frequencies of cycling-cells in naïve-
Tconvs in tonsils and blood; and prompts us to pursue studies to find the niches where 
this homeostatic proliferation is occurring.  
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We also show that in healthy adults, IL-7 induced Bcl-2 expression and PI3K-
dependent proliferation of naïve-Tregs, whilst preserving their naïve phenotype and 
suppressive capacity. Notably their proliferation in response to IL-7 was higher than 
that observed in response to to IL-2, thus revealing an unexpected role for IL-7 in the 
maintenance of naïve-Tregs.  
 
Importantly, our data reveal distinct homeostasis of these subpopulations upon 
thymectomy. We found that: 1) naïve-Tregs were remarkably well preserved in 
individuals lacking thymopoiesis, in contrast to naïve-Tconvs, and featured an ex vivo 
phenotype suggestive of extended survival and proliferation; 2) in culture of purified 
naïve CD4 T-cells with IL-7, naïve-Tregs from individuals lacking thymopoiesis 
maintained better ability to proliferate to IL-7 than naïve-Tconvs. Future studies 
should address whethe, in the absence of thymic activity, naïve-Tregs proliferation in 
response to IL-7 is also PI3K-dependent. Moreover, it would be important to 
understand when possibly during thymic commitment these differences in 
signalling/metabolism between naïve-Tregs and naïve-Tconvs were established. 
Functional studies comparing healthy and thymectomized individuals would be 
informative in this regard. 
 
To our knowledge, there are no published data specifically addressing the changes in 
the naïve-Treg compartment in individuals receiving IL-7 therapy. Nevertheless, an 
increase in total Treg numbers was documented in clinical trials, although the 
expansion of the Tconv compartment was much higher, leading to maintenance [61, 
62] or a relative decrease [48, 49, 63] in Treg proportions. Our data call for reappraisal 
of the results of previous studies.  
 
 
5. Long-term clinical consequences of ceasing thymic activity early in infancy 
 
Clinical consequences of thymectomy performed in early infancy in humans have been 
a matter of debate. The few studies available are not conclusive[17, 19, 26, 30, 31], in 
part due to cohort heterogeneity regarding length of follow-up post-thymectomy and 
degree of residual thymic activity [64], as discussed above. In this study, the same 
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investigator/clinician performed the clinical evaluation of all individuals, using 
extensive structured questionnaires. Of note, none of our thymectomized patients 
reported severe infections or increased frequency of minor infections.  
In face of a better preservation of naïve-Tregs in patients lacking thymopoiesis, despite 
naïve-Tconv pool contraction, we focused on the risk for autoimmunity/allergy.  
We found no significant increase in the frequency of autoimmune manifestations or 
allergy/IgE-sensitizations. It is important to stress that the number of individuals per 
group in our study is obviously limited to assess differences in the prevalence of allergy 
or autoimmunity between thymectomized individuals and controls. Our innovative 
evaluation of subclinical autoreactivity/IgE-sensitizations thus adds interesting input 
to this debate. It has been shown that autoantibodies frequently precede clinical 
manifestations of autoimmunity for many years [65]. Our finding of higher IgG 
autoreactivity to autoantigens associated with autoimmune diseases in patients 
lacking thymopoiesis reinforces the need to extend their follow-up. This will ultimately 
reveal whether peripheral tolerance will be able to limit overt progression towards 
autoimmune disease. 
Final Conclusion 
Overall, our study comparing adults thymectomized early in infancy and age-matched 
controls, provides lessons regarding naïve CD4 T-cell compartment homeostasis in 
healthy, with particular implications for aging. Our data show, for the first time that IL-
7 contributes to naïve-Treg homeostasis and to a thymus-independent survival of 
functional naïve-Tregs and point to the requirement of ongoing thymopoiesis to the 
maintenance of IL-7-driven homeostatic proliferation of conventional naïve CD4 T-
cells. These findings have important implications to lymphopenic clinical settings and 
aging, supporting the future appraisal of strategies targeting the thymus, in order to 
maximize the homeostatic effect of IL-7. 
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